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Chemical damage to mRNA and its impact on ribosome quality-control and stress-response 
pathways in eukaryotic cells 
by 
Liewei (Leo) Yan 
Doctor of Philosophy in Biology and Biomedical Sciences 
Plant and Microbial Biosciences 
Washington University in St. Louis, 2021 
Professor Hani S. Zaher, Chair 
 
Ribosome often faces defective adducts that disrupt its movement along the mRNA template. 
These adducts are primarily caused by chemical damage to mRNA and are highly detrimental to 
the decoding process on the ribosome. Hence, unless dealt with, chemical damage to RNA has 
been hypothesized to lead to the production of toxic protein products. Even more detrimental is 
the ability of damaged mRNA to drastically affect ribosome homeostasis through stalling. This in 
turn would lead to greatly diminished translation capacity of cells. Therefore, the inability of cells 
to recognize and resolve translational-stalling events is detrimental to proteostasis and could even 
lead to disease development. No-go decay (NGD) is a eukaryotic quality control mechanism that 
evolved to cope with translational arrests. The process is characterized by an endonucleolytic 
cleavage near the stall sequence, but the mechanistic details are unclear. It was, however, unclear 
whether organisms evolved NGD to deal with RNA damage. In work presented in this thesis, I 
showed that NGD and the associated ribosome-quality control (RQC) are activated in response to 
nucleobase alkylation and oxidation. Our findings reveal that these processes are important for 
clearing chemically modified mRNA and the resulting aberrant-protein products and highlighted 
x 
 
the burden of chemically damaged mRNA on cellular homeostasis and suggest that organisms 
evolved mechanisms to counter their accumulation.  
In addition to activating RQC, stalling has been recently linked to the activation of the 
integrated-stress response (ISR) by Gcn2, suggesting that the activation of the two processes are 
likely to be coordinated. To investigate this potential coordination, I preformed genetic and 
biochemical analysis in yeast. My data revealed that activation of RQC by Hel2 suppresses that of 
Gcn2. I further showed that Hel2 and Gcn2 are activated by a similar set of agents that cause 
ribosome stalling, with maximal activation of Hel2 observed at a lower frequency of stalling. 
Interestingly, inactivation of one pathway was found to result in the overactivation of the other, 
suggesting that both are activated by the same signal of ribosome collisions. Notably, the processes 
do not appear to be in direct competition with each other; ISR prefers a vacant A site, whereas 
RQC displays no preference. Collectively, our findings provide important details about how 





CHAPTER 1: How do cells cope with RNA 
damage and its consequences? 
 






Similar to many other biological molecules, RNA is vulnerable to chemical insults from 
endogenous and exogenous sources. Noxious agents such as reactive oxygen species or 
alkylating chemicals have the potential to profoundly affect the chemical properties and hence 
the function of RNA molecules in the cell. Given the central role of RNA in many fundamental 
biological processes, including translation and splicing, changes to its chemical composition can 
have a detrimental impact on cellular fitness, with some evidence suggesting that RNA damage 
has roles in diseases such as neurodegenerative disorders. We are only just beginning to learn 
about how cells cope with RNA damage, with recent studies revealing the existence of quality-
control processes that are capable of recognizing and degrading or repairing damaged RNA. 
Here, we begin by reviewing the most abundant types of chemical damage to RNA, including 
oxidation and alkylation. Focusing on mRNA damage, we then discuss how alterations to this 
species of RNA affect its function, and how cells respond to these challenges to maintain 
proteostasis. Finally, we briefly discuss how chemical damage to noncoding RNAs such as 





Biomolecules possess unique chemical properties that are essential for their function. Yet, 
the overabundance of reactive species in both the environment and within living cells constantly 
threaten these properties (Simms and Zaher, 2016; Wurtmann and Wolin, 2009). Unwanted 
modifications to the chemical structure of nucleic acids, proteins, lipids or carbohydrates often 
result in drastic effects on the ability of these molecules to carry out these functions. Changes to 
proteins, for example, are known to cause misfolding and aggregation, and the inability of cells to 
degrade these aberrant protein products has been associated with disease states (Chondrogianni et 
al., 2014; Stefani, 2004). Similarly, lipid peroxidation contributes to the pathogenicity of several 
diseases (Mylonas and Kouretas, 1999). Due to the reactivity of the oxygen and nitrogen atoms on 
the nucleobase, nucleic acids are especially susceptible to certain types of chemical damage from 
sources such as reactive oxygen species (ROS), ultraviolet light (UV), and alkylating agents 
(Wurtmann and Wolin, 2009) (Figure 1A). The oxygen atoms of the ribose and the phosphodiester 
backbone are also vulnerable to chemical damage (Figure 1B). In the case of DNA, and most RNA 
species, small changes have the ability to severely affect their structure and hence their function 
(Lindahl T, 1993). This is due to the fact that, by-and-large, nucleic acids require strict Watson-
Crick base pairs between the nucleobases.  
Since DNA damage can lead to permanent alteration of genomic information, it is not 
surprising that organisms from E. coli to humans evolved exquisite and conserved pathways to 
repair it and respond to it. Given their importance in maintaining genomic integrity together with 
their role in cancer biology, DNA-repair pathways have been extensively studied for more than 




is vulnerable to the same chemical insults, and, as we shall see later, is damaged to a much larger 
extent (Wurtmann and Wolin, 2009). However, until recently the processes by which cells might 
cope with this type of damage was largely ignored likely due to the assumption that the transient 
nature of RNA means that damage to it does not matter. This, for example, is true for bacteria, 
whose mRNAs are known to turn over rapidly with half-lives measured in minutes (Deutscher, 
2006; Ross, 1995). In contrast, functional RNAs like tRNAs and rRNAs are long lived (Deutscher, 
2006; Johnson et al., 1976), and as a result any alteration to their chemical structure could have 
long-lasting effects. Furthermore, many mRNAs in mammals, and especially in certain cell types 
like neurons, are very stable with day-long half-lives (Bolognani and Perrone-Bizzozero, 2008). 
Therefore, modifications to the mRNA that affect its base-pairing properties are likely to lead to 
defects in protein synthesis. Unless cells have pathways to recognize and degrade/repair mRNAs, 
chemical damage to mRNA is highly likely to result in the accumulation of aberrant protein 
products and/or stall ribosomes. Indeed, emerging evidence strongly suggests that quality control 
for damaged RNA is vital to cell survival and should not be ignored (Simms and Zaher, 2016; 
Simms et al., 2014). To this end, the accumulation of damaged RNA has been correlated with the 
development of several neurodegenerative diseases (Fimognari, 2015; Nunomura et al., 2007; 
Simms and Zaher, 2016; Wurtmann and Wolin, 2009).  
This review is divided into two main sections: the first one is focused on the chemistry of 
different types of RNA damage, and how they affect its chemical and functional properties; the second is 
focused on the cellular mechanisms that are likely to respond to damaged RNA. In particular, we discuss 






Figure 1. Effects of alkylation and oxidation on the chemical structure of RNA.  
A) Structures of the four RNA nucleobases with the location of common oxidation sites (red 
arrows) and alkylative damage sites (blue arrows) marked. B) Targets of chemical insults (mainly 
alkylative damage) to the phosphodiester backbone and 2’-OH of the ribose. C) The reaction 
between a  hydroxyl radical and guanosine, forming the 8-oxoG adduct. D) The reaction between 
MNNG and guanosine, which forms the O-alkyl adduct O6-mG (Top). The bottom shows the 
reaction between MMS and adenosine forming the N-alkyl adduct m1A. E) Common modified 
bases that result from chemical insults: Alkylative adducts, grouped by the position of 
modification: O-alkyl adducts: O6-methylguanosine (O6-mG), O4-methyluridine (O4-mU); N-
alkyl adducts: N1-methyladenosine (m1A), N3-methyladenosine (m3A), N3-methylcytidine 
(m3C), N1-methylguanosine (m1G), N7-methylguanosine (m7G); Oxidative adducts: 8-oxo-7,8-
dihydroguanosine (8-oxoG), 8-oxo-7,8-dihydroadenosine (8-oxoA). F) Damaged nucleobases 
disrupt base pairing. The base pairing between adenosine and uridine (top) is disrupted by the 





Chemistries of RNA damage 
Reactive oxygen species. The highly-reactive-superoxide anion (O2•−) is a key component of ROS 
and is produced in eukaryotes under normal physiological conditions by a number of cytosolic 
enzymes and membrane-bound ones (Sohal and Weindruch, 1996). It is essential for stress 
responses, maintenance of the redox state, inflammation, autophagy and signal transduction 
(Schieber and Chandel, 2014). However, the levels of O2•− need to be carefully monitored as high 
levels of superoxide are known to cause cellular damage and even death (Fimognari, 2015). High 
levels of O2•− are produced through side reactions between molecular oxygen (O2) and reduced 
nicotinamide adenine dinucleotide (NADH) and flavin adenine dinucleotide (FADH2) in the 
electron-transport chain in the mitochondria (Murphy, 2009). Thus, the mitochondria, and hence 
cellular respiration, are considered as the major endogenous source of ROS production, including 
both O2•− and hydrogen peroxide (H2O2). In addition to the mitochondria, recent studies on human-
liver cells reported that other organelles such as peroxisomes, microsomes and the endoplasmic 
reticulum are also capable of producing high levels of ROS (Brown and Borutaite, 2012; Casas-
Grajales and Muriel, 2017).  
The highly reactive nature of O2•− makes it exceptionally harmful because as it reacts, it 
generates even more ROS such as hydroxyl radical (•OH), perhydroxyl radical (HO2•) and 
hydrogen peroxide H2O2 (Lü et al., 2010). Due to their ability to severely disrupt the integrity of 
biological molecules, organisms evolved multiple pathways to rid cells of ROS (Imlay, 2008). 
These include superoxide dismutase, which catalyzes the dismutation of O2•− into molecular 
oxygen and hydrogen peroxide (Fukai and Ushio-Fukai, 2011), and catalase, which catalyzes the 




Even with the presence of these mechanisms, disruption of the normal redox state of cells by 
exposure to oxidative agents or aging often leads to the accumulation of free radicals and peroxides 
resulting from an imbalance between the production and detoxification of ROS (Hopkins and 
Neumann, 2019). Under these conditions, pathways such as Haber-Weiss, the Fenton reaction, or 
diethylnitrosamine (DEN) metabolism generate the highly reactive •OH radical (Kehrer, 2000). 
Reactions with •OH have been suggested to be the main source of oxidative damage to nucleic 
acids. Besides •OH, H2O2 is known to elicit damage (Imlay et al., 1988); while singlet-oxygen 
species (1O2), which are produced by wounding or photooxidative stresses, oxidize both RNA and 
DNA (Neeley and Essigmann, 2006). In addition to these endogenous sources, exogenous factors 
including X- and gamma-rays, ultraviolet radiation and toxic compounds from air pollution, 
tobacco and xenobiotics such as drugs, environmental agents and natural compounds are known 
to generate ROS (Cadet and Wagner, 2013).  
Oxidation adducts. The reaction of •OH with free nucleobases, nucleosides, nucleotides and 
nucleic acids abstracts H from C⎯H bonds (Dizdaroglu and Jaruga, 2012; Fimognari, 2015). This 
results in the production of numerous distinct modifications on nucleic acids such as 8-oxo-7,8-
dihydroguanosine (8-oxoG) (Figure 1C), 8-oxo-7,8-dihydroadenosine (8-oxoA), 5-
hydroxyuridine (5-HO-U), 5-hydroxycytidine (5-HO-C), and cytosine glycol (Casas-Grajales and 
Muriel, 2017; Dizdaroglu and Jaruga, 2012; Fimognari, 2015). Furthermore, products such as 2,6-
diamino-4-hydroxy-5-formamidoguanine (FapyG) and 4,6-diamino-5-formamidoadenine 
(FapyA) are also formed as intermediates during the process of generating 8-oxoG and 8-oxoA 




lipid peroxidation is also known to introduce oxidative damage to the nucleobase and generate 
etheno-adducts 1,N6-ethenoadenosine (-rA) and 3,N4-ethenocytidine (-rC ) (Blair, 2008).  
Of the oxidized adducts, oxidation of the guanine base to form 8-oxoG is most notable 
mainly because of its abundance and its effect on the structure of DNA and RNA. The 
accumulation of 8-oxoG in RNA and DNA is driven by the low reduction potential of G among 
all 5 bases (Casas-Grajales and Muriel, 2017; Simms and Zaher, 2016). Under normal 
physiological conditions, the frequency of 8-oxoG in RNA has been estimated to be 1 per 105 of 
unmodified G (Shen et al., 2000). This ratio increases dramatically, as much as 10 fold, under only 
mild oxidative stress such as that experienced during conditions of inflammation (Shen et al., 2000; 
VALAVANIDIS et al., 2009). In addition to its abundance, the modification has a profound effect 
on the structure of the nucleotide and its ability to form a Watson-Crick base pair. The steric clash 
between the oxygen at carbon 8 and the phosphate group at carbon 5 forces the nucleotide to form 
the less favorable syn conformation (Sampoli Benítez et al., 2013). In this conformation, 8-oxoG 
base pairs with A and is the basis of its mutagenic potential during DNA replication (Hsu et al., 
2004; Sampoli Benítez et al., 2013). As we shall see later, 8-oxoG severely disrupts RNA-RNA 
interactions and has a drastic effect on decoding during translation.  
Alkylating agents. Similar to oxidizing agents, alkylating chemicals are widespread; they are 
found endogenously, as a result of cellular metabolism, and exogenously in the environment 
(Drabløs et al., 2004). Endogenous alkylating agents include the universal-methyl donor S-
adenosyl methionine (SAM), nitrosated amines and bile acids. SAM is notable due to its relatively 
high cellular concentration, in the mM range (Hoffman et al., 1980), which overcomes its weak 




number of adducts (Rydberg and Lindahl, 1982). In contrast to SAM, nitrosated amines and bile 
acids result from enzymatic-side reactions (García-Santos et al., 2001). In starving bacterial cells, 
nitrosation of glycine and its derivatives forms N-alkyl-N-nitroso compounds which readily react 
with G to form O6-methylguanosine (O6-mG) (Shuker and Margison, 1997; Taverna and 
Sedgwick, 1996) (Figure 1D). In the intestine, nitrosation of bile acids forms highly reactive O-
alkylating agents and has been associated with elevated levels of methylated bases (Acid et al., 
1985). 
 Among environmental alkylating chemicals, halogenated hydrocarbons are the most 
abundant. For example, chloromethane is produced naturally by plants and fungi, and artificially 
through industrial processes (Gribble, 1994; Hamilton, 2003; McCulloch et al., 1999). In contrast 
to chloromethane, which is found predominantly in the atmosphere, bromomethane and 
iodomethane are mainly found in marine environments (Ballschmiter, 2003). These compounds 
readily react with nucleic acids (Bolt and Gansewendt, 1993), but their contribution to RNA 
damage is unknown given their overall low concentrations. Unlike halocarbons, N-nitroso 
compounds are not abundant in the environment, but they pose the most significant risk to humans 
because of their association with tobacco smoke and certain food compounds. Tobacco smoke 
contains many nitrosamines, which when metabolized by cells are activated to form potent 
alkylating agents (Hecht, 1999). Food products- especially those that are overcooked, smoked and 
cured- contain nitrosoamines and nitrosating agents that are carcinogenic through their mutagenic 
effect on DNA (Song et al., 2015). Finally, some of the most well-known alkylating agents are 
those used as chemotherapeutic agents and their reactivity with nucleic acids is the precise reason 




and Temodar, which are all known to modify RNA in addition to DNA (Bellacosa and Moss, 
2003). The efficacy of many of these drugs in treating cancer to a large extent relies on their ability 
to modify RNA and alter its function. 
Alkylative adducts. Nucleobases, sugars and the phosphate backbone of DNA and RNA harbor 
oxygen and nitrogen atoms that are all susceptible to modification by alkylating agents. In general, 
O-alkyl adducts are highly mutagenic and genotoxic (Margison et al., 2002) because they alter the 
base-pairing preference of the nucleobase. This is best exemplified by O6-alkylguanosine (O6-
AlkylG), such as O6-mG, and O4-alkylthymidine or O4-alkyluridine, such as O4-mU. O6-mG 
readily base pairs with U, whereas O4-mU readily base pairs with G (Eadie et al., 1984; Preston 
et al., 1986) (Figure 1E). The geometry of both base pairs is indistinguishable from that of 
Watson-Crick ones explaining their highly mutagenic nature (Warren et al., 2006). N-alkylation, 
in contrast, is generally cytotoxic because it disrupts base pairing during template-driven 
processes. Cytotoxic modifications include N1- and N3-alkyl adducts of A (e.g: m1A and m3A), 
and N3-alkyl adducts of C (e.g: m3C). These modifications alter either: the Watson-Crick face of 
the nucleobase and introduce a bulky group, which prevents base-pairing from taking place; or the 
minor groove, which disrupts the mechanism by which polymerases and likely the ribosome 
monitor the base-pair geometry (Figure 1F). Interestingly one of the most prevalent modifications 
that results from alkylation stress is m7G (Figure 1E), which neither disrupts hydrogen bonding 
required for base pairing nor the minor groove of the base pair (Soll et al., 2017). However, this 
modification affects binding of proteins that recognize the major groove of helices (Ezaz-Nikpay 
and Verdine, 1994), and also accelerates the depurination of the nucleotide (Boysen et al., 2009). 




 It is also worth noting that the chemotherapeutic drugs of doxorubicin, 5-fluorouracil and 
cisplatin do not alkylate RNA directly but modify RNA through their reactions. This reactivity 
with RNA appears to be important for their effectiveness in treating cancer. Doxorubicin 
intercalates into RNA helices, which affects the activity of many functional RNAs (Zhu et al., 
1999). 5-fluorouracil is metabolized by the cell into a nucleotide triphosphate that is utilized by 
RNA polymerases and, as a result, is incorporated into RNA (Pettersen et al., 2011). Cisplatin 
forms cross-links on the ribosome and inhibits translation (Heminger et al., 1997). Recent 
structural studies of cisplatin-induced Pt-RNA adducts on the ribosome offered some clues about 
how the drug inhibits translation (Melnikov et al., 2016). Many of the sites on the ribosome that 
are modified by cisplatin encompass functionally important regions that include the GTPase center 
and the mRNA channel of the ribosome. Therefore, not only is RNA damage likely to pose 
significant challenges to organisms, but it can also be utilized to treat tumors.  
Susceptibility of RNA to damage 
Although RNA undergoes analogous biochemical reactions to those documented to occur 
between DNA and ROS or alkylating agents (Simms and Zaher, 2016), it has been long predicted 
that RNA molecules, especially mRNAs, are more prone to chemical damage than DNA for 
various reasons. 1) mRNA is on average 30-40% single-stranded; as a result the nucleobase on 
RNA is more vulnerable to chemical modification due to its unprotected Watson-Crick face. In 
DNA, this is protected because it participates in hydrogen-bonding with the complementary strand 
(Cobley et al., 2018; Hofer et al., 2005; Jr et al., 2003). 2) In eukaryotic cells, unlike DNA, mRNA 
typically lacks the protection afforded by proteins such as histones (Cobley et al., 2018; Simms 




DNA from exogenous agents that have to travel through the cytoplasm to access it (Cobley et al., 
2018; Simms and Zaher, 2016); in fact, the close proximity of RNA to mitochondria in the cytosol 
has been proposed as a potential source of oxidative damage to the RNA pool (Nunomura et al., 
1999). 4) the pool size of ribonucleotides is hundreds of times larger than that of 2’-
dexoyribonucleotides (Traut, 1994), and as a result modifications are more likely to get 
incorporated into RNA during transcription relative to DNA incorporation during replication; to 
this end, oxidized and alkylated NTPs have been measured to accumulate to much higher levels 
relative to modified dNTPs (Fiala et al., 1989; Hofer et al., 2006; Nunomura et al., 1999).  
In support of these predictions, findings from numerous reports have revealed that the same 
damage to a nucleobase accumulates to much higher levels in RNA relative to DNA under both 
oxidative and alkylative conditions (Cobley et al., 2018; Hofer et al., 2005). For instance, a recent 
study showed that human lung epithelial cells accumulate the oxidative adduct 8-oxoG to levels 
that are 14-25 times higher than 8-oxodG when challenged with hydrogen peroxide (Hofer et al., 
2005). Similarly, UV-A radiation induces approximately a seven-fold higher degree of RNA 
oxidation over DNA in human skin fibroblast cells, while the hepatocarcinogen 2-nitropropane 
leads to considerably more RNA oxidation over DNA (Fiala et al., 1989; Wamer and Wei, 1997).  
Among the different types of RNA species, the degree to which they associate with proteins 
and their secondary structure appear to be important for the extent a certain RNA is vulnerable to 
chemical damage (Görg et al., 2008). As a-case-in point, a recent report indicates that mRNA 
harbors fivefold higher 8-oxoG levels when compared to total RNA, which consists mainly of 
rRNA and tRNA that adopt complex tertiary structures and are bound by proteins (Simms et al., 




significantly. Certain transcripts and regions within them appear to be more vulnerable to oxidative 
damage than others, in an abundance-independent manner (Chang et al., 2008; McKinlay et al., 
2012; Shan et al., 2003a). Many factors have been speculated to contribute to these differences 
(Núñez et al., 1999). For instance, sequence identity and context play important roles, especially 
given that the oxidation of guanosine relies heavily on the neighboring nucleotides (Núñez et al., 
1999). Additionally, the level of association with RNA-binding proteins, translation efficiency and 
secondary-structural differences affect the reactivity between the mRNA and damaging agents 





Figure 2. Chemical damage to RNA could affect multiple steps of translation.  
At the center is a schematic highlighting a eukaryotic mRNA being translated. Damage might alter 
the structure of the rRNA, the tRNA and the mRNA. On the rRNA, modifications could affect 
important functional sites of the ribosome. Shown are the peptidyl-transferase center (PTC), the 
GTPase activation center (GAC) and the decoding center (DC). On the tRNA, modifications to the 
anticodon and acceptor stem, for example, could affect decoding and aminoacylation, respectively. 
On the mRNA, modifications to the coding sequence could affect the speed and accuracy of 




Damaged mRNA and the ribosome 
A priori, chemical modification to the mRNA could have three distinct effects on its 
function during translation (Figure 2): 1) Modifications that do not alter base pairing between the 
codon and anticodon interaction are expected to have no effect on protein synthesis. 2) 
Modifications that change the base-pairing preference of nucleotides are expected to result in 
miscoding and production of proteins with errors. 3) Modification that disrupts base-pairing 
altogether are expected to stall the ribosome and lead to the production of abortive protein 
products. Obviously the latter two are detrimental to proteostasis and potentially necessitates the 
evolution of pathways to cope with them. This is especially true for the last one, which in addition 
to producing truncated protein products sequesters valuable ribosomes and prevents them from 
carrying out their function (Figure 2). 
Although one could learn a lot about how modifications to the nucleobase affect translation 
from equivalent studies conducted on DNA polymerases, the fact that the ribosome reads three 
nucleotides at a time makes the decoding process somewhat different from replication. 
Furthermore, the RNA-rich decoding center and the mechanism by which it recognizes the codon-
anticodon minihelix is quite different from the active site of polymerases, which is made entirely 
of amino acids (Zaher and Green, 2009). These distinctions between the ribosome and DNA 
polymerases are best exemplified by studies characterizing the effect of 8-oxoG on translation. 
During DNA replication, the oxidative adduct 8-oxoG is highly mutagenic, when it adopts a syn 
conformation and base pairs with A (Hsu et al., 2004). During translation, the modification stalls 
translation and causes little to no miscoding (Simms et al., 2014). Indeed, initial studies by Shan 
et al. found that the yield of protein synthesis from RNAs containing 8-oxoG is significantly lower 




hydrogen peroxide and transfected into cell culture produce significantly less functional proteins 
in a transcript-level-independent manner (Shan et al., 2003b). These observations suggest that 
oxidation of mRNA disrupts protein synthesis and likely stalls elongation by the ribosome. 
Consistent with these ideas, studies by Tanaka et al. showed that oxidized mRNAs associate with 
polysomes but produce much less protein products (Tanaka et al., 2007). Since RNA oxidation 
results in a myriad of modifications, it is difficult to assess which one of these modifications is 
responsible for stalling the ribosome. Later studies by our group showed that 8-oxoG reduces the 
rate of peptide-bond formation by up to four orders of magnitude using a well-defined in vitro 
system (Simms et al., 2014). Interestingly, this effect on decoding is independent of the position 
of the adduct in the codon. In particular, the third position, which allows for unusual base pairing 
between the codon and the anticodon, is equally sensitive to the presence of the modification. 
Based on these observations from multiple groups, it is now generally accepted that 8-oxoG- 
contrary to its effect during DNA replication- does not cause miscoding, but instead is highly 
disruptive to translation and leads to the generation of truncated protein products.  
In contrast to RNA oxidation, which has been investigated by a number of groups, only a 
couple of studies have explored the effect of alkylation damage to mRNA on translation. In one 
study from our group, we examined the effect of O6-mG on decoding using a bacterial 
reconstituted system (Hudson and Zaher, 2015). This adduct is notable as it is highly mutagenic 
during DNA replication, whereby the O6-mG:T base pair is almost indistinguishable from a 
normal Watson-Crick base pair such that mismatch repair is unable to recognize it (Warren et al., 
2006). Instead organisms dedicate specialized ‘suicide’ methyltransferases to recognize and repair 




U but only at the first position of the codon. At the second position, the adduct was found to reduce 
peptide-bond formation by almost three orders of magnitude (Hudson and Zaher, 2015). Again, 
these observations highlight not only the differences between the ribosome and DNA polymerases, 
but also the position-dependent effects of these modifications on decoding.  
N-alkyl adducts, in contrast to O-alkyl ones, tend to be more cytotoxic and less genotoxic 
on DNA as they lead to stalled polymerases (Malvezzi et al., 2017). Whether these modifications 
stall the ribosome during translation was unknown until recently. In particular, You and colleagues 
examined the effect of three N-alkyl modifications on translation efficiency and fidelity using 
bacterial and eukaryotic extracts (You et al., 2017). As expected, based on its deleterious effect on 
base pairing, m1A was found to severely reduce protein-synthesis yield regardless of its position 
within the codon (You et al., 2017). The severity of the effect, especially at the third position, 
highlights the deleterious effect of the substitution on the codon-anticodon interaction. 
Surprisingly, the modification appears to have no effect on the fidelity of translation. Interestingly, 
m1G inhibits protein synthesis only when placed at the first and second position of the codon (You 
et al., 2017). At the third position, the modification has no apparent effect on protein-synthesis 
yield, which is consistent with the promiscuity of tRNA selection at this position. Why m1A and 
m1G affect decoding disparately at the third position, even though the methyl group is added to 
same N1 of the purine, can be explained by the introduction of a positive charge in the case of 
m1A and not m1G. These observations suggest that, in addition to the effect on hydrogen-bonding 
interactions, other parameters, like charge differences, need to be taken into account when 
assessing how modifications might affect tRNA selection. Finally, N-alkyl modifications that do 




synthesis yield and fidelity (You et al., 2017). These include “unintentional” modifications, which 
are not known to occur naturally in mRNAs such as m2G, and “intentional” ones, which occur 
naturally in mRNAs such as m6A (Hudson and Zaher, 2015), (You et al., 2017).  
Ribosome-based-quality control of aberrant mRNAs that stall translation 
As highlighted earlier, damage to mRNA, depending on its type, is highly detrimental to 
its decoding capacity and unless dealt with could lead to the production of toxic protein products. 
Even more detrimental is the ability of damaged mRNA to drastically affect ribosome homeostasis 
through stalling. In particular, since multiple ribosomes typically occupy one mRNA during 
translation, a single stalling event, such as the presence of a single 8-oxoG modification, could 
lead to queuing of multiple ribosomes (Figure 2), sequestering them from the translating pool. 
This in turn would lead to greatly diminished translation capacity for cells, especially those under 
oxidative stress. Therefore, the inability of cells to recognize and resolve translational-stalling 
events is detrimental to proteostasis and could even lead to disease development (Chu et al., 2009; 
Ishimura et al., 2014). In this section, we discuss the role of the ribosome in recognizing and 
targeting defective mRNAs for degradation.   
Recent studies have identified conserved processes in eukaryotes that evolved to resolve 
these stalling events and rescue stuck ribosomes (Brandman and Hegde, 2016; Shoemaker and 
Green, 2012; Simms et al., 2017a) (Figure 3). In addition, these processes are coupled to the 
degradation of the aberrant mRNA and incomplete peptide product. As a result, the ribosome 
appears to be at the center of quality control of aberrant mRNAs and the encoded protein products 
(Brandman and Hegde, 2016; Shoemaker and Green, 2012; Simms et al., 2017a). We note that 




that harbor genetically-encoded-stalling sequences, one could easily infer that they are also likely 
to be activated in response to chemically-modified mRNAs. Indeed, the inactivation of some of 
these processes leads to the accumulation of damaged mRNA and renders cells sensitive to 
chemical insults (Simms et al., 2014). 
In eukaryotes, quality-control processes that are triggered by stalling events accomplish 
three tasks to alleviate stalling-induced translational stresses: 1) degradation of the aberrant 
mRNA, 2) degradation of the nascent peptide, and 3) ribosome rescue (Figure 3). mRNA 
degradation proceeds through a process called no-go decay (NGD), which initiates with an 
endonucleolytic cleavage of the mRNA (Doma and Parker, 2006; Tsuboi et al., 2012). Protein 
degradation is mediated by a process termed ribosome-quality control (RQC), which involves 
ubiquitination of the incomplete peptide and subsequent proteolysis by the proteasome (Bengtson 
and Joazeiro, 2010; Brandman et al., 2012; Defenouillere et al., 2013). Ribosome rescue is carried 
out by three factors: Dom34 in yeast (Pelo in mammals), Hbs1 and Rli1 (ABCE1 in mammals) 
that bind the A site of the ribosome and catalyze the dissociation of the two subunits (Pisareva et 
al., 2011; Shoemaker and Green, 2011; Shoemaker et al., 2010).  
These three processes are triggered by the same originating signal of ribosome stalling, but 
how this signal is propagated to activate them and coordinate these activities remained poorly 
understood until recently. Initial clues came out of studies showing a ubiquitin E3 ligase (Hel2 in 
yeast and Znf598 in mammals) is required for stalling (Letzring et al., 2013; Saito et al., 2015). In 
particular, its deletion results in ribosomes reading through stall sequences (Sitron et al., 2017). 
Hel2 was later found to add K63-linked-ubiquitin chains to a number of ribosomal proteins and 




mammals) (Juszkiewicz and Hegde, 2017; Sundaramoorthy et al., 2017). Some of the first studies 
of Hel2 suggested that it recognizes an unusual conformation that the ribosome adopts during 
stalling (Matsuo et al., 2017). However, a later study by our group showed that ubiquitination by 
the factor requires ribosomes to collide into each other, which is also critical for NGD to occur 
(Simms et al., 2017b). Subsequent cryoEM structures from the Hegde, Ramakrishnan, Beckmann 
and Inada groups provided a molecular rationale for these observations (Ikeuchi et al., 2019; 
Juszkiewicz et al., 2018). Collided ribosomes provide an interface that can be recognized by the 
E3 ligase to ubiquitinate its target proteins. In agreement with these observations, Znf598 and Hel2 
appear to prefer higher-order structures of polysomes during their ubiquitination reactions (Ikeuchi 
et al., 2019; Juszkiewicz et al., 2018). 
How ubiquitination mediates the downstream events of NGD, RQC and ribosome rescue 
is not fully understood. However, we are beginning to learn about how certain ribosomal proteins 
ubiquitination contributes to these processes. In particular, in a recent study, Inada and colleagues 
showed that ubiquitination is required for the activation of both NGD and RQC (Ikeuchi et al., 
2019). Deletion of HEL2 saves the aberrant mRNA and prevents the nascent peptide from 
degradation. NGD, in contrast, is divided into two branches depending on the identity of the 
ubiquitinated ribosomal protein (Ikeuchi et al., 2019). The first branch called the RQC-dependent 
branch requires the ubiquitination of ribosomal protein uS10 (Ikeuchi et al., 2019). In this branch 
of NGD, the cleavage occurs in the vicinity of the lead ribosome. The second branch of NGD, 
whose efficiency depends on whether the first one takes place or not, is called RQC-independent 
and it requires monoubiquitination of ribosomal protein eS7 by another E3 ligase, Not4, and 




upstream of the lead ribosome (Ikeuchi et al., 2019) (Figure 3). These findings strongly suggest 
cleavage of the mRNA is mediated by at least two endonucleases. How these ubiquitination 
reactions recruit the endonucleases is currently unknown.  
As stated before, NGD is initiated by endonucleolytic cleavage reactions in the vicinity of 
stalled ribosomes (Figure 3). This leads to the production of at least two mRNA fragments: a 5’-
end one that lacks a polyA tail and is rapidly degraded by the cytoplasmic exosome, and a 3’-end 
one that lacks a cap structure and is rapidly degraded by the major 5’-3’ exonuclease Xrn1 (Doma 
and Parker, 2006; Tsuboi et al., 2012). The identity of the endonucleases remained unknown for a 
long time, but in a very recent study, D’Orazio and colleagues identified the conserved factor Cue2 
as one of the endonucleases that contributes to NGD (D’Orazio et al., 2019). Using a reverse-
genetic screen, overexpression of Cue2 was found to reduce the level of protein production from 
a stalling reporter suggesting that it contributes to NGD. The overexpression screen was necessary 
to identify Cue2’s activity because of the two branches of NGD and the potential existence of a 
second endonuclease. In particular, in the absence of Cue2, NGD could still occur in a process that 
depended on Xrn1 (D’Orazio et al., 2019). Only in the absence of Xrn1 does the Cue2-dependent 
branch dominate (D’Orazio et al., 2019). Arguably, what makes Cue2 interesting is its domain 
architecture. The factor contains CUE (coupling of ubiquitin to ER degradation) ubiquitin-binding 
domains and putative-UBA (ubiquitin-associated domain) domains, which could allow it to bind 
ubiquitin and hence be recruited to ubiquitinated-stalled ribosomes. Furthermore, the C-terminal 
domain of the enzyme contains an SMR (small MutS related) hydrolase domain. Some SMR-
containing plant proteins exhibit an endonucleolytic activity. Indeed, D’Orazio and colleagues 




Perhaps most interesting about Cue2’s SMR domain is its likelihood to adopt a structure similar 
to the bacterial initiation factor 3 (IF3) based on modeling studies. IF3 binds the ribosome near the 
P and A site close to the mRNA-entry channel. In sum, Cue2 has ubiquitin-binding domains and 
harbors an SMR domain with a putative endonuclease activity that could bind the ribosome near 
where the mRNA would reside. Indeed, ribosome profiling by the same group showed the factor 
to cleave mRNA in the A site of the collided ribosome (D’Orazio et al., 2019).  
Ribosome rescue is most likely to proceed after the initial cleavage as the ribosome runs to 
the end of the mRNA and ends up displaying an empty A site and has a peptidyl-tRNA in the P 
site. As we shall see later dissociation of the two subunits needs to be completed for RQC to occur. 
Two pieces of evidence suggest that rescue occurs after the initial cleavage. First, structural and 
biochemical studies have shown a requirement for little to no mRNA downstream of the P site in 
order for the dissociation reaction to take place efficiently (Pisareva et al., 2011; Shoemaker and 
Green, 2011). The N-terminal domain of the GTPase Hbs1, which is required for the rescue 
reaction, binds in the mRNA entry channel and would sterically clash with the mRNA if it were 
present (Becker et al., 2011). Additionally, a steric clash between Dom34 and the mRNA would 
exist, preventing both factors from binding unless the mRNA is cleaved (Hilal et al., 2016). 
Second, deletion of Dom34 results in multiple secondary cleavage reactions that take place further 
upstream of the initial stall sequence (Ikeuchi and Inada, 2016; Simms et al., 2017b). Hence, 
inhibition of subunit dissociation leads to a ribosome pile up, which results in spreading of 
ubiquitination by Hel2 and more cleavage reactions by Cue2 and the second unknown 




Following ribosome rescue, the incomplete peptide attached to the peptidyl-tRNA remains 
associated with the large-ribosome subunit (60S) (Figure 3). The peptidyl-tRNA-bound 60S 
constitutes an unusual complex that is easily recognized by components of RQC (Brandman et al., 
2012; Defenouillere et al., 2013). The E3 ligase Ltn1 (Listerin in humans) recognizes this atypical 
form of the 60S subunit and, in addition to preventing the reassociation of the 40S subunit, adds 
K48-linked ubiquitin to the peptidyl-tRNA (Bengtson and Joazeiro, 2010; Brandman et al., 2012). 
Additional specificity is afforded by Rqc2, which along with making contacts with the tRNA, 
binds an interface on the 60S subunit that would otherwise be used to bind the 40S subunit (Figure 
3). Rqc2 exhibits an unusual activity, for which it adds untemplated alanine and threonine residues 
(Osuna et al., 2017; Shen et al., 2015). The role of this so-called CAT (C-terminal alanine 
threonine) tagging is controversial. One group suggested that it is used to promote protein 
aggregation, which in turn is used to signal stress (Choe et al., 2016). Another group suggested 
that it is used to move the peptide outside the exit tunnel to place lysine residues of the nascent-
peptide substrate near the active site of LTN1 (Kostova et al., 2017). In a more recent study, Sitron 
and Brandman suggested that in addition to aiding Ltn1 in recognizing structured proteins, CAT 
tails serve as a degradation signal for incomplete peptides as a failsafe for peptides that escape 
Ltn1 (Sitron and Brandman, 2019). Regardless of the role of CAT tailing, the peptidyl-tRNA, once 
ubiquitinated, needs to be released from the ribosome and presented to the proteasome. This is 
accomplished by Vms1 in yeast (AZKF1 in mammals) (Figure 3). Initial data suggested that the 
factor acts like a peptidyl hydrolase, hydrolyzing the ester bond between the peptide and the tRNA 
(Verma et al., 2018). More recent biochemical data, however, showed that the factor instead 




(Kuroha et al., 2018). Following this cleavage reaction, the ubiquitinated peptide is presented to 
the proteasome for degradation by Cdc48 in a process that requires Rqc1 (Defenouillere et al., 






Figure 3. Overview of ribosome-based-quality control of aberrant mRNAs in yeast. 
 Ribosomes stall on an aberrant transcript (such as a damaged one), resulting in ribosome 
collisions. The unique structural feature of collided ribosomes is recognized by the E3 ligase Hel2 
for ubiquitination of multiple targets, including uS10 and eS7 on the 40S subunit. The 
ubiquitinated ribosomes are recognized by a number of factors, which are hypothesized to recruit 
an unknown endonuclease to cleave the mRNA and initiate NGD. In a secondary branch of NGD, 
Cue2 cleaves the mRNA in the A site of the collided ribosome. The cleaved transcript is degraded 
by Xrn1 and the exosome. The resulting ribosomes are rescued by Dom34, Hbs1 and Rli1. The 
incomplete peptide attached to the peptidyl-tRNA on the 60S subunit is recognized and 
ubiquitinated by another E3 ligase Ltn1. Carboxy-terminal alanine and threonine residues (CAT 
tails) are added to the nascent peptide by Rqc2 to help expose lysine residues to the active site of 
Ltn1 and/or mark the nascent peptide for degradation in an Ltn1-independent manner. Released 
from the ribosome by Vms1, the ubiquitinated polypeptides are presented to the proteasome for 





Ribosome-independent recognition of damaged mRNA 
 As detailed above, the ribosome plays a critical role in recognizing aberrant mRNAs and 
targeting them for degradation, which makes sense since it is the only machine that sees every 
single mRNA. Nevertheless, it appears that organisms may have evolved secondary mechanisms 
to recognize and degrade modified mRNA (Simms and Zaher, 2016; Wurtmann and Wolin, 2009). 
The notion that certain RNA-binding proteins are able to recognize a single modification on an 
RNA is best exemplified by the YTHDF class of proteins, which recognize m6A (Patil et al., 
2018). For example, YTHDF2 binds m6A-decorated mRNAs and delivers them to P bodies, where 
they are hypothesized to be degraded (Dominissini et al., 2012; Wang et al., 2014). It should be 
noted though, that this modification is not a damage mark, but instead serves a regulatory role for 
gene expression (for review see (Liu et al., 2019; Roundtree et al., 2017; Yang et al., 2018)). 
Some of the first studies aimed at identifying ribosome-independent factors that recognize 
damaged adducts focused on 8-oxoG. These studies revealed that bacteria and eukaryotes possess 
factors that bind 8-oxoG-containng mRNAs and target them for degradation. For instance, in 
bacteria, the 3’-5’ exonuclease polynucleotide phosphorylase (PNPase) was reported to have a 
preference for oxidized RNAs to target them for rapid degradation (Hayakawa et al., 2001; Wu et 
al., 2009). In humans, the RNA-binding protein YB-1 displays a specificity for 8-oxoG-containing 
mRNAs and is likely to promote their degradation (Hayakawa et al., 2002). In agreement with a 
role for this factor in damaged-mRNA-quality control, its overexpression renders bacteria more 
resistant to oxidative stress (Hayakawa et al., 2002). However, the protein is known to sequester 
RNAs into stress granules, which could offer a protective environment from chemical insults 
(Hayakawa et al., 2001). As a result, whether the protective phenotype induced by YB-1 




Regardless of how YB-1 functions in the quality control of damaged RNA, these observations 
suggest that compartmentalization of RNA during stress is likely to serve as an important 
mechanism for protecting it from chemical insults. 
More recent studies, using 8-oxoG-containing RNAs as bait, identified a new class of 
proteins that bind oxidized mRNA (Hayakawa et al., 2010). The most interesting quality-control 
candidate to come out of this study was AUF1 (also called HNRNPD) (Ishii et al., 2015). Not only 
does AUF1 bind 8-oxoG-containing mRNA specifically, but in its absence oxidized mRNAs are 
stabilized, suggesting that the factor might be responsible for their degradation (Ishii et al., 
2015).The same group that identified a role for AUF1 in targeting oxidized mRNA for degradation 
also identified another 8-oxoG-RNA-specific-binding protein PCBP1 (Ishii et al., 2018). In 
contrast to AUF1, which recognizes RNAs with one 8-oxoG, PCBP1 recognizes heavily oxidized 
RNAs. The factor does not promote the degradation of its target, but instead induces cell death. 
Mutations in one of the two RNA-binding KH domains, which abolish 8-oxoG binding, suppress 
the induction of apoptosis-related reactions, suggesting that its RNA-binding activity is required 
for the induction of programmed cell death (Ishii et al., 2018). These observations highlight the 
ability of cells to use damaged mRNA as a signal for stress. Interestingly, this PCBP1-mediated 
response is only activated in the presence of heavily modified RNAs (Ishii et al., 2018), which in 
turn only happens if the oxidative stress is excessive. Under these conditions, it would make sense 
to induce apoptosis. Whether cells have evolved factors that recognize other types of modifications 






 Until now our discussion has focused on quality-control pathways that degrade aberrant 
mRNAs. The transient nature of the molecule makes the utilization of such processes appropriate. 
However, as the synthesis of mRNAs requires energy, these degradative pathways are costly. 
Therefore, pathways that could repair mRNAs would save cells energy and be evolutionarily 
beneficial. It is worth noting that a precedent for this exists for repair of damaged proteins. Like 
RNA, proteins are transient, and when damaged are typically degraded through proteasome action 
or autophagy (Goldberg, 2003; Grune et al., 1997; Pickering and Davies, 2012; Vilchez et al., 
2014). Of the 20 canonical amino acids, cysteine and methionine are most susceptible to ROS. 
Oxidation of methionine results in methionine sulfoxide (Stadtman et al., 2003), whose 
accumulation may contribute to the progression of neurodegenerative disease (Schöneich, 2005). 
The enzymes methionine sulfoxide reductases are able to repair oxidized methionine (Boschi-
Muller et al., 2008). Therefore, it would not be surprising if cells evolved pathways to repair RNA. 
 Although similar to DNA, RNA lacks a complementary strand and a homologous partner. 
As a result, RNA-repair pathways may not use most of the mechanisms used for DNA repair, 
which take advantage of unaltered information contained within the complementary strand or the 
homologous chromosome. This leaves at least two direct-reversal pathways to potentially repair 
RNA: 1) methyl-guanine-methyl transferases (MGMT), which repair O6-mG (Kaina et al., 2007), 
and 2) the oxidative demethylases, which repair m1A and m3C (Dinglay et al., 1998; Jr et al., 
2003). Currently there are no reports that implicate the MGMT class of proteins in RNA repair 
and given the suicide nature of these enzymes it is difficult to imagine why cells would utilize this 
strategy to repair O6-mG-containing RNA. In contrast, the AlkB family of oxidative demethylases 




m1A and m3C, can also be products of damage, suggesting that these enzymes are capable of 
repairing damage-induced adducts. This is beside the fact that many of the AlkB enzymes prefer 
ssRNA (and ssDNA) as substrates in vitro (A. Alemu et al., 2016). This is especially true for the 
founding member of the family, the bacterial AlkB, which is capable of reactivating alkylated-
MS2 RNA phage in vivo (Jr et al., 2003; Ougland et al., 2004). The human homologue of AlkB, 
hAlkB3, displays a similar substrate specificity towards ssRNA (Falnes, 2004; Jr et al., 2003), 
suggesting that RNA repair is likely to be conserved. Perhaps the most convincing argument about 
the existence of RNA-repair pathways and their utility for cellular fitness is the observation that 
many RNA viruses encode Alkb-like proteins within their RNA genomes (van den Born et al., 
2008; Simms and Zaher, 2016). Given how compact the RNA genomes of these viruses are, this 
suggests that the process of RNA repair is very important to maintain the integrity of the polymer.  
mRNA damage and disease  
In the previous sections, we discussed the susceptibly of RNA to damage and how it 
impacts the chemical properties and function of the molecule. Naturally the next question is 
whether these alterations have any profound effect on organismal fitness. In this section, we 
discuss the connections between RNA damage and several disease states. Since an mRNA is 
translated multiple times, and in some cases more than a thousand times, a damaged mRNA has 
the potential of producing significant amounts of aberrant protein products. As defective protein 
products are more likely to misfold and aggregate, damaged mRNAs would pose significant 
challenges to tissues that are more sensitive to protein misfolding. As a result, neurons, with their 
long-life span, appear to be the most vulnerable to RNA damage (Gandy, 2005). Indeed, more than 




(Nunomura et al., 1999). Since then many studies have shown that oxidized RNAs accumulate to 
very high levels in neurons during neurodegeneration as well as through aging (Shan and Lin, 
2006). In one of the initial studies, Nunomura et al. (Nunomura et al., 1999) demonstrated that 
RNA oxidation is a distinct feature of neuronal vulnerability to oxidative stress, as samples from 
brain tissue of Alzheimer’s disease (AD) patients accumulated high levels of 8-oxoG in both 
cytoplasmic and nuclear RNA (Nunomura et al., 1999). A more recent study revealed that neuronal 
mRNA oxidation in AD patients can reach as much as 50-70% for some transcripts, while the 
percentage is less than 2% of the total mRNA pool of healthy individuals (Shan and Lin, 2006). 
Aside from AD, the accumulation of 8-oxoG in cellular RNAs has been reported in several 
neurodegenerative disorders (Bradley-Whitman et al., 2014; Chang et al., 2008; Ding, 2005; 
Nunomura et al., 2002; Shan and Lin, 2006; Zhang et al., 1999). For instance, in Parkinson’s 
disease (PD) patients, the presence of 8-oxoG can be observed in cerebrospinal fluid and serum, 
and an increase in the levels of 8-oxoG was found in substantia nigra (SN) compared to other brain 
regions (Kikuchi et al., 2002; Zhang et al., 1999). Highlighting the significance of RNA oxidation 
for neurodegeneration, the levels of oxidized RNAs have the potential to be used as a diagnostic 
marker for certain diseases. In particular, oxidized CuZnSOD mRNA can be used as an early pre-
clinical feature of ALS (Chang et al., 2008). It should be noted that, given that a hallmark of many 
neurodegenerative diseases is increased oxidative stress, the accumulation of oxidized RNA under 
these conditions could be a side effect of the disease pathogenicity. A direct causal relationship 
between oxidized mRNA and pathogenicity of neurodegenerative disease remains ambiguous 




to explore, especially in light of a convincingly demonstrated causal connection between the 
inability of cells to resolve stalled ribosomes and neurodegeneration (Ishimura et al., 2014). 
Damage to non-coding RNAs and its effect on their functions 
So far, the focus of our discussion has been on mRNA damage, but the bulk of the RNA in cells, 
~95%, is non coding (Rosenow, 2001; Westermann et al., 2012). These RNAs carry out important 
functions in the cell, which include translation, splicing, transcription, RNA-directed modification 
and regulation of gene expression (Bushati and Cohen, 2007; Esteller, 2011). For instance, rRNA 
and tRNA are essential for translation, and- given their long-lived nature- modifications that 
interfere with their function could have drastic consequences on cellular homeostasis. Unlike 
mRNA, studies addressing the effect of chemical damage to tRNA and rRNA on their function are 
sparse. However, we note that unlike mRNAs, for which the majority of the nucleotides are seen 
by the ribosome, changes to the majority of the nucleotides of rRNA would be expected to be 
tolerated (Figure 2). Most of the functional sites of the rRNA are buried within the ribosome, 
making them less accessible to reactive chemicals. Nucleotides on the surface, which are 
accessible to modification, tend to be less conserved and are often functionally unimportant. 
Nevertheless, recent studies by the Polacek group showed that the peptidyl-transferase center 
(PTC) of the ribosome is susceptible to oxidation (Willi et al., 2018). Using atomic mutagenesis, 
the authors were able to show that placing a single 8-oxoA within the PTC inhibits peptide-bond 
formation, suggesting that oxidation of the ribosome could severely disrupt its function (Willi et 
al., 2018). Equivalent studies on the effect of modification to tRNA are lacking. Nevertheless, 
changes to a tRNA’s anticodon that do not affect the aminoacylation reaction but change the base-




tRNAs harbor modifications that contain sulfur substitutions that are very sensitive to the redox 
state of cells (Nawrot et al., 2011). Many of these reside in the anticodon, and their oxidation is 
known to affect their base-pairing properties (Nawrot et al., 2011).  
How cells cope with chemical damage to rRNA and tRNA is largely unknown. It is, 
however, evident that cells have the ability to recognize defective rRNA and tRNA molecules. In 
the case of rRNA, non-functional rRNA decay (NRD) targets defective ribosomes for rapid 
turnover (Cole et al., 2009; LaRiviere et al., 2006). NRD has been studied in the context of 
ribosomes harboring mutations in the peptidyl-transferase center (PTC) of the 25S rRNA and the 
decoding center (DC) of the 18S rRNA. Interestingly, the process by which cells rid themselves 
of defective small subunits is distinct from that used to degrade defective large subunits. For 
example, 18S NRD is dependent on translation, whereas 25S NRD is not. Furthermore, 18S NRD 
is intimately coupled to mRNA surveillance as it utilizes factors that are used during NGD. In 
contrast, 25S NRD employs distinct factors and takes place prior to the assembly of the 80S subunit 
in perinuclear foci (Cole et al., 2009; LaRiviere et al., 2006). Since 18S and 25S NRD recognize 
defective ribosomes that are unable to carry out protein synthesis, it is tempting to speculate that 
these processes are induced in response to chemically-damaged ribosomes. Future research should 
be focused on exploring this potential connection and the utility of these processes in ridding cells 
of oxidized, alkylated and cross-linked ribosomes. 
Similar to rRNA, defective tRNA molecules are also subject to quality control that ensures 
that they are rapidly degraded before they can participate in translation. In particular, eukaryotes 
evolved the process of rapid-tRNA decay (RTD), which targets aberrant tRNAs (Chernyakov et 




tRNAs especially those lacking important post-transcriptional modifications. These tRNAs are 
subject to rapid decay by Rat1 in the nucleus and Xrn1 in the cytoplasm (Chernyakov et al., 2008; 
Whipple et al., 2011). It is generally accepted that these factors are able to recognize changes to 
the post-transcriptional-modification status of the tRNA through changes to its overall secondary 
structure. As alkylation and oxidation of the tRNA nucleobases are likely to induce a profound 
effect on the overall structure of the molecule, it is highly likely that RTD is also responsible for 
recognizing chemical damage to tRNA molecules. 
 What about other classes of noncoding RNAs? Almost all of these require base-pairing to 
carry out their function. Many of them are also long lived so that any changes that alter their 
function would be expected to linger unless cells have pathways to deal with them. For example, 
snRNAs are used by the spliceosome to identify splice-junction sites through base pairing (Will 
and Luhrmann, 2011); changes to this class of RNAs is likely to have profound effects on splicing 
and hence gene expression. Similarly, snoRNAs are used to guide 2’-O methylation and 
pseudouridylation on many RNAs (Watkins and Bohnsack, 2012), and changes to their base-
pairing properties could affect the specificity of these reactions and likely be detrimental to the 
function of the target molecule. As a-case-in point of the downstream effects of RNA 
modifications to functional RNAs, Wang et al. showed that oxidation of a microRNA alters its 
targets and induces apoptosis (Wang et al., 2015). How cells cope with chemical damage to these 
classes of RNAs- be it snRNAs, snoRNAs and microRNAs- is unclear and whether they evolved 




CONCLUDING REMARKS  
 As outlined here, we have been aware of the vulnerability of nucleic acids to chemical 
insults for more than half a century. We have also known how this type of damage would alter 
their chemical properties and interactions with other molecules. In particular, most modifications 
affect the base-pairing potential of nucleic acids, which in turn is arguably their most important 
feature. Interestingly, however, while DNA damage has been systematically studied for decades, 
RNA damage in contrast has received little attention. Of course, the importance of maintaining 
genomic integrity supersedes that of RNA, but that cannot fully justify this disparity. RNA plays 
a central role in many fundamental biological processes and most of these depend on its ability to 
base pair correctly. These include intermolecular ones like those between tRNA and mRNA during 
translation, snRNA and pre-mRNA during splicing, and snoRNA and rRNA during RNA-guided 
modification; but also, intramolecular ones that are responsible for maintaining the structural 
integrity of complex molecules like the ribosome. It is not surprising then that RNA damage is 
detrimental to cellular fitness and has been associated with many disease states. 
 Recent efforts from our group and others have focused on mRNA damage. These studies 
have begun to highlight how damage to this molecule affects the efficiency and accuracy of protein 
synthesis. We are also beginning to appreciate the role of the ribosome in detecting many damage-
formed adducts and triggering quality-control processes to degrade the damaged transcript. It is 
also clear that ribosome-independent mechanisms are at play to degrade or repair damaged mRNA 
that may escape recognition by the ribosome. This increased interest in how modifications affect 
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CHAPTER 2: Ribosome collision is critical 
for quality control during no-go decay 
 





No-go decay (NGD) is a eukaryotic quality control mechanism that evolved to cope with 
translational arrests. The process is characterized by an endonucleolytic cleavage near the stall 
sequence, but the mechanistic details are unclear. Our analysis of cleavage sites indicates that 
cleavage requires multiple ribosomes on the mRNA. We also show that reporters harboring stall 
sequences near the initiation codon, which cannot accommodate multiple ribosomes, are not 
subject to NGD. Consistent with our model, we uncover an inverse correlation between ribosome 
density per mRNA and cleavage efficiency. Furthermore, promoting global ribosome collision in 
vivo resulted in ubiquitination of ribosomal proteins suggesting that collision is sensed by the cell 
to initiate downstream quality control processes. Collectively our data suggests that NGD and 
subsequent quality control are triggered by ribosome collision. This model provides insight into 





During protein synthesis ribosomes face obstacles that impede their movement along the 
mRNA template (Brandman and Hegde, 2016; Simms et al., 2016). These obstacles include, but 
are not limited to, stable secondary structures, stretches of inhibitory and rare codons, poly 
lysine/arginine encoding mRNA and chemically damaged nucleotides (Doma and Parker, 2006; 
Letzring et al., 2010; Simms et al., 2014; Tsuboi et al., 2012). These events of ribosomal arrest, 
unless resolved, are detrimental to cellular homeostasis as they diminish the cellular concentration 
of available ribosomes for translation. In eukaryotes, the mRNA-surveillance process of no-go 
decay (NGD) evolved to degrade these defective mRNAs (Doma and Parker, 2006). The process 
is characterized by an endonucleolytic cleavage; the resulting 5’ and 3’ fragments are rapidly 
degraded by the cytoplasmic exosome and XRN1, respectively. Although the identity of the 
endonuclease remains elusive, the ribosome appears to play a major role in specifying the NGD 
targets as the initial cleavage reaction is dependent on translation (Doma and Parker, 2006; Tsuboi 
et al., 2012). Furthermore, the process is intimately coupled to ribosome rescue and degradation 
of the short protein products through a ribosome-associated complex (RQC) (Bengtson and 
Joazeiro, 2010; Brandman et al., 2012; Shoemaker et al., 2010). 
Ribosome rescue through disassembly of the two subunits is carried out by a ternary 
complex of Dom34 (Pelota in mammals), Hbs1 and GTP (Pisareva et al., 2011; Shoemaker et al., 
2010; Shoemaker and Green, 2011). Dom34 and Hbs1 are homologs of the eukaryotic release 
factors eRF1 and eRF3, respectively (Chen et al., 2010; Graille et al., 2008; Lee et al., 2007). 
However, Dom34 lacks the catalytically important GGQ motif required for peptide hydrolysis as 
well as the NIKS motif required for stop-codon recognition. As a result, in contrast to eRF1:eRF3-




subunit (Shoemaker et al., 2010). Recent studies have shown that this atypical form of the 60S 
subunit is recognized by the RQC (Chiabudini et al., 2012; Defenouillere et al., 2013; Shao et al., 
2015; Shao and Hegde, 2014; Shao et al., 2013; Shen et al., 2015; Verma et al., 2013). The complex 
mediates the ubiquitination, extraction and rapid degradation of the incomplete nascent peptide. In 
addition to ubiquitination of the nascent peptide, regulatory ubiquitination of ribosomal proteins 
appears to take place on stalling ribosomes. In humans the E3 ligase ZNF598 ubiquitinates several 
ribosomal proteins both in vitro and in vivo, and in the absence of the factor, stalling on polyA 
sequences is significantly alleviated (Juszkiewicz and Hegde, 2017; Sundaramoorthy et al., 2017). 
In yeast the equivalent E3 ligase HEL2 was shown to be important for stalling (Letzring et al., 
2013; Saito et al., 2015). Recent studies using ribosomal profiling have, however, argued that 
HEL2 is not required for stalling but instead in its absence mRNA reporters are stabilized (Sitron 
et al., 2017). Here, nonetheless, deletion of HEL2 results in increased ribosome occupancy (> 
twofold) beyond the stall site. Therefore, emerging from all of these studies is a potentially critical 
role for ribosomal protein ubiquitination in initiating quality control on stalled ribosomes. 
Arguably much of the emphasis on NGD to date has focused on the identification and 
characterization of trans factors that communicate with the ribosome during the process, namely 
those that are required to initiate ribosome rescue and nascent-peptide degradation. Interestingly, 
comparable studies on the role of the ribosome itself and especially its functional part in 
recognizing NGD targets are sparse. Importantly, we do not have a clear mechanistic 
understanding of the signals responsible for initiating the endonucleolytic cleavage. Additionally 
it is unclear how the ribosome and the NGD machinery distinguish between defective mRNAs and 




Discriminating between programmed pauses/stalls and those that are unwanted is paramount for 
cellular homeostasis. 
In this study we carried out a detailed characterization of the nature of the endonucleolytic 
reaction using reporters in yeast. In an effort to gain mechanistic insights into the endonuclease 
specificity, we mapped the 5’ fragments for a number of stalling reporters in the absence of SKI2. 
In agreement with earlier reports (Chen et al., 2010; Doma and Parker, 2006; Tsuboi et al., 2012), 
the 5’-fragment maps upstream of the stall. However, we were surprised to observe that the 
majority of the sequence reads mapped well upstream of the stall site. These observations suggest 
that multiple ribosomes are required to load on the mRNA for efficient NGD. Consistent with 
these ideas, NGD-induced cleavage was not observed unless the stall site was greater than 105 nt 
downstream of the start codon. Furthermore, mutations and reporters that result in a low ribosome 
density on mRNA significantly reduce NGD efficiency. Finally, by genetically manipulating yeast 
to have a mixed population of cycloheximide-resistant and -sensitive ribosomes, we globally 
induced ribosomal collision through the addition of the antibiotic. Interestingly only under these 
circumstances do we observe robust ubiquitination of ribosomal protein RPS3 in a HEL2-
dependent manner. These observations suggest that similar to the cleavage reaction ribosome 
ubiquitination is associated with collision events and provides a mechanism by which HEL2 
recognizes its substrate ribosomes. Collectively our data suggests that the trigger for quality 






NGD results in multiple endonucleolytic cleavages that map well upstream of the stall site 
A collection of reporters has been utilized by a number of groups to study NGD in 
Saccharomyces cerevisiae by presenting a genetically-encoded translational block. We elected to 
use a PGK1 reporter, initially engineered by Parker and colleagues, which expresses a stable stem 
loop (SL) known to inhibit ribosome movement along the mRNA (Doma and Parker, 2006). We 
also constructed two additional reporters, which contain a stretch of the inhibitory codons CGA 
(PGK1-CGA12) encoding poly-Arg or AAA sequence (PGK1-AAA12) encoding poly-Lys; both of 
these sequences have been well documented to inhibit translation and elicit NGD (Doma and 
Parker, 2006; Kuroha et al., 2010; Letzring et al., 2010; Lu and Deutsch, 2008; Tsuboi et al., 2012). 
As a negative control, we constructed a reporter with a polyU stretch (PGK1-UUU12) encoding 
poly-Phe instead. As has been seen previously, all of the reporters that present a block to the 
ribosome were found to produce shorter mRNA products in a ski2 background; these strains are 
defective for 3’-5’ exonuclease activity by the cytoplasmic exosome (Anderson and Parker, 1998). 
Also consistent with earlier reports, these products ran as smears on the gel suggesting that they 
are heterogeneous in nature (Figure 1A). In the absence of XRN1 (Stevens, 1980), 3’-PGK1 
fragments accumulated in the presence of the stalling reporters (PGK1-SL, PGK1-CGA12 and 
PGK1-AAA12) (Figure 1B). Similar to the 5’ intermediates, the 3’ intermediates ran as 





Figure 1. NGD reporters produce heterogeneous 5’ and 3’ fragments.  
(A) Northern analysis of 5’ fragments accumulation from the indicated PGK1 mRNA reporters in 
wild-type and ski2 strains. PGK1 indicates no additional sequence was added to the PGK1 ORF. 
SL indicates a stem loop was inserted at position 1040 of the ORF; (CGA)12, (AAA)12 and (UUU)12 
indicate the corresponding codons were inserted at position 950 of the ORF. (B) Northern analysis 
of 3’ fragments accumulation in wild-type and xrn1 strains. The fragments were labeled as per 
(Chen et al., 2010). Note that the asterisk depicts an endogenous endonucleolytic cleavage specific 
for the PGK1 sequence. (C-F) Mapping sites of mRNA cleavage in cells expressing stalling 
reporters. The 5’ ends of 3’ fragments from xrn1 cells were mapped relative to the stall site (C) 
(data from Chen et al. 2010). (D-F) The 3’ ends of 5’ mRNA cleavage products from ski2 cells 






Although noted earlier by others (Chen et al., 2010; Doma and Parker, 2006; Tsuboi et al., 
2012), we were surprised by the extent of the smear length (> 500 nt) (Figure 1A). These 
observations suggested to us three different scenarios: 1) The cleavage reaction is inefficient 
relative to the elongation rate of the ribosome so that by the time cleavage initiates multiple 
ribosomes had protected the mRNA; 2) The endonuclease requires multiple stacked ribosomes for 
efficient cleavage; 3) Rescue of ribosomes behind the primary ribosome is relatively inefficient 
resulting in secondary stalls that trigger more NGD cleavages. 
To explore these different scenarios, we sought to map cleavage sites for the reporters using 
RACE assays. Previous studies focused on mapping the 3’-fragments in the xrn1 background. In 
Figure 1C we used the data reported by the Parker and Song groups (Chen et al., 2010) to plot the 
number of reads from the (CGA)4 reporter as a function of their relative position from the stall site. 
Consistent with the northern analysis, the 3’-fragments mapped to a broad region of the reporter 
(~0-250 nt upstream of the stall site). In these experiments cDNA was prepared by ligating an 
RNA oligo at the 5’ end of the mRNA and reverse transcribing using a primer that anneals 
downstream of the stall sequence (Chen et al., 2010). As a result, secondary cleavage reactions 
resulting from inefficient rescue are lost during this step since they do not possess the 
complementary sequence for the RT primer, thus excluding the third scenario.  
The corresponding 5’ fragments have not been mapped to single-nucleotide resolution and 
are likely to provide further hints about the endonucleolytic reaction. We mapped these fragments 
by first ligating an adenylated DNA oligo to the 3’ end. Following first-strand synthesis with a 
primer complementary to the ligated oligo, the cDNA was amplified from the start of the PGK1 




cleavage reaction. In contrast to the 3’ fragments, for which most clustered within 200 nt of the 
stall site, the 5’ fragments mapped to a broader region upstream of the stall site (Figure 1D) 
suggesting that the 5’ fragments are subject to multiple cleavage reactions, presumably due to 
inefficient recycling by Dom34 and Hbs1. In agreement with this proposal, inhibition of ribosome 
rescue by deleting DOM34 leads to even more dramatic heterogeneity of the 5’-fragments (Figure 
S1B) (Ikeuchi and Inada, 2016). 
Mapping of the 5’-fragments for the SL and (AAA)12 reporters was largely consistent with 
that for the (CGA)12 reporter. However, unlike the (CGA)12 reporter, for which the reads were 
uniformly distributed across a broad region upstream of the stall site, the reads for the SL and 
(AAA)12 reporters are clustered either 100-175 nt upstream of the stall (Figure 1E) or close to the 
stall site (Figure 1F). These findings suggest that the endonucleolytic reaction is to a certain extent 
dependent on the nature of stall. Some of these distinctions are likely to be rationalized by 
differences in the precise location of where the ribosome stalls as well as the makeup of the polyA 
sequence, especially given its slippery nature (Koutmou et al., 2015). These distinctions between 
AAA- and CGA-mediated stalling are likely to be the result of subtle differences between bona-
fide-no-go decay and non-stop decay (NSD) (Frischmeyer et al., 2002; van Hoof et al., 2002). 
Cleavage appears to takes place between stacked ribosomes 
To gain further insight into the nature of the cleavage reaction, we decided to carry out 
high-throughput sequencing to map the 5’-fragments from the NGD reporters in the ski2 









(A) Plot of sequencing reads of 3’RACE products from ski2 cells expressing a (CGA)12 reporter. 
Each point represents one read, mapped relative to the stall site. Inset shows a wider view of the 
mapped data. (B) Plot of smoothed data from (A) reveals a strong periodicity in the location of 
cleavage sites. Data was smoothed by using a 5-point quadratic polynomial. Peaks were assigned 
by taking the derivative of the smoothed data and finding the + to - inflection point. (C) Graph 
depicting the number of reads as mapped to the translation frame of the reporter. (D) Plot of the 
distance between peaks in (B). 
 
from our analysis. First, very few cleavage products map downstream of the stall site. We 
mapped more than 7 × 106 reads to the (CGA)12 reporter with greater than 99.7% mapping 
upstream of the stall site (Figure 2A). The first major peak of reads mapped at about -43-nt (likely 
behind the secondary stalled ribosome). Second, we observe a predominant peak at 75 – 150 nt 
upstream, depending on the identity of the stall sequence (Figure 2B, S2). Third, and arguably 
most interesting, is the observation that cleavage takes place significantly in frame (Figure 2C, 
S2). This latter observation is similar to what has been observed recently using ribosomal profiling 
(Guydosh and Green, 2017) and suggests that the endonuclease is using the ribosome as a ruler. 
Consistent with this proposal, smoothing of the (CGA)12 mapping data revealed a regular 
oscillation of read peaks with a median period of 29-nt (Figure 2B, 2D) and a tight distribution 
(standard deviation of 2.5-nt). The 29-nt periodicity has important ramifications for the nature of 
the endonuclease as it suggests that the cleavage reaction takes place among stacked ribosomes. 
This observation argues against the potential proposal that the heterogeneity of the cleavage 
products is the result of secondary cleavage reactions as this would result in a 15-nt periodicity 
instead; during secondary cleavage reactions ribosomes are expected to run to the end of the 




For the SL and (AAA)12 reporters, we were able to map ~5 × 106 and ~ 4 × 106 reads to 
their corresponding sequence, respectively (Figure S2). Interpretation of the mapping results, 
however, was not as straightforward as for the CGA reporter, presumably due to imprecise stalling 
on these sequences (Figure S2). This can be rationalized in light of earlier reports showing that 
tandem CGA sequences present harder stalls relative to other motifs in yeast (Chen et al., 2010). 
Notwithstanding, we also document a similar correlation between the cleavage reaction and frame 
to that observed for the CGA reporter. Collectively our analysis suggests that cleavage on NGD 
substrates is intimately coupled to the translational machinery and that the endonuclease may sense 
stacked ribosomes to initiate its reaction. 
Multiple stacked ribosomes are required for robust NGD 
Perhaps one of the most important findings to come out of our sequencing efforts is the 
observation that the primary cleavage is likely to take place well upstream of the stall site. This is 
especially true for the SL reporter, for which the cleavage sites appear to cluster to regions >100 
nt from the stall (Figure S2A). These results are in agreement with a model whereby multiple 
stacked ribosomes are required to activate the endonuclease. To empirically provide support for 
this proposal we constructed new PGK1 reporters that place the SL sequence at distances close to 
the start codon, which allowed us to control a maximum number of ribosomes that can load onto 
the reporter (Figure 3A). In particular we positioned the SL at 10, 22, 48, 60, 105, 135, 175, 200 
and 1040 nts from the AUG  
In agreement with our sequencing results, we only observe robust cleavage on reporters 





Figure 3. Endonucleolytic cleavage is not efficient on ribosomes that stall within 175 nt of 
the start codon.  
(A) Northern analysis of 5’ fragment accumulation in ski2 cells expressing a reporter with the 
SL located at the indicated positions (relative to the start codon), performed on formaldehyde-
agarose (top) or denaturing PAGE (bottom). 5’ cleavage products are indicated by arrowheads. 
(B) Northern blot of RNA from xrn1 cells expressing the same set of reporters as in (A) 
performed on formaldehyde-agarose. 3’ cleavage products are indicated by arrowheads. (C) 
Polysome profile, ethidium bromide-stained agarose gel, and northern blot from ski2 cells 
expressing the indicated SL reporter. The band corresponding to endogenous PGK1 is labeled 
PGK1 end. Blots in all panels were probed with an oligo complementary to the 5’UTR immediately 





the 5’-fragments in the ski2 background (Figure 3A). Although we can detect minimal cleavage 
products in the SL10 through SL105 reporters, cleavage was more evident in the SL135 reporter and 
was much stronger in the SL175 reporter. To rule out the possibility that the absence of cleavage 
products in the reporters with SL close to the start codon is due to probing issues or due to possible 
trimming by an unknown exonuclease, we looked at the accumulation of the 3’-fragments in the 
xrn1 background. Similar to what we observe for the 5’-fragments, robust accumulation of the 
3’-fragments was only detected for reporters expressing the SL at sites that are >105 nt from the 
AUG codon (Figure 3B). The effect of its position within the ORF on cleavage efficiency was not 
dependent on the identity of the stall. Indeed similar to the SL stall, cleavage efficiency was 
significantly reduced for the CGA and AAA stalls when they were placed <105 nucleotides from 
the initiation codon (Figure S3). 
As NGD is fully dependent on translation (Doma and Parker, 2006), we next sought to 
verify that reporters that are not subject to NGD are capable of associating with the ribosome. We 
carried out polysome analysis on the SL60, SL135, SL175 and SL1040 mRNA reporters to assess their 
distribution across the different ribosomal fractions. As expected the SL60 mRNA was found to 
associate with monosomes and disomes, whereas the SL135 was found to associate with trisomes 
and tetrasomes. The SL175 and SL1040 mRNAs, including their stabilized 5’-fragments due to the 
ski2 background, could be detected in the heavier fractions of the polysomes (Figure 3C). We 
note that the endogenous PGK1 mRNA, which migrates faster and can be detected with our probes, 
was found to associate with the heavy fractions in all of our samples offering an internal control. 




associates with ribosomes, it is not a good target of NGD. Collectively, our data argues that robust 
endonucleolytic initiation of NGD requires multiple ribosomes to load onto the mRNA target.  
Reduction of ribosome density inhibits NGD 
 Although our data so far suggest that ribosome collision is key for initiating NGD, the 
mechanism by which this signal is communicated to the endonuclease is unclear. The L1 stalk of 
the ribosome, which protrudes away from the ribosome facing the mRNA exit channel, is an 
obvious candidate for sensing collision events. Structures of polysomes from human cells revealed 
a likely interaction between the ribosome and the small subunit of the upstream neighboring 
ribosome near the mRNA entry tunnel (Brandt et al., 2010). Furthermore, recent studies from the 
Grayhack group showed that deletion of RPL1B, one of two genes that encodes ribosomal protein 
L1 and is more highly expressed than its paralog RPL1A, allows for read through of inhibitory 
CGA codons suggesting that it may play a role in NGD (Letzring et al., 2013). However, an 
alternative possibility is that deletion of RPL1B is affecting overall ribosome homeostasis, by 
reducing the levels of available 60S subunits. Indeed studies from multiple groups have 
documented a profound relationship between ribosomal protein availability and ribosome 
assembly. In particular, deletion of ribosomal protein paralogues has been shown to result in 
defects in ribosome biogenesis (Ferreira-Cerca et al., 2005; Moritz et al., 1990; Mueller et al., 
1998; Rudra et al., 2007).  
 Before exploring the effect of the RPL1B deletion on ribosome homeostasis we sought to 
assess its effect on the endonucleolytic reaction. Consistent with its effect on readthrough of 
inhibitory codons (Letzring et al., 2013), we observe a significant reduction in 5’-fragment 




of NGD intermediates can be rescued by reintroducing RPL1B on a plasmid suggesting that the 
effect is due to the loss of RPL1B. To evaluate whether the effect of RPL1B deletion is due to 
limiting levels of available ribosomes or altered ribosome composition, we isolated ribosomes 
from wild-type as well as rpl1b cells and performed mass spectrometry to quantify the relative 
levels of the ribosomal proteins. We measured almost identical stoichiometries of the near 
complement of ribosomal proteins between the wild-type and the mutant strains (Figure 4B). In 
particular, in the rpl1b strain, the level of RPL1 was found to be reduced by a modest 15% relative 
to its parent (Figure S4). This confirms that the effects of RPL1B deletion on NGD cannot be 
explained simply by altered ribosome composition and instead are likely due to changes in the 
cellular concentration of ribosomes. The polysome profile of rpl1b provided support for this 
model; the profile exhibited a significant reduction of polysomes relative to the 80S monosome 
peak when compared to profiles from the wild type strain (Figure 4C). As expected, we observe a 
gradual increase in polysome levels in the wild type strain whereas in the rpl1b strain an opposite 
steep and immediate drop in polysomes levels was noted, indicating that ribosome density on 
mRNAs is significantly reduced in the rpl1b strain. This in turn could explain the effect of the 
deletion on NGD in a manner that is consistent with our collision-based model for triggering 
cleavage; ribosome density and hence “traffic” has a profound impact on the likelihood of 









Figure 4. Deletion of RPL1B reduces mRNA cleavage efficiency by lowering ribosome 
density on mRNAs.  
(A) Efficiency of mRNA cleavage is reduced in ski2 rpl1b cells compared to ski2 cells 
expressing PGK1-SL. Cleavage activity is rescued by RPL1B expression from a plasmid 
(pAG426-rpl1b). Cleavage products were quantified relative to the PGK1 full-length reporter (top 
band on blot) and to SCR1 (bottom panel). % abundance compared to WT is shown. (B) 
Quantification of ribosomal protein content from ribosomes for rpl1b versus wild type cells by 
mass spectrometry. Values are relative ion counts  SD from three biological replicates. (C) 
Polysome profiles from wild type and rpl1b cells. (D) Western blots of cell lysates from wild 
type and rpl1b cells used to assess RPS9 levels. Quantification of RPS9 relative to PGK1 is 
shown in the lower panel. Value is mean ±SD from three biological replicates. Full blots are shown 
in Figure S3. (E) A phosphorimage of an SDS PAGE gel used to follow the incorporation of 35S-
Met in nascent proteins in wild type and rpl1b cells. Middle panel shows coomassie stained 
samples used to assess the steady state levels of proteins. Bottom panel is a western blot of PGK1. 
Radiolabeled proteins from two independent biological samples were quantified relative to the 
steady state levels of PGK1 and the resulting plot is shown to the right. (F) A dual luciferase 
reporter was used to assess readthrough on (CGA)4. Plot of normalized firefly luciferase relative 
to Renilla luciferase expression from a control reporter and one containing a (CGA)4 sequence in 
wild type and rpl1b cells. (G) Western blot of cell lysates from WT and rpl1b cells expressing 
the indicated PGK1 reporters. (H) Northern blot of RNA isolated from WT and rpl1b cells 
expressing the indicated reporters. Cleavage products were quantified relative to the full PGK-stall 
reporter (top band) or to SCR1 (bottom panel). The band corresponding to endogenous PGK1 is 
labeled PGK1 end. 
 
 To provide further support for the effect of RPL1B deletion on ribosome homeostasis, we 
looked at the relative level of another ribosomal protein as a proxy for gauging the cellular levels 
of ribosomes. As predicted, the level of the small subunit ribosomal protein RPS9 is significantly 
reduced in the rpl1b strain relative to wild-type cells (~30% reduction) as judged by western 
blotting (Figure 4D). This apparent reduction in ribosome concentration was corroborated by 
assessing the global rate of protein synthesis using 35S-methionine incorporation. The rate by 
which the radiolabel was incorporated into nascent proteins was observed to be ~fivefold slower 
in the rpl1b strain relative to wild-type cells (Figure 4E). We note that, superficially, these 




ribosome-based surveillance mechanism. However, this rationale falls short of explaining that in 
the absence of RPL1B we observe increased accumulation of full-length protein products from a 
number of NGD reporters. We utilized a reporter similar to the one used by Grayhack and 
colleagues (Letzring et al., 2013), for which a dual luciferase construct is interrupted with CGA 
codons between the renilla and firefly luciferase coding sequences. In the absence of RPL1B, the 
ratio of firefly- to renilla-dependent luminescence increased more than twofold (Figure 4F). 
Similar effects of the deletion were seen with the PGK1 constructs; both the SL and (AAA)12 
reporters produced > twofold more protein in the rpl1b strain (Figure 4G). These findings suggest 
that although decreasing ribosome density per mRNA has an overall negative effect on translation, 
it increases protein output on NGD reporters because it reduces the probability of ribosome 
collision and hence cleavage efficiency. 
The likelihood of elongating ribosomes running into each other, in principal, depends on 
two parameters (assuming the elongation rate is similar): 1) the strength of the stall, which affects 
the dwell time of the ribosome on the pause sequence, and 2) ribosome density, which affects the 
arrival time of the ribosome behind the primary ribosome. We manipulated the first parameter by 
presenting stall sites of varying strengths to the ribosome. Previous work suggested that stretches 
of CGA and AAA codons present harder blocks to translation as compared to SL structures (Chen 
et al., 2010). Indeed in our hands, we observe little to no full-length protein products from these 
reporters, whereas we observe significant full-length protein product from the SL reporter (Figure 
4G). In agreement with our model, the effects of RPL1B deletion on NGD efficiency was 
completely dependent on the strength of the stall sequence. Cleavage was significantly inhibited 




(Figure 4H). These findings suggest that by increasing the stalling time, NGD becomes less 
affected by ribosome density. 
To provide further support for our model we deleted other ribosomal protein genes 
encoding RPS26 and RPS28. Both are encoded by duplicated genes, and deletion of RPS28B 
appears to impart defects on the biogenesis of the 40S as evidenced by accumulation of 18S rRNA 
precursors in a ski2 rps28b strain (Figure S5) (Ferreira-Cerca et al., 2005). Similar to what we 
observe for the rpl1b strains, the stoichiometry of ribosomal proteins in the 80S ribosomes was 
largely unaffected in the rps26b and rps28b strains (Figure S5) as evidenced by mass 
spectrometry analysis suggesting that ribosome composition is not compromised in these strains. 
Consistent with our proposal, deletion of RPS28B inhibited NGD on the SL and, to a lesser 
extent, on the (CGA)12 and (AAA)12 reporters (Figure 5A). In contrast deletion of RPS26B had 
little effect on the accumulation of the 5’-fragments. This difference between the two deletions can 
be easily rationalized by the severity of the RPS28B deletion relative to the RPS26B deletion. This 
was evident in the polysome profiles, for which the rps28b strain exhibited a much more 
pronounced peak for the 60S subunit relative to the rps26b strain (Figure 5B). Furthermore, in 
contrast to the rps28b strain, the rps26b strain did not accumulate 18S rRNA precursor. 
Corroborating these observations is the finding that the growth rate of the rps26b strain was only 
slightly reduced, whereas that of the rps28b strain was significantly reduced (Figure S5). 








Figure 5. Reducing ribosome density by deletion of rps28b or by limiting initiation inhibits 
NGD.  
(A) Northern analysis of 3’ fragment accumulation in ski2 cells expressing the indicated reporters 
and deleted for rpl1b, rps26b, or rps28b respectively. Cleavage products were quantified relative 
to the full PGK-stall reporter or to SCR1. The band corresponding to endogenous PGK1 is labeled 
PGK1 end. (B) Polysome profiles from ski2, ski2 rps26b, and ski2 rps28b cells. (C) 
Western blot used to assess reporter protein expression downstream of the indicated 5’UTR for 
either control PGK or (CGA)12. Cells were grown in the presence of glucose (-) to suppress 
induction or in the presence of galactose (+) to induce reporter expression. (D) Northern blot 
analysis of mRNA cleavage from reporters containing longer 5’UTRs.  
 
NGD efficiency is to a large extent dictated by ribosome density as a result of its direct 
consequence on the frequency of ribosome collision. 
So far our analysis of the effect of ribosome density on cleavage focused on altering 
ribosome homeostasis, which is likely to have pleiotropic effects on cellular fitness. In our next 
set of experiments we focused our efforts on changing ribosome density per mRNA by modifying 
the reporter itself. We reasoned that by significantly increasing the UTR length, resulting in 
prolonged scanning by the small subunit, initiation rates should be reduced to an extent that can 
considerably limit the number of elongating ribosomes on the reporter (analogous to highway on-
ramp signals to manage traffic). In particular, we replaced the UTR of the PGK1 gene in our 
control and (CGA)12 reporter with that of the RPO21 and SCH9 genes (516- and 454-nts, 
respectively). As expected, increasing the length of the UTR led to a profound decrease in protein 
synthesis; in particular whereas induction of the PGK1-UTR control reporter resulted in an 
eightfold increase in PGK1 protein levels, induction of the RPO21- and SCH9-UTR reporters 
resulted in a dismal twofold increase of protein levels (Figure 5C). As important, these experiments 




machinery and the new reporters are translated, albeit inefficiently. We note that we did not 
observe an effect on protein accumulation of the (CGA)12 NGD reporter, most likely because these 
reporters do not produce significant amounts of protein regardless of the UTR sequence (Figure 
5C). Nevertheless, in contrast to the PGK1-UTR NGD reporter, for which short abortive products 
are observed, the reporters with the long UTRs failed to produce observable short protein products 
suggesting that they are not subject to NGD. In agreement with these observations, we detected 
little to no 5’-RNA fragments in the presence of the reporters that harbor the long UTRs (Figure 
5D). These observations provide independent support for our model that cleavage is sensitive to 
ribosome “traffic” on NGD targets. 
Induction of global collision events is accompanied by ubiquitination of the ribosomal 
protein RPS3 
 Two recent reports from the Hegde and Bennett groups (Juszkiewicz and Hegde, 2017; 
Sundaramoorthy et al., 2017) provided evidence to support that monoubiquitination of a number 
of ribosomal proteins is critical for resolving stalled ribosomes. Deletion of the E3 ligase ZNF598, 
or introducing mutations to its ribosomal proteins targets allows for readthrough on polyA 
sequences and inhibits downstream RQC events. In agreement with these proposals, deletion of 
HEL2, the yeast orthologue of ZNF598, was also previously shown to result in a similar phenotype 
(Letzring et al., 2013; Saito et al., 2015). Motivated by these observations, we sought to explore 
whether ribosome monoubiquitination is also triggered by ribosome collision. To accomplish this, 
we took advantage of the fact that substituting proline for glutamine at residue 56 (P56Q) of 
ribosomal protein RPL42 (eL42) renders ribosomes resistant to cycloheximide (Roguev et al., 
2007; Shirai et al., 2010). Fortuitously, in yeast RPL42 is encoded by two paralogues, RPL42A 




with respect to cycloheximide sensitivity. Hence, addition of cycloheximide to these strains should 
result in global ribosomal collision. 
We initially set out to assess the relative expression of RPL42A and RPL42B in our strain. 
However, since the protein sequence is identical we opted to use qRT-PCR with gene-specific 
primers to assess their transcript levels. Both genes express to substantial levels (as compared to 
taf10), with RPL42B expressing at approximately twice the levels of RPL42A (Figure 6A). With 
this in mind, we chose to introduce the P56Q mutation to RPL42B as we hypothesized this will 
lead to increased ribosome stacking upon cycloheximide addition. We also introduced the same 
mutation to both genes to make a strain that is fully resistant to cycloheximide. As expected, a 
strain carrying wild-type copies of both genes was very sensitive to cycloheximide, for which no 
growth was observed when the antibiotic was added to concentrations higher than 160 ng/mL 
(Figure 6B). A strain harboring mixed populations of ribosomes was slightly more resistant to 
cycloheximide but overall sensitive; robust growth was observed at an antibiotic concentration of 
160 ng/L. Finally a strain carrying P56Q-mutant copies of both genes was fully resistant to 
cycloheximide even when the antibiotic was added to 10 g/mL. 
Having established that the RPL42 strains display the expected sensitivity towards 
cycloheximide, we next explored the effect of the antibiotic on ribosomal protein 
ubiquitination. We focused our efforts on RPS3, which has been shown to be ubiquitinated 
in response to stalling (Juszkiewicz and Hegde, 2017; Sundaramoorthy et al., 2017). Tagging 








Figure 6. Ribosome collision is accompanied by ubiquitination of ribosomal protein RPS3.  
(A) Bar graph showing the relative transcript levels of the RPL42A and RPL42B genes to 
TAF10 as assessed by qRT-PCR. The values are the mean of three biological repeats with 
error bars depicting the standard deviation. (B) Growth curves of the indicated strains in the 
presence of the specified cycloheximide concentrations. (C) Western-blot analysis of RPS3 
modification (assessed by anti-FLAG antibody) in the cycloheximide –sensitive, –mixed and 
–resistant strains in the presence or absence of the antibiotic. Arrowheads point to bands 
that appear in the presence of cycloheximide. (D) Western-blot analysis of anti-FLAG 
immunoprecipitated protein under conditions as in (C). Arrowheads point to bands that are 
enriched after cycloheximide treatment. (E) Western-blot analysis used to explore the effect 
of HEL2 on the cycloheximide-dependent modification of RPS3 as well as appearance of 
ubiquitinated protein products in the cycloheximide-mixed strain. (F) Western-blot analysis 
used to follow RPS3 modification and appearance of ubiquitinated protein products as a 
function of cycloheximide concentration. Antibiotic concentrations from left to right: 100, 
33, 11, 3.7, 1.2, 0.41, 0.14, 0.045, 0.015, 0.0051 and 0.00 g/mL.  
 
function of cycloheximide addition using western blotting. We note that tagging RPS3 with 
the longer 3 × FLAG tag altered the modification pattern, suggesting that ubiquitination is 
likely dependent on the context of the C-terminus of RPS3. As expected, in the absence of 
cycloheximide we observe little to no modification of RPS3 regardless of the strain 
background (Figure 6C). In agreement with our collision-based model, we only observe 
robust modification of RPS3 upon addition of cycloheximide to the mixed-ribosome strain. 
The appearance of a band that corresponds to a mass shift of ~8 kDa (Figure 6C) is consistent 
with monoubiquitin being added to the protein as has been shown by others (Juszkiewicz 
and Hegde, 2017; Sundaramoorthy et al., 2017). In support of these ideas, we also detect an 
accompanying accumulation of ubiquitinated proteins as judged by anti-ubiquitin blotting. 
The addition of ubiquitin to RPS3 was further confirmed by immunoprecipitation of the 
protein (using anti-FLAG resin) and subsequent blotting for ubiquitin (Figure 6D). 




ubiquitin was only observed for the mixed strain in the presence of cycloheximide. 
Furthermore as expected, the modification was no longer detected when HEL2 was deleted 
from the mixed-ribosome strain, and the accumulation of ubiquitinated proteins was also 
absent (Figure 6E).  
The observation that cycloheximide on its own does not result in modification of RPS3 
suggests stalling on its own cannot activate the RQC pathway. Having said that, we reasoned 
that modification of RPS3 should be observed in the wild-type strain by titrating 
cycloheximide to a concentration where it no longer saturates ribosomes. In other words, 
concentrations at which binding of the antibiotic is dynamic should lead to collision of 
ribosomes since at any given point some ribosomes will be bound by the antibiotic whereas 
others will not. We titrated cycloheximide from 100 g/mL down to 5 ng/mL and looked at 
the modification of RPS3. As expected, no ubiquitination was observed at the high and low 
concentrations of cycloheximide (Figure 6F). Instead, and in agreement with our model, we 
observed appreciable modification of RPS3 when the antibiotic was added at intermediate 
concentrations (0.13-3.7 g/mL or 0.45–13 M). Interestingly, these concentrations are 
close to the measured KD values for cycloheximide binding to the eukaryotic ribosome 
(Garreau de Loubresse et al., 2014; Schneider-Poetsch et al., 2010), and as such association 
between the antibiotic and the ribosome is most dynamic. In summary, these findings on the 
RQC pathway strongly suggest that ribosome collision is somehow detected by the E3 ligase 






 Quality control pathways are widespread and utilized by all organisms to ensure that 
cellular homeostasis is maintained. These processes typically inspect the integrity of biological 
polymers and respond through repair or degradation of the aberrant molecules. Failing to respond 
rapidly is often deleterious as is evident in the case of DNA repair, for which defects in the 
machinery’s response to DNA damage can result in cellular death or cancer (Jeggo et al., 2016). 
On the other hand, these processes are energetically expensive and as a result should not be called 
upon unless needed. Therefore, it is paramount that these processes distinguish between real targets 
and their look-alikes. This is especially true for the mRNA surveillance pathway of no-go decay. 
The process responds to stalled ribosomes on defective mRNAs, but there are many examples in 
biology that take advantage of slow ribosomes to regulate gene expression. Chief among these is 
SRP targeting of nascent peptides to the ER (Akopian et al., 2013), during which the ribosome 
essentially comes to a complete stop before being moved to the ER membrane to resume 
translation. These events do not appear to trigger NGD and the corresponding mRNAs are not 
short lived. These observations can be readily rationalized by a model whereby SRP’s interaction 
with the ribosome inhibits the action of the endonuclease. Our data, however, argues that SRP 
targeting does not elicit NGD because stalling occurs during the synthesis of the N-terminus before 
multiple ribosomes can stack on the mRNA. Furthermore, efficiency of NGD is directly correlated 
to ribosome density suggesting that ribosome collision is key in transmitting the activation signal 
to the endonuclease. It is important to note that under normal conditions, initiation rates have been 
estimated to be at least 100 fold slower than elongation rates (Yan et al., 2016). As such, ribosome 
collisions are not typically encountered during translation, making undamaged transcripts poor 




This in turn can explain why elongation rates are capable of varying greatly, which is an essential 
feature of translation that is required for proper protein folding and trafficking (Kim et al., 2015). 
Our model is also supported by observations that upstream open reading frame (uORF) 
sequences that stall the ribosome are not subject to NGD (Guydosh and Green, 2014). These 
sequences tend to be extremely short and can only accommodate one ribosome and as a result 
collision cannot take place on these mRNAs. Perhaps the most compelling support comes from 
studies on the ribosome-associated factor ASC1 (RACK1 in humans); a factor that appears to play 
a role during NGD. Deletion of ASC1 or mutations that affect its association with the ribosome 
results in significant read through on inhibitory CGA codons, but only when these are located deep 
inside the open reading frame (Letzring et al., 2013; Wolf and Grayhack, 2015). Deletion of the 
factor has no effect on read through when the CGA codons are located near the initiation codon 
(4th amino acid). Also, no cleavage products were observed in this reporter; in contrast robust 
cleavage is observed for the internal reporter. It should be noted that the read-though effects are 
not specific to ASC1 as deletion of other NGD factors such as HEL2 results in a similar phenotype 
(Letzring et al., 2013). 
 At least two important and related questions come out of our studies reported here: 1) Why 
are multiple ribosomes required for efficient NGD? 2) How does collision activate the 
endonuclease? While our data does not directly answer these questions, one can propose multiple 
scenarios to address them. For instance it is possible that the endonuclease associates with a small 
fraction of ribosomes and is activated upon stalling through perhaps an atypical conformation of 
the ribosome such as a rotated state. Although this scenario does not explain the precipitous drop 




SL reporter (Figure 3). One could also imagine that the endonuclease is activated through 
oligomerization, which can be mediated through stacked ribosomes. A precedent for this is the 
yeast IRE1 endonuclease. The protein mediates the unfolded protein response through 
translational-coupled splicing of the transcription factor HAC1. Upon ER-stress, the protein 
oligomerizes into a higher order structure that appears to be responsible for its final activation 
(Korennykh et al., 2009).  
 Our collision model for NGD is corroborated by recent ribosomal profiling studies in 
eukaryotes as well as bacteria, for which < 2 ribosomes are typically seen behind a primary stalling 
ribosome. In yeast, the addition of 3-Amino-1,2,4-triazole (3-AT), an inhibitor of HIS3, results in 
global stalling as evident by the accumulation of ribosomal footprints near histidine codons 
(Guydosh and Green, 2014). In contrast, footprints for the trailing ribosomes did not appreciably 
increase. This absence of an expected “traffic jam” (Mitarai et al., 2008) suggests that collisions 
are readily resolved. We note that even under these global conditions of stalling, polysomes were 
found to collapse predominantly to monosomes after the addition of RNase I (Guydosh and Green, 
2014) suggesting that ribosomes are not in close proximity to each other. Similar observations 
were also made in E. coli, when stalling is induced through amino-acid starvation (Subramaniam 
et al., 2014). 
 Arguably the most compelling evidence for ribosome collision playing a critical role in 
quality control came from our analysis on ribosomal protein ubiquitination as a consequence of 
cycloheximide-induced stalling. It has been noted for a while now that addition of the antibiotic 
stabilizes mRNAs on the ribosome (Jacobson and Peltz, 1996), which puts forward a conundrum: 




rationalized by a scenario whereby the antibiotic stabilizes a ribosome state that is not productive 
for endonucleolytic cleavage. Our model, however, provides an alternative explanation for the 
inability of the antibiotic to trigger NGD. Under normal circumstances, cycloheximide stalls every 
translating ribosome and as a result collisions are avoided. Similar to its apparent lack of effect on 
NGD, cycloheximide-induced stalling does not result in the ubiquitination of the ribosomal protein 
RPS3. However, by introducing a mutation that results in a mixed population of cycloheximide-
responsive ribosomes, RPS3 was modified upon the addition of the antibiotic (Figure 6). Under 
these conditions, global collision events are more likely to occur, which explains the gain of 
modification observed. In agreement with this, titrating cycloheximide to a range of concentrations 
near its binding affinity to the ribosome also resulted in modification of RPS3. At these 
concentrations binding of the antibiotic to the ribosome is dynamic and hence at any given point a 
subset of the ribosomes will be arrested. These observations reconcile earlier observations from 
the Weissman group (Brandman et al., 2012), which linked the RQC pathway to HSF1 induction. 
In these studies, cycloheximide activated HSF1 only at low concentrations.  
 Finally, our data offers some clues about the identity of the endonuclease. Our 
observations, as well as those of others, of the ~30-nt gaps between mapped cleavage products 
suggest that it is ribosome associated (Guydosh and Green, 2017). Our proposal of activation 
through ribosome collision offers an elegant mechanism for its regulation. Interestingly, as 
cleavage takes place in between tightly packed ribosomes, for which the downstream cleavage by 
our estimate occurs 10-15 nt inside the secondary ribosome, it is feasible that the ribosome itself 




that this redundancy is responsible for the failure of many NGD- and NSD-based screens to 






Yeast strains and growth conditions 
Cells were cultured at 30°C in either YPD or in defined media when expressing reporter plasmids. 
Yeast knockout strains were made using standard PCR-based disruption techniques in the 
background BY4741 (MATa (his3Δ1 leu2Δ0 met15Δ0 ura3Δ0). HIS3 and HYG cassettes were 
amplified from plasmids pFAGa-6xGLY-FLAG-HIS3 (Funakoshi and Hochstrasser, 2009) and 
pFA6a-HTB-hphMX4 (Tagwerker et al., 2006) respectively using oligos complementary to the 
target insertion sites. 
The RPL42B(P56Q):HIS strain was constructed by cloning the RPL42B coding sequence into the 
AscI/BglII sites and the RPL42B UTR into the SacI site of pFA6a-6xGLY-FLAG-HIS3. The 
P56Q mutation was introduced by site directed mutagenesis and the entire cassette was amplified 
and transformed. The RPL42A gene was mutated by amplifying overlapping regions of the coding 
sequence, incorporating the P56Q mutation. These products were fused using PCR and the 
resulting cassette used to transform the RPL42B(P56Q):HIS. 
Strains carrying mixed cycloheximide-sensitive ribosome populations were treated with 100 
g/mL cycloheximide for 30 min prior to pelleting for protein isolation. 
Plasmid construction 
The plasmids encoding the PGK1 gene and PGK1-SL under control of the GAL1 promoter were 
obtained from R. Parker (Doma and Parker, 2006). PGK1-(CGA)12, PGK1-(AAA)12 and PGK1-
(UUU)12 were made by annealing complementary oligos and ligating them to XbaI digested PGK1 
plasmid. To make stem loop reporters with the stall sequence at different positions, the existing 
XbaI site from PGK1 was removed and new sites added using site-directed mutagenesis. The stem-
loop sequence was made by annealing a partially self-complementary oligo and extending it with 
Klenow enzyme. The resulting double stranded sequence was then digested with XbaI and ligated 
to XbaI-digested plasmids. Plasmids with longer 5’UTRs were constructed by amplifying the 




BamHI site and inserting a PCR product with the 5’UTR of RPO21 or SCH9, using BamHI and 
XhoI. 
The (CGA)4 luciferase assay reporter was made using site directed mutagenesis to insert the 
(CGA)4 sequence between the Renilla and Firefly luciferase genes in pDB688 (Salas-Marco and 
Bedwell, 2005). 
Northern blotting 
Culture was grown overnight in a defined media (-Ura) in the presence of glucose. The culture was 
washed twice in media containing 2% raffinose and 2% galactose, diluted to OD 0.1 in the same 
media and allowed to grow to an OD of 0.5-0.8 to induce the gal-driven reporters. RNA was 
isolated using the hot phenol extraction method followed by chloroform extraction and ethanol 
precipitation. The samples were then phenol-chloroform extracted and ethanol precipitated a 
second time. 2 g of total RNA was resolved on 1.2% formaldehyde agarose gel, followed by 
transfer to positively-charged nylon membrane (GE Lifesciences) using a vacuum blotter (Biorad). 
Nucleic acids were UV cross-linked to the membrane and baked at 80°C for 15 minutes. 
Membranes were then pre-hybridized in Rapid-Hyb buffer (GE Lifesciences) for 30 minutes in a 
hybridization oven. Radiolabeled DNA probe, which was labeled using polynucleotide kinase and 
[-32P]ATP, was added to the buffer and incubated overnight. Membranes were washed with 
nonstringent buffer (2 × SSC, 0.1% SDS) three times, in some cases followed by three washes in 
stringent buffer (0.2 × SSC, 0.1% SDS), all at hybridization temperature. Membranes were 
exposed to a phosphorimager screen and analyzed using a Biorad personal molecular imager. 
Northern blots performed on denaturing PAGE were resolved on 6% PAGE in TBE/urea followed 
by transfer to positively-charged nylon membrane using a semi-dry transfer apparatus (Biorad) in 
0.5 × TBE. The membranes were then treated exactly as those used for denaturing agarose. 
3’-RACE mapping of cleavage products 
Total RNA samples were ligated to a short adenylated DNA oligonucleotide, 5' 
rAppCTGTAGGCACCATCAAT/3ddC/ 3', using truncated T4 RNA ligase 2 (NEB). Following 




5’-primer that annealed at the start codon. The forward and reverse primers introduced BamHI and 
XhoI restriction sites, respectively, which allowed us to clone the samples into pPROEX-htb 
(Invitrogen). 
Next generation sequencing libraries 
Next generation sequencing libraries were prepared as above except the cDNA was amplified 
using primers designed for the Illumina HiSeq platform that contain sequence complementary to 
the adaptor and to position 585 of PGK1. This position was chosen based on results from our lower 
resolution mapping experiments. Samples were then column purified to remove primers. 
Polysomes analysis 
Yeast cultures were grown to mid-log phase before cycloheximide was added to a final 
concentration of 100 μg/mL. The culture was chilled by adding an equal volume of ice and 
centrifuged at 4°C. Cells were then resuspended in polysome lysis buffer (20 mM Tris pH 7.5, 140 
mM KCl, 5 mM MgCl2, 0.5 mM DTT, 1% Triton-100, 100 μg/mL cycloheximide, 200 μg/mL 
heparin), washed once and lysed with glass beads using a FastPrep (MP Biomedical). Supernatant 
from cleared lysate corresponding to 1 mg of total RNA was layered over a 10-50% sucrose 
gradient and centrifuged at 37,000 rpm for 160 min in an SW41Ti (Beckman) swinging bucket 
rotor. Gradients were fractionated using a Brandel tube-piercing system combined with continuous 
absorbance reading at A254 nm. RNA was isolated using phenol/chloroform extraction in the 
presence of 1% SDS followed by ethanol precipitation. The extraction/precipitation protocol was 
repeated to clean up the RNA samples further. Fractions were resolved on 1.2% formaldehyde 
agarose and analyzed by Northern blots as described above. 
Luminescence and western blot 
5-10 ml of exponentially growing culture (defined media –Ura) was collected. The cell pellet was 
washed with TE and resuspended in 100-200 L of passive lysis buffer (Promega). Lysis was 
accomplished by adding glass beads (~ 50 L) to the sample and vortexing 5 × for a minute each 
time at high speed, with incubation on ice in between each interval. The lysate was clarified by 




Reporter Assay System (Promega) on a Tecan plate reader equipped with an automated injection 
system.  
For western blot assays, proteins were isolated using the NaOH/TCA method and resuspended in 
HU buffer (8 M Urea, 5% SDS, 200 mM Tris pH 6.8, 100 mM DTT). Proteins were resolved on 
12% SDS PAGE gels and transferred to PVDF membranes using a semi-dry transfer apparatus 
(BioRad). The membranes were blocked with milk in PBST for ~ 30 minutes at room temperature 
followed by incubation with primary antibody overnight at 4°C. After washing with PBST, the 
membrane was incubated with the appropriate HRP-conjugated secondary antibody for ~ 1hr at 
room temperature before washing 3-4 × with PBST. Detection was carried out on a GE 
ImageQuant LAS 4000 using the Pierce SuperSignal West Pico Chemiluminescent Substrate. The 
following antibodies were used: rabbit anti-RPS9 (ab117861), and mouse anti-PGK1[22C5D8] 
(ab113687) from Abcam; mouse anti-FLAG [M2] from Sigma-Aldrich; mouse anti-Ub [P4D1] 
(sc-8017) from Santa Cruz; rabbit anti-eRF1 was a gift from R. Green (Eyler et al., 2013); goat 
anti-mouse IgG HRP (31430) and goat anti-rabbit IgG HRP (31460) from Thermo Scientific. 
In vivo 35S-met labeling 
Cultures were grown overnight in YPD, washed twice, diluted to OD 0.2 in defined media (-Ura) 
and allowed to grow to OD 0.6. Cells were then washed twice in media lacking methionine (-Ura, 
-Met) and resuspended at OD 0.6. 35S-methionine was added to ~10 nM (0.2 mCi 35S-met) and 
cells were collected at intervals from 8 to 40 minutes. An aliquot was taken prior to addition of 
labeled methionine for T=0. Proteins were isolated using the NaOH/TCA method and resuspended 
in HU buffer. Samples were separated on 12% SDS-PAGE, transferred to PVDF membrane and 
exposed to a phosphorimager screen, followed by western blotting for PGK1 as a steady-state 
control. Samples were also separated on a second gel for Coomassie staining.  
Quantitative RT-PCR 
Total RNA from yeast cells was isolated following the hot phenol method (Kohrer and Domdey, 
1991). cDNA was generated with M-MuLV reverse transcriptase (Promega) from 1ug of total 




Quantitative RT-PCR was conducted using iTaq Universal SYBR Green Supermix (BIO-RAD) 
with ~50 ng of cDNA. Relative fold change was obtained by following the Ct method. Gene 
expression was normalized to the expression level of the taf10 gene. 
Yeast sensitivity assay 
The sensitivity assay was carried out as described here (Toussaint and Conconi, 2006). In brief, 
yeast cells were grown to mid-log-phase (OD600 of 0.5-0.7). Cells were collected, washed and 
resuspended in YPD to a final density of OD 0.8. 5 ul of the cell suspensions were added to 195 
ul of YPD with CHX at various concentrations, from 0-10 g/mL. All samples were prepared in 
biological triplicates as well as technical duplicates in 96-well polystyrene microplates. The plate 
was incubated at 30°C with shaking on a microplate scanning spectrophotometer (Biotek). Cell 
density was monitored every 10 min over 24-48 h at 600nm. 
Immunoprecipitation with anti-FLAG resin 
Yeast cells were grown to mid-log phase (OD600 of 0.5-0.7). Cycloheximide was added at 100 
ug/mL to one half of the culture and cells collected after an additional 30 minutes. Cells were 
washed once and resuspended in lysis buffer (50 mM Tris-HCl, pH 7.4; 150 mM NaCl; 1 mM 
EDTA, 1% Triton), then lysed with glass beads using a FastPrep (MP Biomedical). 
Resin (Anti-FLAG M2 affinity gel, Sigma) was prepared by rinsing in TBS twice, washing three 
times with 0.1 M Glycine HCl, pH 3.5, and washing 5 times in TBS. Lysate was added to the 
washed resin and allowed to incubate for 4 hours at 4°C while rotating. Resin was collected by 
brief centrifugation and proteins were eluted using SDS loading buffer. DTT was added to the 
samples following the elution step and proteins were analyzed by western blotting. 
Tandem mass spectrometry 
Approximately 50 µg ribosomes were denatured in 8M urea in a total volume of 100 µl. Proteins 
were then reduced in the presence of 10 mM dithiothreitol at room temperature for 1 hour, and 
alkylated in the dark in the presence of 50 mM 2-iodoacetamide at room temperature for a further 




room temperature, and the sample was diluted with 900 µl of 25 mM ammonium bicarbonate to 
reduce the urea concentration to below 1.5 M. Proteolytic digestion was then initiated by adding 
0.5 µg of sequencing grade modified porcine trypsin (Promega), giving a total protein to trypsin 
ratio of approximately 30:1, and the samples were incubated overnight at 37°C. Peptides then were 
vacuum dried in a Speed Vac™ centrifugal evaporator (Savant Instruments, model number 
SUC100H) to a final volume of approximately 250 µl, acidified with 10% trifluoroacetic acid 
(TFA) until the pH was less than 3, then desalted and concentrated on a 100 µl Bond Elut™ OMIX 
C18 pipette tip (Agilent Technologies), as according to the manufacturer’s instructions. The 
sample was eluted in 50 µl of 75% acetonitrile, 0.1% acetic acid, then dried and resuspended in 50 
µl 5% acetonitrile, 0.1% formic acid. Nano-scale liquid chromatography (LC) separation of tryptic 
peptides was performed on a Dionex Ultimate™ 3000 Rapid Separation LC system (Thermo 
Scientific). The protein digests were loaded onto a 1 μl nanoViper™ sample loop (Thermo 
Scientific), and separated on a C18 analytical column (Acclaim® PepMap™ RSLC C18 column, 
2 μm particle size, 100 Å pore size, 75 µm x 15 cm (Thermo Scientific)) by the application of a 
linear 2 hour gradient from 1.8% to 32% acetonitrile in 0.1% formic acid, with a column flow rate 
set to 250 nl/min. Analysis of the eluted tryptic peptides was performed online using a Q 
Exactive™ Plus mass spectrometer (Thermo Scientific) possessing a Nanospray Flex™ Ion source 
(Thermo Scientific) fitted with a stainless steel nano-bore emitter operated in positive electro-spray 
ionisation (ESI) mode at a capillary voltage of 1.85 kV. Data-dependent acquisition of full MS 
scans within a mass range of 380-1500 m/z at a resolution of 70,000 was performed, with the 
automatic gain control (AGC) target set to 1 x 106 , and the maximum fill time set to 100 ms. High 
energy collision-induced dissociation (HCD) fragmentation of the top 15 most intense peaks was 
performed with a normalized collision energy of 28, with an intensity threshold of 2 x 105 counts 
and an isolation window of 3.0 m/z, excluding precursors that had an unassigned, +1, +7 or +8 
charge state. MS/MS scans were conducted at a resolution of 17,500, with an AGC target of 2 x 
105 and a maximum fill time of 100 ms. Dynamic exclusion was performed with a repeat count of 
2 and an exclusion duration of 8 seconds, while the minimum MS ion count for triggering MS/MS 
was set to 4 x 103 counts. The resulting MS/MS spectra were analyzed using Proteome 
Discoverer™ software (version 2.0.0.802, Thermo Scientific), which was set up to search the S. 




UP000002311). Peptides were assigned using SEQUEST HT (Eng et al., 1994), with search 
parameters set to assume the digestion enzyme trypsin with a maximum of 2 missed cleavages, a 
minimum peptide length of 6, precursor mass tolerances of 10 ppm, and fragment mass tolerances 
of 0.02 Da. Carbamidomethylation of cysteine was specified as a static modification, while 
oxidation of methionine and N-terminal acetylation were specified as dynamic modifications. The 
target false discovery rate (FDR) of 0.01 (strict) was used as validation for peptide-spectral 
matches (PSMs) and peptides. Proteins that contained similar peptides and which could not be 
differentiated based on the MS/MS analysis alone were grouped, to satisfy the principles of 
parsimony. Label-free quantification as previously described (Silva et al., 2006) was performed in 
Proteome Discoverer™ with a minimum Quan value threshold of 0.0001 using unique peptides, 
and “3 Top N” peptides used for area calculation. All samples were injected in duplicate, and the 
resulting values were averaged. 
QUANTIFICATION AND STATISTICAL ANALYSIS 
High throughput sequencing analysis 
Single read HiSeq 2500 sequencing was performed by the Genome Technology Access Center 
(GTAC) at Washington University. Quality of Raw data was analyzed using the Fastx toolkit 
(http://hannonlab.cshl.edu/fastx_toolkit/index.html), followed by trimming using cutadapt 
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CHAPTER 3: Ribosome collisions result in 
+1 frameshifting in the absence of no-go 
decay 
 





During translation, an mRNA is typically occupied by multiple ribosomes sparsely distributed 
across the coding sequence. This distribution, mediated by slow rates of initiation relative to 
elongation, ensures that they rarely collide with each other, but given the stochastic nature of 
protein synthesis, collision events do occur. Recent work from our lab suggested that collisions 
signal for mRNA degradation through no-go decay (NGD). We have explored the impact of 
stalling on ribosome function when NGD is compromised and found it to result in +1 
frameshifting. We provide multiple lines of evidence to suggest that +1 frameshifting is induced 
through ribosome collision. For instance, efficient +1 frameshifting does not occur unless the stall 
sequence is placed beyond ~20 nucleotides from the initiation codon, suggesting that it requires 
multiple ribosomes to load onto the mRNA. Furthermore, we observe a positive correlation 
between ribosome density and frameshifting efficiency. For programmed frameshifting no such 
correlation was observed, suggesting that they exploit a distinct mechanism for recoding. In a well-
defined bacterial system, we find that frameshifting at a stall sequence within the downstream gene 
of a polycistronic mRNA depends on the translation of the upstream gene and hence collisions. As 
a result, it is tempting to speculate that NGD, in addition to its role in mRNA-quality control, 





At any point during protein synthesis, a single mRNA is typically occupied by multiple 
ribosomes (Warner et al., 1963). Biochemical assays, as well as computational studies, have shown 
ribosomes to be thinly distributed across transcripts, rarely coming in close proximity to one 
another (Brandt et al., 2010, Brandt et al., 2009, Kennell and Riezman, 1977, Kierzek et al., 2001, 
Siwiak and Zielenkiewicz, 2013). This sparse distribution is the result of at least two distinct 
mechanisms. The first involves vastly differential translation-initiation and -elongation rates. In E. 
coli, the rate of initiation has been estimated to be in the range of ~1 codon s-1 (Mitarai et al., 2008), 
whereas that of elongation has been measured to be ~20 codons s-1 (Sorensen and Pedersen, 1991). 
The second mechanism involves the apparent clustering of rare codons near the start codon (Eyre-
Walker and Bulmer, 1993, Tuller et al., 2010), which has been hypothesized to slow down early 
elongating ribosomes, acting like a ramp and hence ensuring that ribosomes do not collide into 
each other downstream (Dobrzynski and Bruggeman, 2009). Despite these mechanisms, modeling 
studies suggest that ribosome collisions are inevitable given the stochastic nature of translation 
(Mitarai et al., 2008). Collisions are predicted to slow down the lagging ribosome significantly, 
which would, in turn, increase the likelihood of additional collisions and subsequent ribosome 
pileups. These effects can be minimized by decreasing the stability of the mRNA, but this comes 
at a cost of reduced protein output per mRNA. It has been estimated that, for a codon-optimized 
lacZ mRNA, which is translated an average of 30 times in E. coli, stochastic collisions lengthen 
the translation time by 5% compared to an mRNA that is translated once (Mitarai et al., 2008). 
These models suggest that not only do ribosome collisions occur frequently, even on codon-




Ribosome collisions have been best studied in the context of defective mRNAs that stall 
ribosomes. More specifically, mRNAs harboring stable secondary structures, inhibitory codons, 
internal polyA sequences, damaged nucleobases and ones that encode for peptides that interact 
with the exit tunnel of the ribosome are all well documented to dramatically inhibit translation 
(Brandman and Hegde, 2016, Simms et al., 2016). These mRNAs activate the processes of no-go 
decay (NGD) and ribosome-associated-quality-control (RQC) to rapidly degrade the defective 
mRNAs and the incomplete nascent peptide (Bengtson and Joazeiro, 2010, Doma and Parker, 
2006). NGD is initiated through an endonucleolytic cleavage- by an unknown enzyme- upstream 
of the stall site, exposing the mRNA for the exonucleolytic action of Xrn1 and the exosome (Doma 
and Parker, 2006, Tsuboi et al., 2012). RQC requires the action of a number of factors that 
recognize a peptidyl-tRNA-bound large subunit (Brandman et al., 2012, Defenouillere et al., 
2013). Briefly, the E3 ligase Ltn1 (Listerin in mammals) adds K48-linked-ubiquitin chains to the 
peptide (Bengtson and Joazeiro, 2010). Following release by Vms1 (ANZF1 in mammals)(Verma 
et al., 2018), the ubiquitinated peptide is recognized by the adaptor protein Cdc48 and presented 
to the proteasome for degradation (Defenouillere et al., 2013, Verma et al., 2013). In addition to 
RQC and NGD, dissociation of the stalled ribosomes into their respective small and large subunits 
by Dom34/Hbs1/Rli1 ensures that they are rescued to be utilized for new bouts of translation. 
Ribosome rescue, NGD and RQC are all dependent on the action of the E3 ligase Hel2 (Znf598 in 
mammals) (Matsuo et al., 2017, Garzia et al., 2017, Juszkiewicz and Hegde, 2017, 
Sundaramoorthy et al., 2017). The factor ubiquitinates various ribosomal proteins through K63-





Until recently, an important question for the field was: how are these stalls recognized; in 
other words, how does Hel2 distinguish stalled ribosomes from slow ones? Initial models 
suggested that stalled ribosomes adopt a distinct conformation that is recognized by the E3 ligase 
(Matsuo et al., 2017). While this model was tempting, it lacked mechanistic insights into how this 
conformation could be attained. Instead, a more appealing model emerged recently that describes 
the factor recognizing collided ribosomes resulting from stalls. A major basis of this model, as put 
forward by our group, is the observation that ribosomal-protein ubiquitination by Hel2 is 
significantly increased when global ribosome collisions are induced (Simms et al., 2017). Recent 
studies from the Hegde, Ramakrishnan, Inada and Beckman groups provided important structural 
support for this model; collided ribosomes form an interface on the small subunits that bring 
together the target ribosomal proteins for ubiquitination by Hel2 (Ikeuchi et al., 2019, Juszkiewicz 
et al., 2018). Further biochemical characterization of these reactions showed the factor to prefer 
higher-order structures of ribosomes, i.e. polysomes. Analysis of Hel2 binding to RNA in vivo 
revealed that, although it binds most mRNA species, binding to the initial 150-nt of the coding 
sequence is significantly depleted, suggesting that it requires multiple ribosomes to initiate quality 
control (Winz et al., 2019). This is consistent with the observation that NGD is only robust when 
the stall sequence is >100 nt from the initiation codon (Simms et al., 2017). Therefore, it appears 
that eukaryotic cells have evolved a pathway to recognize and respond to ribosome collisions, 
suggesting that they are detrimental to cellular homeostasis if they go unresolved.   
  Analogous biochemical studies on replication and transcription have revealed that DNA- 
and RNA-polymerases often collide with each other resulting in so-called “conflicts” (Garcia-




thus necessitating mechanisms for their resolution (Azvolinsky et al., 2009, Merrikh et al., 2011). 
To this end, DNA-damage-response factors are able to sense these collision events, and in most 
cases remove the RNA polymerase (Poli et al., 2016, Tehranchi et al., 2010, Tuduri et al., 2009). 
Failure to resolve collided polymerases has been shown to be associated with genomic instability 
(Prado and Aguilera, 2005, Helmrich et al., 2013). In contrast to replication, the consequences of 
unresolved collision events during translation is poorly understood. In particular, whether they 
could modify the decoding properties of the ribosome, and especially frame maintenance, is 
unknown.  
 This potential connection between mRNA-quality control and frame maintenance is 
consistent with the observation that deletion of asc1 (RACK1 in mammals), which is a key factor 
in RQC (Kuroha et al., 2010, Brandman et al., 2012) and is predicted to act upstream of hel2 
(Juszkiewicz and Hegde, 2017, Sundaramoorthy et al., 2017, Matsuo et al., 2017, Sitron et al., 
2017), leads to +1 frameshifting in yeast (Wolf and Grayhack, 2015). However, a connection 
between frame maintenance and ribosome collision has not been explored. Equally important is 
the fact that stochastic ribosome collisions are predicted to be frequent and are likely to activate 
Hel2. Indeed, we have previously shown that increasing stochastic collisions by addition of sub-
inhibitory concentrations of cycloheximide leads to robust ribosomal protein ubiquitination by 
Hel2 (Simms et al., 2017). These observations beg the question of whether ribosome-based-quality 
control evolved to cope with stochastic collision events that would otherwise lead to frameshifting.  
Here we show, using various reporters in yeast as well as a well-defined in vitro bacterial 
translation system, that collisions result in +1 frameshifting. In yeast, inhibition of NGD was found 




frameshifting does not occur unless the stall sequence is placed beyond ~20 nucleotides from the 
initiation codon, suggesting that it requires multiple ribosomes to load onto the transcript. 
Furthermore, we observe a positive correlation between ribosome density and frameshifting 
efficiency. No such correlation was observed for programmed frameshifting, suggesting that they 
exploit a distinct mechanism for recoding. In agreement with our model that ribosome collisions 
induce +1 frameshifting we find that, in a well-defined bacterial system, frameshifting on a stall 
sequence within the downstream gene of a polycistronic mRNA depends on the translation of the 
upstream gene and hence, collisions. In conclusion, our data strongly suggest that collisions are 
detrimental to frame maintenance and that NGD is likely activated frequently on regular mRNAs 





Inhibition of NGD leads to +1 frameshifting 
As collisions activate NGD and are accompanied by the rapid degradation of the mRNA 
(Simms et al., 2017), their effect on ribosome function could only be studied in the absence of 
pathway activity. We have recently reported that the entry tunnel residues of ribosomal protein 
Rps3 (Figure 1A, 1B) are important for the endonucleolytic cleavage reaction (Simms et al., 2018), 
thus providing us a means to examine frameshifting in the context of inhibited NGD. To probe 
frameshifting in these variant yeast strains, we utilized a dual luciferase reporter (Salas-Marco and 
Bedwell, 2005), for which the downstream firefly luciferase (FL) coding region is in different 
frames relative to the upstream renilla luciferase (RL) coding region, either -1, in frame, or +1 
(Figure 1C). Stalling on this reporter was promoted through the addition of inhibitory CGA codons 
between the two genes (Letzring et al., 2010). The ratio of FL luminescence to that of RL was used 
to measure the amount of frameshifting that occurred. We note that since this reporter is a 
translational fusion any effects of the mutations on the RNA stability, and hence its levels, should 
be minimized. Indeed, qRT-PCR analysis using primers specific to the FL region and the RL one 
showed that the mutations in RPS3 as well as in ASC1, known to affect NGD, have little to no 
effect on the RNA ratio of the two reporters (Figure S1). 
On a reporter containing AGA codons, which are synonymous for CGA codons but do not 
cause stalling, mutation of Rps3’s entry tunnel residues had no discernable effect on relative FL 
expression levels. In contrast and as expected, FL expression was significantly reduced (to 31 ± 
15%) in wild type cells carrying the reporter with in-frame CGA codons. Interestingly, in the 
presence of the Rps3 mutations the relative FL expression was further reduced (to 13 ± 9.2%), 




measurements using frameshifting reporters showed that in the presence of CGA codons, +1 
frameshifting is significantly higher relative to that seen in the presence of AGA codons. In 
particular, the relative FL expression was measured to be 0.16 ± 0.1% and 1.0 ± 0.2% for the 
(AGA)4+1 and (CGA)4+1 reporters, respectively. Including the Rps3 mutations increased 
frameshifting a further fivefold (to 5.3 ± 1.2%) on the (CGA)4+1 reporter (Figure 1C). To provide 
further support for this observed effect of the mutations on frameshifting, we also tested 4 more 
sequences that were previously identified by the Grayhack group to promote frameshifting in the 
absence of Asc1 (Gamble et al., 2016, Wang et al., 2018). On two of these sequences, namely 
(CGACCG)3+1 and (AGAATT)3+1, the mutations in the entry tunnel increased frameshifting, 
albeit to a lesser extent than that observed on the CGA codons (Figure 1D). This suggests that 
collision-induced +1 frameshifting occurs in the absence of functional NGD. 
As expected, the mutations did not promote frameshifting on codons that do not induce 
stalling and also did not promote -1 frameshifting (Figure S2). Furthermore, the Rps3 mutations 
had no effect on programmed frameshifting efficiency, as assessed using a construct that had the 
frameshifting sequence from the Ty1 transposable element (Figure 1D). This particular 
programmed frameshifting construct was chosen due to its simple sequence requirement of a 7-nt 
motif and high frameshifting efficiency (Belcourt and Farabaugh, 1990). Western analysis 
corroborated these results and revealed that the mutations increase +1 frameshifting specifically 
on the (CGA)4+1 reporter, but not on the Ty1 one (Figure S3). These findings suggest that since 
programmed frameshifting likely occurs in a collision-independent manner, inhibition of NGD is 
inconsequential. Similarly, the mutations do not promote nonsense and missense types of 




(K529) (Kramer and Farabaugh, 2007) by other amino acids or a stop codon (Figure 1E). In these 
constructs, firefly luminescence reports on the frequency of the ribosome misreading the mutated 
codon as a Lys. Collectively, our data supports the notion that, when NGD does not occur, 





Figure 1. Mutation of Rps3’s entry tunnel residues increases +1 frameshifting on stalling 
sequences. 
A) Overview of the structure of the eukaryotic small ribosomal subunit complexed with mRNA 
and P-site tRNA (PDB ID 5AJ0). The mRNA entry tunnel, encompassing residues from Rps3 and 
Rps2, is highlighted as well as the proximity of Rack1 (Asc1 in yeast) and its interaction with 
Rps3. B) A close up view of the entry tunnel, where the ribosome makes the most intimate contacts 




other ribosomal proteins are shown in green, whereas the rRNA is depicted in cyan. C) The 
R116A; R117A mutations increase +1 frameshifting on CGA codons. The architecture of the dual-
luciferase reporter is shown on top; the XYZ indicates the different nucleotides that were inserted 
in the linker region between the two coding sequences. An additional adenosine (A) was added for 
the +1 frameshifting reporters. Relative luminescence of firefly luciferase (FL) to that of renilla 
luciferase (RL) from the indicated reporters in the wild-type and mutant Rps3 strains is plotted. 
The readings were normalized to those measured from the non-stalling (AGA)4 reporter. Asterisk 
denotes a significant difference between wild type and mutant rps3 for (CGA)4+1 (p<0.005). For 
comparison, p=0.096 for the (AGA)4+1 reporter.  D) The Rps3 mutations promote frameshifting 
on previously-described stalling sequences. Bar graphs of the normalized luminescence ratio (to 
the original reporter with no insertion between the two reporters) for the indicated reporters in the 
wild-type and Rps3-mutant strains. E) The Rps3 mutations have little to no effect on programmed 
frameshifting. Normalized ratios of FL luminescence to that of RL for a reporter harboring the 
Ty1 transposon frameshifting site in wild-type and rps3 strains. F) The entry tunnel mutations do 
not affect missense and nonsense miscoding. Normalized luminescence ratios for reporters, which 
have the active-site FL Lys residue (K529) mutated to the indicated amino acid. In all cases, the 
mean + SD of at least three biological repeats is plotted.  
Entry tunnel residues of Rps2 do not affect frameshifting 
Alongside Rps3, the mRNA entry tunnel of the ribosome encompasses residues of Rps2 
(Figure 1B), namely K119, E120, Q94, R95, suggesting that the protein may also play a role in 
frame maintenance. However, previous data from our group showed mutations in this region of 




Consistent with their apparent lack of effect on NGD, these mutations did not change frameshifting 
efficiency on the (CGA)4+1 reporter (Figure S4). Furthermore, the RPS2 mutations did not alter 
the increased levels of frameshifting observed in the rps3 (R116A; R117A) background. These 
observations suggest that Rps3 plays an especially important role in frame maintenance beyond its 
role as a constituent of the helicase domain of the ribosome. In agreement with this notion, genetic 
screens by the Culbertson and Grayhack groups identified a separate mutation in Rps3 (K108E), 
which promotes efficient +1 frameshifting (Hendrick et al., 2001, Juszkiewicz et al., 2018, Wang 
et al., 2018). This mutation also caused increased frameshifting on our (CGA)4+1 reporters (Figure 
S4) lending additional support to the idea that Rps3 plays a general role in preventing unwanted 
+1 frameshifting. 
Asc1/RACK1 promotes frame maintenance independently of Rps3 
To examine the potential contribution of other NGD components, we introduced the Rps3 
mutations into yeast backgrounds that affect the pathway, but none were found to alter the observed 
increased levels of frameshifting seen in the Rps3 mutant alone (Figure 2A). Furthermore, in 
addition to Rps3, the ribosome-associated factor Asc1 (human RACK1) has been documented to 
affect multiple facets of NGD and ribosome-quality control (RQC) of nascent peptides during 
stalling (Ikeuchi and Inada, 2016, Letzring et al., 2013, Sitron et al., 2017, Wolf and Grayhack, 
2015). Most relevant to our studies is the observation that in yeast its deletion results in increased 
frameshifting on CGA codons (Wolf and Grayhack, 2015); furthermore, the protein interacts with 
the C-terminal end of Rps3 on the ribosome (Ben-Shem et al., 2011). Hence, it is possible that the 
increased frameshifting we observe in the presence of the Rps3 mutations are due to Asc1-specific 




reduce its association with the ribosome (Coyle et al., 2009). As has been reported earlier for the 
asc1 deletion (Wolf and Grayhack, 2015), these mutations enhanced frameshifting on our 
(CGA)4+1 construct to 5.8 ± 0.18%. In the presence of the Rps3 mutations alone, the observed 
occurrence of frameshifting was 13.7 ± 0.9%, and surprisingly, when combined with the asc1 
mutations we observe a compounding effect, resulting in 36.0 ± 2.4% frameshifting, suggesting 
that the factors may, at least in part, contribute to NGD independently (Figure 2B). This is 
consistent with structural and biochemical studies showing that Asc1 interacts with Rps3 away 
from the entry tunnel (Ben-Shem et al., 2011), and that mutations of Rps3’s entry-tunnel residues 
do not affect the interaction between Asc1 and the ribosome (Simms et al., 2018). The same 
mutations appear to have little to no effect on +1 frameshifting on polyA sequences, presumably 
because frameshifting on these sequences results in the same sequence in the A site and does not 
alleviate stalling (Figure S5). Similarly, frameshifting on reporters harboring other stretches of 






Figure 2. +1 frameshifting does not depend on NGD components but is correlated with 
ribosome density.  
A) Deletion of NGD factors does not alter the effect of the Rps3 mutations on frameshifting. 
Normalized ratios of FL luminescence to that of RL for the (CGA)4+1 reporter in the indicated 
strains. B) The effects of Rps3 mutation on frameshifting are additive with mutations in Asc1. The 
bar graph shows the normalized luminescence ratios for the (CGA)4+1 reporter in the indicated 
strains. In the double mutant (rps3; asc1), frameshifting efficiency is nearly 40%. C) Bar graph of 
normalized FL/RL luminescence ratios for the indicated reporters in wild-type and rpl1b strains. 
D) Similar to first dataset in C). Deletion of rpL1b results in decreased +1 frameshifting. In all 
cases, the mean + SD is plotted from at least three biological replicates, normalized to values for 




Ribosome density is correlated with +1 frameshifting 
Our analysis suggests that there is a correlation between NGD inhibition and increased +1 
frameshifting, but the underlying mechanism is unclear. We suggest that in the absence of efficient 
cleavage of the aberrant mRNA, an increase in collision events, which go unresolved, results in a 
steric clash between ribosomes. Consequently, this somehow causes the leading ribosome to move 
out of frame, which in turn alleviates stalling (the P-site codon changes from the inhibitory CGA 
one to GAC). A prediction of this model is that frameshifting should be correlated to ribosome 
density. Earlier work by our laboratory has shown that reducing cellular ribosome concentrations 
by depleting ribosomal proteins strongly inhibits NGD (Simms et al., 2017). This in turn results in 
readthrough of CGA codons. It is important to note that the mechanism by which reduction of 
ribosome density inhibits NGD –decreased collision events– is different from the one induced by 
the rps3 mutations –increased collision events–; hence their effects on frameshifting should also 
be divergent. In complete agreement with our model, deletion of one of the two genes that encode 
ribosomal protein Rpl1 (rpl1b) decreased frameshifting by fourfold (from 2.8 ± 0.17% to 0.7 ± 
0.15%) (Figure 2C, 2D). Deletion of rpl1b has a dramatic effect on ribosome concentrations, but 
not its composition, that is apparent in polysome profiles of the deletion strain; a marked decrease 
in the amount of polysomes indicates a reduction in the density of ribosomes on mRNAs (Simms 
et al., 2017). Interestingly, this relationship between ribosome density and “unwanted” +1 
frameshifting is in direct contrast to what we know about programmed frameshifting, for which 
slowed translation is a major determinant for increased recoding (Kawakami et al., 1993). 
+1 frameshifting increases at greater distances from the initiation codon 
To further probe the mechanism for collision-induced frameshifting, we placed the 




rationale behind these experiments is that at distances close to the initiation codon, the stalling 
sequence would prevent multiple ribosomes from loading onto the transcript, precluding collisions. 
Indeed, we observe no increase in frameshifting relative to the wild-type strain in the rps3 and 
asc1 mutants, unless the stalling sequence is placed at least 22 nts from the initiation codon (Figure 
3A). The efficiency of frameshifting increases as the stalling sequence moves farther from the 
initiation codon, consistent with the idea that loading multiple ribosomes behind the primary 
stalled ribosome increases frameshifting. This pattern was by and large independent of the rps3 
mutations; we observe a very similar dependence on stalling-sequence placement in the K108E 
mutant (Figure S6), which is also in agreement with data reported by Wolf and Grayhack (2015). 
Although programmed frameshifting also appears to be dependent on the frameshifting site, there 
was no obvious correlation between distance from start site and frameshifting efficiency. For Ty1, 
we observe equivalent efficiencies for constructs harboring the site between 3 and 83 nt from the 
start codon, but frameshifting significantly increases when it was placed at position 429 (Figure 
3B). For the programmed frameshift sequence EST3, frameshifting efficiency was higher for 
position 3 relative to positions 22 and 83, but significantly increased for position 429 (Figure S6). 






Figure 3. Frameshifting on CGA inhibitory codons depends critically on the position of the 
stalling sequence and is likely to require multiple ribosomes to load onto the mRNA.  
A schematic of the reporter indicates the dual-luciferase-fusion reporter together with a GFP 
reporter under a constitutive promoter that is oriented opposite to the luciferase reporter. The 
frameshifting site (fs) was placed at different positions throughout the renilla coding sequence. A) 
Frameshifting only occurs on reporters that have the fs site placed at least 22 nucleotides from the 
initiation codon. Ratios of FL luminescence to GFP fluorescence for the indicated reporters, 
normalized to values obtained using the wild-type strain, obtained in the presence of the rps3 
(R116A; R117A), asc1 (R38D; K40E) and the double mutation are plotted. B) Similar to A), but 
the (CGA)4+1 fs sequence was substituted with the (programmed fs) Ty1 transposon sequence. In 
all cases, the mean + SD of at least three biological repeats is plotted.  
 
+1 frameshifting correlates with the efficiency of gene expression 
Next, we sought to change ribosome density specifically on our frameshifting reporters 
without affecting overall ribosome homeostasis. We reasoned that by modifying the 5’-UTR 
sequence, we should be able to change initiation efficiency and hence ribosome density. In the first 




slow or inhibit scanning by the small subunit during initiation (Hinnebusch et al., 2016). These 
reporter plasmids, in addition to having the dual luciferase gene to measure frameshifting, harbor 
a gene that encodes sf-GFP (Pedelacq et al., 2006). Both genes are under constitutive promoters. 
As a result, the ratio of renilla luminescence to GFP fluorescence reports on translation efficiency 
of the reporters with the different stem loops; and that of firefly luminescence to the renilla one 
reports on frameshifting. As expected, the introduction of the stem loops reduced the expression 
of renilla luciferase by as much as four orders of magnitude and this reduction correlated well with 
the equilibrium constant of unwinding for the stem loops (Figure 4A). Importantly, the level of 
frameshifting correlated well with gene expression, and presumably ribosome density, regardless 
of the mutation. For the rps3; asc1 mutant, we measured an R value of 0.84; for the rps3(K108E), 
we measured an R value of 0.79 (Figure 4B, 4C and Figure S7). Therefore, initiation efficiency, 
and likely ribosome density, is a good predictor for frameshifting efficiency. 
As a second approach for this collision model, we introduced different natural yeast 5’-
UTRs into our frameshifting reporter. In total, we generated 22 reporters with 5’-UTRs that span 
a broad length (30 to 829 nucleotides), which we expected to have drastic effects on initiation 
efficiency and hence gene expression (Hinnebusch et al., 2016). We measured ratios of renilla 
luminescence to GFP fluorescence (our measure for translation efficiency) that were more than an 
order of magnitude different among the different UTRs. Likewise, frameshifting efficiency varied 
by more than fivefold among the different reporters (Figure 4D, 4E and Figure S7). Most pertinent 
to our model, however is the observation that, similar to our stem-loop reporters, the amount of 
frameshifting we observed was found to correlate tightly with gene expression, with R values of 




documented for the stem-loop reporters, no correlation between translation efficiency and 
frameshifting was observed for programmed Ty1 frameshifting (Figure 4F). The results for asc1 
may highlight differences in its role with respect to frameshifting as it correlates with gene 
expression in the stem loop experiments, but not in the UTR ones (Fig. S7). It may also be due to 
our choice of strain – we observe lower frameshifting efficiencies with the R38DK40E mutations 
than are reported for the asc1 deletion strain (Wolf and Grayhack, 2015). Collectively, our use of 
reporters with disparate initiation rates suggests that translation efficiency, and hence ribosome 





Figure 4: Efficiency of stalling-induced frameshifting correlates with gene expression.  
A schematic of the reporter, which harbors the fs site between RL and FL coding sequence, is 
shown on top. Stem loops of various lengths were introduced in the UTR of the dual-luciferase 
gene. A) Plot of the ratio of RL luminescence relative to GFP fluorescence versus the equilibrium 
constant of unwinding of the stem loops. The equilibrium constants were calculated from G 
values determined by mfold (Zuker, 2003). B) A plot of luminescence ratios (RL/FL), which 
reports on fs efficiency, against that of RL luminescence to GFP fluorescence, which reports on 
gene-expression, in the rps3; asc1 double mutant. C) Similar to B, but in the rps3 K108E mutant. 
D) A schematic of the reporter is shown on top. It is similar to the one shown in A, but instead of 
stem loops various native yeast UTRs were introduced upstream of the dual-luciferase gene. The 
plot is similar to B) but uses the UTR reporter set. E) Similar to C), with UTR reporter set. F) A 
schematic of the reporter used to assess the effect of gene-expression efficiency on programmed 
fs is shown. The reporter is similar to that used in D) but harbors the Ty1 fs sequence between RL 
and FL instead of the stalling (CGA)4+1 sequence. The plot shows FL/RL luminescence ratios 
versus RL luminescence divided by GFP fluorescence. Note the lack of correlation between the 
two. In all cases, the mean + SD of at least three biological repeats is plotted.  
 
Collision is required for +1 frameshifting-dependent gene expression in vitro 
To address the collision model more directly, we chose to use the bacterial reconstituted 
PURE system (NEB) because of the polycistronic organization of genes in bacteria. This allowed 
us to generate mRNA reporters consisting of two genes with overlapping coding sequences. In 
particular, the initiation codon of the downstream gene resides within the coding region of the 
upstream one, and translation of its full-length product depends on an early frameshifting event 
(poor stop-codon context with CCC UGA coding for Pro-STOP at codon 7 from the start codon) 
(Gurvich et al., 2003). In other words, translation of this gene in isolation would allow for a 
maximum of one ribosome to load before the frameshift site is encountered. As a result, if 
frameshifting is dependent on ribosome collision, then the translation of the downstream gene 
should be dependent on the translation of the upstream gene. As a positive control, we generated 
a reporter for which translation of the downstream gene does not depend on frameshifting (Figure 




downstream one does not and, as expected, translation of the upstream gene, which contains an N-
terminal-HA tag, was dependent on cysteine for both reporters. In the absence of cysteine, the 
amount of protein products as assessed by western blotting decreased by ~twofold (Figure 5B). 
This incomplete inhibition of synthesis of the upstream product is likely due to partial deacylation 
of the tRNAs in the reaction mix. Regardless, synthesis of the downstream protein products, as 
assessed by western blotting against the C-terminal-Flag tag, differed between the two reporters. 
For the positive-control reporter, depletion of cysteine had little to no effect on its translation 
(Figure 5B). This was expected as the downstream gene does not encode cysteine residues. In 
contrast and in agreement with our prediction, for the frameshifting reporter we observed a 
~twofold reduction of protein produced for the downstream gene in the absence of cysteine. This 
suggests that its synthesis depends on translation of the upstream gene, since the downstream 
protein does not contain any cysteine residues, and therefore it is likely that collisions from 
ribosomes translating the upstream gene are required to induce frameshifting on the downstream 
gene. Not only do these observations add support for ribosome collisions playing an important role 
in promoting frameshifting, but they also suggest that the mechanism is conserved, occurring in 





Figure 5. Collisions result in frameshifting in a reconstituted bacterial system.  
A) A schematic of the reporters used to assess the effect of collisions on frameshifting. The 
reporters are bicistronic, with the initiation codon of the downstream gene residing within the 
upstream gene. The first ORF codes for an N-terminal HA tag as well as cysteine residues 
throughout. ORF 2 codes for a C-terminal FLAG tag and no cysteine residues; it is in the +1 frame 
relative to the upstream gene. For the collision reporter, the downstream gene has a stop codon in 
a poor context (CCC TGA) and requires a frameshift to translate the C-terminal FLAG. B) 
Western-blot analysis of in vitro translation reactions with the indicated reporters in the presence 
or absence of cysteine. Synthesis of the upstream protein, assessed by probing with HA, is more 
robust in the presence of cysteine. Synthesis of the downstream protein from the collision reporter 
is twice as abundant in the presence of cysteine, and hence the synthesis of the upstream protein. 






The ability of the ribosome to precisely and repetitively move three nucleotides at a time 
during the elongation phase of protein synthesis is an indispensable feature of the translation 
machinery. This maintenance of reading frame ensures that the genetic code is faithfully 
deciphered. To this end, frameshifting errors are among the most deleterious ones, especially when 
compared to missense errors, as they result in peptide products that bear no resemblance to the 
intended protein. Precise translocation, and hence the prevention of frameshifting, is not an easy 
task given the multiple coordinated movements of the mRNA, tRNA and the ribosomal subunits 
that must occur (Noller et al., 2017). After peptidyl transfer, the peptidyl-tRNA residing in the A 
site must move to the adjacent P site. Initially, the acceptor stem of the tRNA moves from the A 
site to the P site of the large subunit, while the anticodon stem remains in the A site of the small 
subunit, forming the so-called “hybrid” state (Moazed and Noller, 1989). Following EF-G (eEF2) 
binding, GTP hydrolysis and Pi release, full translocation of the tRNA to the P site of the ribosome 
is completed (Brilot et al., 2013, Pulk and Cate, 2013, Ramrath et al., 2013, Tourigny et al., 2013, 
Voorhees and Ramakrishnan, 2013, Zhou et al., 2013, Zhou et al., 2014, Belardinelli et al., 2016, 
Noller et al., 2017). During this process, multiple interactions between the tRNA-mRNA complex 
and the ribosome must be disrupted, and new ones established. Multiple elements of the ribosome, 
translation factors and the tRNA contribute to these interactions and hence the precision of the 
translocation process. Indeed, mutations in the tRNA, mRNA and the ribosome that alter some of 





The P-site tRNA, through its interaction with the mRNA codon, appears to play an 
important role in reading frame maintenance (Baranov et al., 2004). More specifically, the 
likelihood of the tRNA anticodon to transiently dissociate and establish new out-of-frame base-
pairing interactions is governed by the energetics of binding to the P-site codon. In addition to 
tRNA-mRNA interactions, stalling plays a major role in promoting frameshifting. This is mainly 
dictated by the nature and availability of the A-site ligand (Farabaugh et al., 2006). For example, 
during RF2-programmed frameshifting in bacteria, the efficiency of frameshifting at the poorly 
decoded RF2-specific UGA stop codon is significantly impacted by the concentration of cellular 
RF2 (Craigen and Caskey, 1986). Finally, frameshifting is heavily influenced by structural 
impediments upstream or downstream of the ribosome. Using RF2-programmed frameshifting as 
an example again, this impediment is provided by a Shine-Dalgarno sequence upstream that has 
been hypothesized to base pair with the rRNA, pulling the mRNA out of frame (Marquez et al., 
2004, Devaraj and Fredrick, 2010). 
Here we provide compelling evidence that, if left unresolved, ribosomes colliding behind 
the primary stalled one provide the necessary structural element for efficient frameshifting. To 
look at unintended frameshifting, we chose the CGA codon and yeast as a model system. The 
wobble adenosine nucleotide, as decoded by inosine on the anticodon, provides the necessary weak 
interaction in the P site, which presumably allows for dissociation and reassociation of the tRNA. 
The presence of an adjacent slowly-decoded CGA codon in the A site lends the additional 
requirement of stalling for efficient frameshifting (Letzring et al., 2010). Our data suggests that 
these two requirements are not sufficient for frameshifting to occur. Ribosome queuing is needed 




Previous data from our group as well as others have shown ribosome collisions to activate 
the process of NGD (Simms et al., 2017, Juszkiewicz et al., 2018, Ikeuchi et al., 2019), which 
results in the endonucleolytic cleavage of the mRNA and hence resolving collisions. Consistent 
with our collision-induced frameshifting model, inhibition of the cleavage reaction by introducing 
mutations to the ribosomal protein Rps3 in the entry tunnel increases frameshifting significantly. 
This agrees with data from the Grayhack group that showed deletion of the NGD/RQC factor Asc1 
also results in significant frameshifting (Wolf and Grayhack, 2015). Here, we too show that 
mutations of Asc1 that disrupt its interaction with the ribosome promote frameshifting. Ribosome-
associated Asc1 appears to be important for the recruitment of the E3 ligase Hel2 (Juszkiewicz 
and Hegde, 2017, Sundaramoorthy et al., 2017, Matsuo et al., 2017, Sitron et al., 2017), which 
adds K63-linked ubiquitin chains on collided ribosomes (Ikeuchi et al., 2019). Deletion and 
mutation of Asc1 have been documented to inhibit NGD-associated cleavage of the mRNA and 
downstream ribosome rescue by Dom34/Hbs1/Rli1 (Ikeuchi and Inada, 2016). Asc1 likely senses 
collided ribosomes and somehow communicates that information to Hel2. In its absence, 
ribosomes pile up behind the primary stalled one and cause it to move out of frame. Interestingly, 
previous work also from the Grayhack group has suggested that the ribosome associated protein 
Mbf1 is recruited to stalled ribosomes where, together with Rps3, they may act as bumpers, 
preventing adjacent ribosomes from colliding (Wang et al., 2018). 
Although there are previous reports of a relationship between frameshifting and NGD, the 
connection between frameshifting and ribosome collision, and the underlying mechanics have not 
been explored prior to the work presented here. We provide various pieces of evidence to support 




cellular concentration of ribosomes, which decreases their density on mRNA and hence their 
likelihood of collision, lowered frameshifting by more than threefold (Figure 2D). Furthermore, 
when the stalling sequence is placed near the initiation codon, so that a maximum of one ribosome 
can occupy the mRNA before encountering the stall site, we observe little to no increase in 
frameshifting as a result of NGD inhibition. The correlation between ribosome density and 
frameshifting efficiency is bolstered by our observation that alteration of ribosome loading onto 
the mRNA by modulating initiation efficiency impacted frameshifting by almost an order of 
magnitude (Figure 3). We document a significantly positive correlation between translation 
efficiency, and hence ribosome loading, and frameshifting (Figure 3). It should be noted that in 
these experiments, ribosome density was only altered on our reporters without globally affecting 
translation. Finally, and perhaps the strongest piece of supporting evidence comes from our 
experiments in a reconstituted bacterial translation system. Here we observe that frameshifting on 
the downstream gene of a polycistronic mRNA depends critically on the ability of ribosomes to 
translate the upstream gene and collide with the ribosomes stalled on the downstream one (Figure 
5). Collectively through the use of various reporters and genetic manipulations in yeast as well as 
a high-resolution in vitro bacterial translation system, we provide data that strongly suggest that 
ribosome collisions result in +1 frameshifting. 
Given that ribosome collisions are likely to happen during translation under normal 
conditions, it should not be surprising that a mechanism for reducing their impact on cellular fitness 
may have evolved. In conclusion, we propose a mechanism for collision-induced frameshifting 
(Figure 6), whereby the behind ribosome translocates along the mRNA until it reaches the stalled 




cleavage and downstream events of NGD. Under conditions where cleavage is inhibited, the 
behind ribosome is free to pull on the mRNA –since its A-site codon is competent –exerting force 
on the fully-stretched RNA, resulting in slippage by the stalled ribosome causing it to frameshift.  
 
Figure 6. A model for collision-induced frameshifting.  
In this model the colliding, behind ribosome pulls on the mRNA resulting in its slippage from 
the A site of the lead, stalled ribosome. 
 
Not only does this study add critical insights into frame maintenance and its relationship 
to mRNA-quality control processes, but also suggests that ribosomes are able to change the 
decoding properties of their neighboring ones. While there has been a wealth of studies that have 
looked at the role of RNA structure and sequence on frameshifting (Farabaugh et al., 2006), this 
study may be the first to look at the ribosome itself acting in trans to affect the decoding properties 









promoting frameshifting, our findings suggest that this is a widespread phenomenon that cells need 
to deal with, especially given that ribosome collisions are predicted to occur frequently. As a result, 
it is tempting to speculate that NGD, in addition to its primary role in mRNA-quality control 
(Simms et al., 2016), evolved to cope with stochastic collisions events that are bound to take place 
occasionally and, if left unresolved, result in deleterious frameshifting events. At a minimum our 
data reveals a profound connection between an mRNA surveillance mechanism and maintaining 






Yeast strains were cultured in YPD or defined media (when expressing reporter plasmids) 
at 30°C. Strains carrying mutations were constructed using standard PCR-based recombination 
techniques in the background BY4741 (MATa (his31 leu20 met150 ura30). Strains used in 
this study are included as Supplemental Table 1. 
The RPS2 mutant strains were generated by cloning a PCR fragment encoding RPS2-
LEU2-rpS2 3’UTR into the BamHI/XbaI sites in pPROEX-Htb. Point mutations in RPS2 were 
introduced by site directed mutagenesis, the entire region PCR amplified and the resulting 
fragment used for transformation of target yeast strains. RPS3 (K108E) strains were made in the 
same manner, except a HIS3 gene was used to tag RPS3 and the PCR product was cloned into 
pPROEX-Htb using BamHI and XhoI sites. The HIS3 and LEU2 coding regions were amplified 
from plasmids pFA6a-6xGLY-FLAG-HIS3 and pAG415 respectively(Alberti et al., 2007, 
Funakoshi and Hochstrasser, 2009). pAG415-GPD-ccdB was a gift from Susan Lindquist 
(Addgene plasmid # 14146; http://n2t.net/addgene:14146). 
Plasmids 
The Renilla-Firefly dual luciferase reporter was constructed from plasmid pDB688(Salas-
Marco and Bedwell, 2005) using site-directed mutagenesis to insert various sequences between 
the two coding regions. These included the CGA and AGA codon repeats (with an extra A in the 
+1 constructs), and the Ty1 and EST3 fs sequences. The Lys 529 constructs were built similarly, 




The GFP-dual luciferase reporter was assembled from overlapping PCR products; the GPD 
promoter sequence from pAG415 driving GFP(Wolf and Grayhack, 2015) in one orientation, with 
a dual luciferase frameshifting cassette positioned in the opposite direction and driven by a PGK1 
promoter. In the first set of constructs, frameshifting sequences ((CGA)4+1, Ty1, or EST3) were 
inserted into the Renilla luciferase gene by PCR amplifying the entire plasmid and re-ligating using 
AgeI sites that were included in the primer oligos. For experiments with constructs containing 
various stem loop or 5’ UTR sequences, PCR fragments were cloned into BglII sites downstream 
of the PGK1 promoter or AscI/SbfI sites, respectively. 
The in vitro fs constructs were designed with two overlapping coding regions, derived from 
sequences for E. coli InfA and DHFR, and the dsDNA templates were obtained from IDT.  
All plasmid constructs and DNA oligos used in this study are included as Supplemental Table 2. 
Luminescence Assays - Dual Luciferase Reporters 
5-10 ml of exponentially growing culture (defined media –Ura) was collected. The cell 
pellet was washed with TE and resuspended in 100-200 µL of passive lysis buffer (Promega). 
Lysis was accomplished by adding glass beads (~ 50 µL) to the sample and vortexing 5 × for a 
minute each time at high speed, with incubation on ice in between each interval. The lysate was 
clarified by centrifugation and diluted 30 to 50-fold. Luminescence was measured using the Dual-
Luciferase Reporter Assay System (Promega) on a Tecan plate reader equipped with an automated 
injection system. 




Overnight cultures were grown to saturation in 0.5 mL media in 96-well deep well plates, 
diluted 1:100 into 1 mL media and grown to OD ~ 0.5-0.8. Cells were then pelleted, washed once 
with sterile water and pelleted again. 25 L of 1 mg/mL zymolase in buffer [50 mM Tris-Cl (pH 
7.5); 10 mM MgCl2; 1 M sorbitol; 30 mM DTT] was added per well, shaken briefly to mix, and 
incubated at 37C for 30 minutes. Cells were lysed by adding 250 L 1X Passive Lysis Buffer 
(Promega) and shaking vigorously for 10 minutes. After brief centrifugation, 50 L of lysate was 
added to each well of a 96-well plate. GFP fluorescence was measured using a Tecan plate reader 
(485 nM excitation/530 nM emission) immediately followed by luminescence measurement using 
the Dual Luciferase Reporter Assay system (Promega). 
For all luciferase reporter assays, experiments were run in triplicate and the data was 
analyzed and plotted using Graphpad Prism. 
Quantitative RT-PCR. 
Total RNA from different yeast cells was isolated following the hot phenol method. cDNA was 
then generated with M-MuLV reverse transcriptase (Promega) from 2ug of total RNA that was 
treated with DNase 1 (Themo Fisher Scientific). Quantitative RT-PCR was conducted by using 
iTaq Universal SYBR Green Supermix (BIO-RAD) with ~50ng of cDNA. Relative fold change 
was obtained by following the Ct method between the RL and FL PCR products. 
In vitro translation assays 
Assays were performed using the PUREexpress in vitro protein translation kit (NEB), 





Proteins were isolated using NaOH/TCA and were resuspended in HU buffer (8 M Urea, 
5% SDS, 200 mM Tris pH 6.8, 100 mM DTT). Proteins were resolved on 12% SDS PAGE gels 
and transferred to PVDF membrane using a semi-dry transfer apparatus (BioRad). Membranes 
were blocked in 5% milk/PBST for ~ 30 minutes at room temperature followed by incubation with 
primary antibody overnight at 4°C. After washing with PBST, the membrane was incubated with 
the appropriate HRP-conjugated secondary antibody for ~ 1hr at room temperature before washing 
3-4 × with PBST. Detection was carried out on a GE ImageQuant LAS 4000 using Pierce 
SuperSignal West Pico Chemiluminescent Substrate. The following antibodies were used: mouse 
anti-FLAG [M2] from Sigma-Aldrich; HA-probe antibody, Y-11 (Santa Cruz, sc-805), Anti-
Renilla Luciferase Antibody, clone 1D5.2 (milipore, MAB4410), Anti-Firefly Luciferase antibody 
(Abcam, ab21176) rabbit anti-eRF1 was a gift from R. Green(Eyler et al., 2013); goat anti-mouse 





Akopian, D., Shen, K., Zhang, X., and Shan, S.O. (2013). Signal recognition particle: an essential 
protein-targeting machine. Annu Rev Biochem 82, 693-721. 
 
Anderson, J.S., and Parker, R.P. (1998). The 3' to 5' degradation of yeast mRNAs is a general 
mechanism for mRNA turnover that requires the SKI2 DEVH box protein and 3' to 5' exonucleases 
of the exosome complex. EMBO J 17, 1497-1506. 
 
Bengtson, M.H., and Joazeiro, C.A.P. (2010). Role of a ribosome-associated E3 ubiquitin ligase 
in protein quality control. Nature 467, 470-473. 
 
Brandman, O., and Hegde, R.S. (2016). Ribosome-associated protein quality control. Nat Struct 
Mol Biol 23, 7-15. 
 
Brandman, O., Stewart-Ornstein, J., Wong, D., Larson, A., Williams, C.C., Li, G.-W., Zhou, S., 
King, D., Shen, P.S., Weibezahn, J., et al. (2012). A Ribosome-Bound Quality Control Complex 
Triggers Degradation of Nascent Peptides and Signals Translation Stress. Cell 151, 1042-1054. 
 
Brandt, F., Carlson, L.A., Hartl, F.U., Baumeister, W., and Grunewald, K. (2010). The three-
dimensional organization of polyribosomes in intact human cells. Mol Cell 39, 560-569. 
 
Chen, L., Muhlrad, D., Hauryliuk, V., Cheng, Z., Lim, M.K., Shyp, V., Parker, R., and Song, H. 
(2010). Structure of the Dom34-Hbs1 complex and implications for no-go decay. Nat Struct Mol 
Biol 17, 1233-1240. 
 
Chiabudini, M., Conz, C., Reckmann, F., and Rospert, S. (2012). Ribosome-Associated Complex 
and Ssb Are Required for Translational Repression Induced by Polylysine Segments within 
Nascent Chains. Mol Cel Biol 32, 4769-4779. 
 
Defenouillere, Q., Yao, Y., Mouaikel, J., Namane, A., Galopier, A., Decourty, L., Doyen, A., 
Malabat, C., Saveanu, C., Jacquier, A., et al. (2013). Cdc48-associated complex bound to 60S 
particles is required for the clearance of aberrant translation products. Proc Natl Acad Sci USA 
110, 5046-5051. 
 
Doma, M.K., and Parker, R. (2006). Endonucleolytic cleavage of eukaryotic mRNAs with stalls 
in translation elongation. Nature 440, 561-564. 
 
Eng, J.K., McCormack, A.L., and Yates, J.R. (1994). An approach to correlate tandem mass 
spectral data of peptides with amino acid sequences in a protein database. J Am Soc Mass Spectrom 
5, 976-989. 
Eyler, D.E., Wehner, K.A., and Green, R. (2013). Eukaryotic release factor 3 is required for 






Ferreira-Cerca, S., Poll, G., Gleizes, P.E., Tschochner, H., and Milkereit, P. (2005). Roles of 
eukaryotic ribosomal proteins in maturation and transport of pre-18S rRNA and ribosome function. 
Mol Cell 20, 263-275. 
 
Frischmeyer, P.A., van Hoof, A., O'Donnell, K., Guerrerio, A.L., Parker, R., and Dietz, H.C. 
(2002). An mRNA surveillance mechanism that eliminates transcripts lacking termination codons. 
Science 295, 2258-2261. 
 
Funakoshi, M., and Hochstrasser, M. (2009). Small epitope-linker modules for PCR-based C-
terminal tagging in Saccharomyces cerevisiae. Yeast 26, 185-192. 
 
Garreau de Loubresse, N., Prokhorova, I., Holtkamp, W., Rodnina, M.V., Yusupova, G., and 
Yusupov, M. (2014). Structural basis for the inhibition of the eukaryotic ribosome. Nature 513, 
517-522. 
 
Graille, M., Chaillet, M., and van Tilbeurgh, H. (2008). Structure of yeast Dom34: a protein related 
to translation termination factor Erf1 and involved in No-Go decay. J Biol Chem 283, 7145-7154. 
 
Guydosh, N.R., and Green, R. (2014). Dom34 rescues ribosomes in 3' untranslated regions. Cell 
156, 950-962. 
 
Guydosh, N.R., and Green, R. (2017). Translation of poly(A) tails leads to precise mRNA 
cleavage. RNA 23, 749-761. 
 
Ikeuchi, K., and Inada, T. (2016). Ribosome-associated Asc1/RACK1 is required for 
endonucleolytic cleavage induced by stalled ribosome at the 3' end of nonstop mRNA. Sci Rep 6, 
28234. 
 
Jacobson, A., and Peltz, S.W. (1996). Interrelationships of the pathways of mRNA decay and 
translation in eukaryotic cells. Annu Rev Biochem 65, 693-739. 
 
Jeggo, P.A., Pearl, L.H., and Carr, A.M. (2016). DNA repair, genome stability and cancer: a 
historical perspective. Nat Rev Cancer 16, 35-42. 
 
Juszkiewicz, S., and Hegde, R.S. (2017). Initiation of Quality Control during Poly(A) Translation 
Requires Site-Specific Ribosome Ubiquitination. Mol Cell 65, 743-750 e744. 
 
Kim, S.J., Yoon, J.S., Shishido, H., Yang, Z., Rooney, L.A., Barral, J.M., and Skach, W.R. (2015). 
Protein folding. Translational tuning optimizes nascent protein folding in cells. Science 348, 444-
448. 






Korennykh, A.V., Egea, P.F., Korostelev, A.A., Finer-Moore, J., Zhang, C., Shokat, K.M., Stroud, 
R.M., and Walter, P. (2009). The unfolded protein response signals through high-order assembly 
of Ire1. Nature 457, 687-693. 
 
Koutmou, K.S., Schuller, A.P., Brunelle, J.L., Radhakrishnan, A., Djuranovic, S., and Green, R. 
(2015). Ribosomes slide on lysine-encoding homopolymeric A stretches. Elife 4. 
 
Kuroha, K., Akamatsu, M., Dimitrova, L., Ito, T., Kato, Y., Shirahige, K., and Inada, T. (2010). 
Receptor for activated C kinase 1 stimulates nascent polypeptide-dependent translation arrest. 
EMBO Rep 11, 956-961. 
 
Lee, H.H., Kim, Y.S., Kim, K.H., Heo, I., Kim, S.K., Kim, O., Kim, H.K., Yoon, J.Y., Kim, H.S., 
Kim do, J., et al. (2007). Structural and functional insights into Dom34, a key component of no-
go mRNA decay. Mol Cell 27, 938-950. 
 
Letzring, D.P., Dean, K.M., and Grayhack, E.J. (2010). Control of translation efficiency in yeast 
by codon-anticodon interactions. RNA 16, 2516-2528. 
 
Letzring, D.P., Wolf, A.S., Brule, C.E., and Grayhack, E.J. (2013). Translation of CGA codon 
repeats in yeast involves quality control components and ribosomal protein L1. RNA 19, 1208-
1217. 
 
Lu, J., and Deutsch, C. (2008). Electrostatics in the Ribosomal Tunnel Modulate Chain Elongation 
Rates. J Mol Biol 384, 73-86. 
 
Martin, M. (2011). Cutadapt removes adapter sequences from high-throughput sequencing reads. 
EMBnet.journal 17, 10-12. 
 
Mitarai, N., Sneppen, K., and Pedersen, S. (2008). Ribosome collisions and translation efficiency: 
optimization by codon usage and mRNA destabilization. J Mol Biol 382, 236-245. 
 
Moritz, M., Paulovich, A.G., Tsay, Y.F., and Woolford, J.L., Jr. (1990). Depletion of yeast 
ribosomal proteins L16 or rp59 disrupts ribosome assembly. J Cell Biol 111, 2261-2274. 
 
Mueller, P.P., Grueter, P., Hinnebusch, A.G., and Trachsel, H. (1998). A ribosomal protein is 
required for translational regulation of GCN4 mRNA. Evidence for involvement of the ribosome 
in eIF2 recycling. J Biol Chem 273, 32870-32877. 
 
Pisareva, V.P., Skabkin, M.A., Hellen, C.U., Pestova, T.V., and Pisarev, A.V. (2011). Dissociation 
by Pelota, Hbs1 and ABCE1 of mammalian vacant 80S ribosomes and stalled elongation 
complexes. EMBO J 30, 1804-1817. 
 
Roguev, A., Wiren, M., Weissman, J.S., and Krogan, N.J. (2007). High-throughput genetic 





Rudra, D., Mallick, J., Zhao, Y., and Warner, J.R. (2007). Potential interface between ribosomal 
protein production and pre-rRNA processing. Mol Cell Biol 27, 4815-4824. 
 
Saito, K., Horikawa, W., and Ito, K. (2015). Inhibiting K63 polyubiquitination abolishes no-go 
type stalled translation surveillance in Saccharomyces cerevisiae. PLoS Genet 11, e1005197. 
 
Salas-Marco, J., and Bedwell, D.M. (2005). Discrimination between defects in elongation fidelity 
and termination efficiency provides mechanistic insights into translational readthrough. J Mol Biol 
348, 801-815. 
 
Schneider-Poetsch, T., Ju, J., Eyler, D.E., Dang, Y., Bhat, S., Merrick, W.C., Green, R., Shen, B., 
and Liu, J.O. (2010). Inhibition of eukaryotic translation elongation by cycloheximide and 
lactimidomycin. Nat Chem Biol 6, 209-217. 
 
Shao, S., Brown, A., Santhanam, B., and Hegde, R.S. (2015). Structure and Assembly Pathway of 
the Ribosome Quality Control Complex. Mol Cell 57, 433-444. 
 
Shao, S., and Hegde, R.S. (2014). Reconstitution of a Minimal Ribosome-Associated 
Ubiquitination Pathway with Purified Factors. Mol Cell 55, 880-890. 
 
Shao, S., von der Malsburg, K., and Hegde, R.S. (2013). Listerin-Dependent Nascent Protein 
Ubiquitination Relies on Ribosome Subunit Dissociation. Mol Cell 50, 637-648. 
 
Shen, P.S., Park, J., Qin, Y., Li, X., Parsawar, K., Larson, M.H., Cox, J., Cheng, Y., Lambowitz, 
A.M., Weissman, J.S., et al. (2015). Rqc2p and 60S ribosomal subunits mediate mRNA-
independent elongation of nascent chains. Science 347, 75-78. 
 
Shirai, A., Sadaie, M., Shinmyozu, K., and Nakayama, J. (2010). Methylation of ribosomal protein 
L42 regulates ribosomal function and stress-adapted cell growth. J Biol Chem 285, 22448-22460. 
 
Shoemaker, C.J., Eyler, D.E., and Green, R. (2010). Dom34:Hbs1 promotes subunit dissociation 
and peptidyl-tRNA drop-off to initiate no-go decay. Science 330, 369-372. 
Shoemaker, C.J., and Green, R. (2011). Kinetic analysis reveals the ordered coupling of translation 
termination and ribosome recycling in yeast. Proc Natl Acad Sci USA 108, E1392-1398. 
 
Silva, J.C., Gorenstein, M.V., Li, G.Z., Vissers, J.P., and Geromanos, S.J. (2006). Absolute 
quantification of proteins by LCMSE: a virtue of parallel MS acquisition. Mol Cell Proteomics 5, 
144-156. 
 
Simms, C.L., Hudson, B.H., Mosior, J.W., Rangwala, A.S., and Zaher, H.S. (2014). An active role 





Simms, C.L., Thomas, E.N., and Zaher, H.S. (2016). Ribosome-based quality control of mRNA 
and nascent peptides. Wiley Interdiscip Rev RNA. 
 
Sitron, C.S., Park, J.H., and Brandman, O. (2017). Asc1, Hel2, and Slh1 couple translation arrest 
to nascent chain degradation. RNA. 
 
Stevens, A. (1980). Purification and characterization of a Saccharomyces cerevisiae 
exoribonuclease which yields 5'-mononucleotides by a 5' leads to 3' mode of hydrolysis. J Biol 
Chem 255, 3080-3085. 
 
Subramaniam, A.R., Zid, B.M., and O'Shea, E.K. (2014). An integrated approach reveals 
regulatory controls on bacterial translation elongation. Cell 159, 1200-1211. 
 
Sundaramoorthy, E., Leonard, M., Mak, R., Liao, J., Fulzele, A., and Bennett, E.J. (2017). ZNF598 
and RACK1 Regulate Mammalian Ribosome-Associated Quality Control Function by Mediating 
Regulatory 40S Ribosomal Ubiquitylation. Mol Cell 65, 751-760 e754. 
 
Tagwerker, C., Zhang, H., Wang, X., Larsen, L.S., Lathrop, R.H., Hatfield, G.W., Auer, B., Huang, 
L., and Kaiser, P. (2006). HB tag modules for PCR-based gene tagging and tandem affinity 
purification in Saccharomyces cerevisiae. Yeast 23, 623-632. 
 
Toussaint, M., and Conconi, A. (2006). High-throughput and sensitive assay to measure yeast cell 
growth: a bench protocol for testing genotoxic agents. Nat protoc 1, 1922-1928. 
 
Tsuboi, T., Kuroha, K., Kudo, K., Makino, S., Inoue, E., Kashima, I., and Inada, T. (2012). 
Dom34:hbs1 plays a general role in quality-control systems by dissociation of a stalled ribosome 
at the 3' end of aberrant mRNA. Mol Cell 46, 518-529. 
 
van Hoof, A., Frischmeyer, P.A., Dietz, H.C., and Parker, R. (2002). Exosome-mediated 
recognition and degradation of mRNAs lacking a termination codon. Science 295, 2262-2264. 
Verma, R., Oania, R.S., Kolawa, N.J., and Deshaies, R.J. (2013). Cdc48/p97 promotes degradation 
of aberrant nascent polypeptides bound to the ribosome. Elife 2. 
 
Wilson, M.A., Meaux, S., and van Hoof, A. (2007). A genomic screen in yeast reveals novel 
aspects of nonstop mRNA metabolism. Genetics 177, 773-784. 
 
Wolf, A.S., and Grayhack, E.J. (2015). Asc1, homolog of human RACK1, prevents frameshifting 
in yeast by ribosomes stalled at CGA codon repeats. RNA 21, 935-945. 
Yan, X., Hoek, T.A., Vale, R.D., and Tanenbaum, M.E. (2016). Dynamics of Translation of Single 





CHAPTER 4: Oxidation and alkylation 
stresses activate ribosome-quality control 
 





Oxidation and alkylation of nucleobases are known to disrupt their base-pairing properties 
within RNA. It is, however, unclear whether organisms have evolved general mechanism(s) to 
deal with this damage. Here we show that the mRNA-surveillance pathway of no-go decay and 
the associated ribosome-quality control are activated in response to nucleobase alkylation and 
oxidation. Our findings reveal that these processes are important for clearing chemically modified 
mRNA and the resulting aberrant-protein products. In the absence of Xrn1, the level of damaged 
mRNA significantly increases. Furthermore, deletion of LTN1 results in the accumulation of 
protein aggregates in the presence of oxidizing and alkylating agents. This accumulation is 
accompanied by Hel2-dependent regulatory ubiquitylation of ribosomal proteins. Collectively, our 
data highlight the burden of chemically damaged mRNA on cellular homeostasis and suggest that 





The mRNA-surveillance pathway of no-go decay (NGD) is a eukaryotic ribosome-based, 
quality-control mechanism that targets transcripts stalled on ribosomes during translation . Much 
of the mechanistic details of NGD have emerged from a wealth of studies using yeast as the 
model(Doma and Parker, 2006; Passos et al., 2009; Shoemaker and Green, 2011; Shoemaker et 
al., 2010; Tsuboi et al., 2012), but the process appears to be highly conserved and employs a 
homologous set of factors in most other eukaryotes. In particular, when ribosomes stall upon 
encountering a defective mRNA, three key events occur: (i) the defective transcript is degraded 
rapidly; (ii) the stalled ribosomes are rescued; and (iii) the incomplete-nascent peptides are 
subjected to proteolysis. RNA breakdown is accomplished by at least two pathways; a primary 
route that involves the major 5’-3’ exonuclease Xrn1 and a secondary route triggered through an 
endonucleolytic cleavage of the bound transcript upstream of the stalled ribosome(Bengtson and 
Joazeiro, 2010; Brandman et al., 2012; Defenouillere et al., 2013; Doma and Parker, 2006; 
D’Orazio et al., 2019; Pisareva et al., 2011; Shoemaker and Green, 2011; Shoemaker et al., 2010; 
Tsuboi et al., 2012). Endonucleolytic cleavage generates an uncapped 3’-fragment and a 
deadenylated 5’-fragment, which are rapidly turned over through the exonucleolytic actions of 
Xrn1 and the exosome, respectively. As a result of this cleavage, ribosomes translating the 5’-
fragment run to the end of the mRNA, hence displaying an empty A site, which in turn marks them 
for the dissociating activity of Dom34/Hbs1/Rli1(Pisareva et al., 2011; Shoemaker and Green, 
2011; Shoemaker et al., 2010). The splitting action of Dom34/Hbs1/Rli1 leaves a peptidyl-tRNA-
bound large ribosomal subunit that is recognized by the ribosome-associated-quality-control 




factors to recognize the incomplete-nascent peptide, release it from stalled ribosomes, and deliver 
it to the proteasome for breakdown. The ubiquitin-protein ligase (E3) Ltn1 plays a key role during 
this process by adding K48-linked polyubiquitin chains to the nascent peptide while bound to the 
60S subunit as a peptidyl-tRNA adduct(Bengtson and Joazeiro, 2010; Brandman et al., 2012). 
Following release of the ubiquitylated peptide by the nuclease Vms1(Izawa et al., 2017; Kuroha 
et al., 2018; Verma et al., 2018; Yip et al., 2019; Zurita Rendón et al., 2018), the free species is 
recognized by the Cdc48-Ufd1-Npl4 disaggregase complex for final presentation to the 
proteasome(Defenouillere et al., 2013; Shao et al., 2013; Verma et al., 2013, 2018). 
Although NGD and RQC are initiated by the same signal - a stalled ribosome - how 
activation of the two processes is coordinated and, more specifically, how quality-control factors 
recognize and are recruited to ribosomes stalled on aberrant mRNAs remained largely unclear until 
recently. The discovery that ribosomal proteins are ubiquitylated during stalling and that the trigger 
for this modification is collided ribosomes shed new light on the activation events surrounding 
NGD and RQC(Juszkiewicz and Hegde, 2017; Matsuo et al., 2017; Saito et al., 2015; 
Sundaramoorthy et al., 2017). In yeast, the E3 ligase Hel2 has been shown to be a critical effector; 
it adds K63-linked polyubiquitin chains onto stalled ribosomal proteins, especially those within 
the small subunit. Accordingly, its deletion alleviates stalling and increases the production of full-
length-protein products from reporters engineered to stall(Brandman et al., 2012; Kuroha et al., 
2010; Letzring et al., 2013; Sitron et al., 2017). Hel2 appears to recognize collided 
ribosomes(Ikeuchi et al., 2019a; Juszkiewicz et al., 2018), which are expected to arise during 
stalling given that most mRNAs are occupied by multiple ribosomes such that collisions with 




ubiquitylation of stalled ribosomes provides the signal for the degradation of the aberrant mRNA, 
as either deletion of Hel2 or the introduction of mutations that prevent ribosomal protein 
ubiquitylation stabilizes the aberrant transcript(D’Orazio et al., 2019; Ikeuchi et al., 2019a; Simms 
et al., 2018). In this capacity, Hel2 is considered to be a master regulator that connects NGD and 
RQC. 
NGD and RQC have been studied almost exclusively in the context of artificial reporters 
that were genetically engineered to harbor roadblocks that stop ribosomes from translating. These 
blocks include: stable-RNA-secondary structures such as long stem loops, internal polyA 
sequences, stretches of rare codons, inhibitory codon pairs, and sequences encoding peptides that 
interact with the exit tunnel of the ribosome(Arribere and Fire, 2018; Chen et al., 2010; Doma and 
Parker, 2006; Guydosh and Green, 2017; Letzring et al., 2013; Tsuboi et al., 2012). While studies 
employing these reporters have been instrumental in unraveling the key mechanistic details related 
to NGD and RQC, the utility of these processes and their activation in response to different 
biological cues remain unclear.  
We previously showed that mRNAs harboring 8-oxoguanosine (8-oxoG) stall translation 
in an in vitro reconstituted translation system, suggesting that oxidized mRNAs are targeted for 
NGD(Simms et al., 2014). Furthermore, many alkylative adducts, especially those with a modified 
Watson-Crick face that are predicted to interrupt base-pairing during tRNA selection, also stall 
translation(You et al., 2017). In addition, unwanted modification of nucleic acids, especially in the 
context of DNA damage, has been well documented to occur as a result of nucleobase reactivity 
with endogenous and exogenous agents(Cadet and Wagner, 2013; Yan and Zaher, 2019). One 




pairing properties(Neeley and Essigmann, 2006; Sampoli Benítez et al., 2013). The adduct 8-oxoG 
is of particular note given its abundance, due to the inherent reactivity of guanosine with ROS(Lü 
et al., 2010; Simms and Zaher, 2016), as well as its proclivity to adopt a syn conformation capable 
of Hoogsten-type basepair interactions with adenosine(Sampoli Benítez et al., 2013). Conversely, 
alkylating agents can modify the nitrogen and oxygen atoms of the nucleobases(Sedgwick, 2004). 
Some of these modifications, including N1-methyladenosine (m1A), N1-methylguanosine (m1G) 
and N3-methylcytosine (m3C), are cytotoxic when present in DNA as they block replication and 
hence are predicted to stall translation(Larson et al., 1985; Simms and Zaher, 2016). 
While the above observations imply that cells have evolved pathways to recognize 
damaged mRNA and rapidly degrade it, the mechanistic details are not fully appreciated. Because 
transcripts that harbor damaged adducts are likely to stall translation, we hypothesize that damaged 
mRNA is subject to NGD while the encoded peptide is cleared by a RQC mechanism. Here, we 
tested this hypothesis and showed that both processes are activated by alkylation and oxidative 
stress to rapidly degrade chemically-modified mRNAs and the resulting aberrant peptides encoded 
by them. Collectively, our data suggest that NGD and RQC evolved coordinately to cope with 
adduct-mediated ribosome stalling and highlight the potential burden of chemically-modified 






Xrn1 deletion leads to oxidized and alkylated adducts in mRNA 
During NGD, regardless of the pathway involved, the aberrant mRNA is degraded by Xrn1(Doma 
and Parker, 2006; Tsuboi et al., 2012) . Deletion of this factor is known to stabilize not only a full-
length NGD reporter transcript but the cleaved 3’ fragment as well(Tsuboi et al., 2012). We 
reasoned that if damaged mRNA is subject to NGD, then deletion of XRN1 should increase the 
levels of modified nucleotides in the mRNA pool such as the oxidation product 8-oxoG. We 
previously used competitive ELISAs to show increased levels of 8-oxoG in xrn1 yeast 
cells(Simms et al., 2014). As this method is not sufficiently sensitive or quantitative, we used here 
two more analytical methods, namely electrochemical detection (ECD) (Fig. 1a) coupled with 
HPLC(Park et al., 1992) and LC-MS to better quantify the adduct(Su et al., 2014). Total RNA was 
isolated from wild-type and mutant cells and subjected to two rounds of poly-dT purification to 
enrich for poly-A RNA (Fig. 1 and Supplementary Fig. 1a). Total RNA and mRNA-enriched 
samples were then treated with P1 nuclease and the resulting nucleotides were dephosphorylated 
to nucleosides using calf-intestinal phosphatase (CIP) before analysis. Consistent with previous 
reports(Shen et al., 2000), we measured under normal conditions a ratio of 8-oxoG to G of 4 x 10-
5 and 3.7 x 10-5 in total RNA by ECD and LC-MS, respectively. As expected, this ratio did not 
change in xrn1 cells (Fig. 1b and Supplementary Fig. 1b, c). However, when poly-A RNA was 
specifically analyzed, the ratio of 8-oxoG to G increased by more than twofold when XRN1 was 
deleted (Fig. 1b and Supplementary Fig. 1c), suggesting that oxidized mRNA is selectively prone 






Figure 1. Oxidized and alkylated mRNAs accumulate in the absence of Xrn1.  
a, A representative HPLC-ECD chromatogram used to quantify the concentration of 8-oxoG in 
our samples. b, Bar graphs showing the ratio of 8-oxoG to G in total and polyA RNA in presence 
and absence of Xrn1. c, Bar graphs showing that the ratio of 8-oxoG to G in total and polyA RNA 
significantly increases when 4-NQO is added to growing yeast cells. d, Bar graphs demonstrating 
the ratio of the indicated alkylation adducts relative to their respective unmodified nucleoside in 
polyA RNA in the presence and absence of Xrn1. e, Same as d, but in the absence and presence 
of MMS. In all cases, Bars represent the average (±SD) of at least three independent biological 





To add further support for our model that damaged mRNA in general is selectively targeted 
for degradation, we analyzed specific alkylative damage marks, including m1A, m1G and m3C, 
which are known to disrupt base pairing(Larson et al., 1985; Simms and Zaher, 2016), as well as 
N7-methylguanosine (m7G), which does not disrupt base pairing. After processing of the RNA, 
the modified nucleosides were quantified by sensitive LC-MS methods(Su et al., 2014) that can 
detect 3.5-8.8 fmol of nucleoside (Supplementary Fig. 1e, f). Similar to our observations with 8-
oxoG, deletion of XRN1 significantly increased levels (2-3 fold) of the alkylative adducts known 
to disrupt Watson-Crick base pairing within mRNA (m1A, m1G, and m3C), while a more modest 
increase (~1.5 fold) was seen for m7G that does not modify Watson-Crick base pairing (Fig. 1d). 
As expected, deletion of XRN1 has little to no effect on the levels of these modifications in total 
RNA given their natural presence in rRNA and tRNA (Supplementary Fig. 1g). Collectively, the 
data agreed with our model that modified mRNAs, for which base pairing with tRNAs could be 
significantly disrupted, are subject to quality control with Xrn1 playing a critical role in their 
prompt degradation.  
Oxidizing and alkylating agents increase modifications in mRNA 
 Our initial findings implicated Xrn1 in rapidly degrading chemically-damaged mRNAs. 
We expect NGD to be responsible for this process whereby modified mRNAs are recognized by 
ribosomes, which in turn recruit downstream factors required for RNA degradation and RQC 
activation. To provide support for this model, we initially focused on increasing the levels of 
damaged mRNAs in yeast, which would allow us to assess whether different components of the 
quality-control pathways are activated. We took advantage of several damaging agents known to 




ROS and hence the oxidation of G(Arima et al., 2006; Kohda et al., 1986), and methyl 
methanesulfonate (MMS) which alkylates RNA via SN2-reactive species that modify the exocyclic 
oxygen and nitrogen atoms within the nucleobase(Lawley, 1974). As expected, the addition of 4-
NQO at 5 g/mL for 30 minutes led to a greater than 10-fold increase of 8-oxoG in polyA-RNA, 
but no significant increase in total alkylated bases (Fig. 1a, c, Supplementary Fig. 1i). Similarly, 
the addition of MMS at 0.1% for 30 minutes produced a 30-fold, 160-fold and 50-fold increase of 
m1A, m3C, and m7G in polyA-RNA, respectively, but no significant changes to the level of total 
8-oxoG (Fig. 1e, Supplementary Fig. 1d). We noted that the basal levels of these modified 
nucleosides in total RNA, were much higher given their natural presence in rRNA and tRNA 
species(Boccaletto et al., 2018). As a result, the addition of MMS led to only a modest increase in 
their levels (Supplementary Fig. 1h). Regardless, our findings revealed that the addition of 4-NQO 
and MMS causes the widespread accumulation of damaged nucleotides in the mRNA, which in 
turn should pervasively stall ribosomes.  
4-NQO and MMS increase ubiquitylation of nascent peptides 
 During RQC, the peptidyl-tRNA bound to the 60S subunit is recognized by Ltn1, which 
adds K48-linked polyubiquitin chains to the nascent peptide before its extraction by Cdc48 and 
presentation to the proteasome for degradation(Defenouillere et al., 2013; Verma et al., 2013). We 
reasoned that if 4-NQO increased the accumulation of 8-oxoG within mRNA, which in turn would 
stall ribosomes, a hyper-accumulation of ubiquitylated nascent peptides upon addition of the 
chemical would be observed. The levels of these peptides should increase when Cdc48 is 
inactivated and decrease without Ltn1. As CDC48 is an essential gene in yeast; we opted to use a 




ubiquitylation of nascent peptides, we used puromycin, a ribosomal A-site mimic that reacts with 
peptidyl tRNAs on the ribosome and terminates protein synthesis, to label nascent peptides.  
 
Figure 2. Ubiquitinated-nascent peptides accumulate in the presence of the oxidizing agent 
4-NQO.  
a, A schematic showing the experimental setup used to assess the amount of nascent peptides in 
the ubiquitinated pool. After the addition of 4-NQO, cells are harvested, lysed and puromycin is 
added to react with stalled ribosomes. TUBE beads are then used to bind ubiquitinated proteins. 
The purified proteins are separated using SDS-PAGE and probed with anti-puromycin antibody. 
b, Western-blot analysis of the input and TUBE-bound samples in the absence and presence of 4-
NQO for the wild-type, cdc48-ts, ltn1 and cdc48-ts;ltn1 cells. Note the signal for puromycin in 




absence of the drug to that in its presence at the permissive temperature. Red lines compare wild-
type cells to the cdc48-ts ones in the presence of the drug under the restrictive conditions. Blue 




Ubiquitylated forms of these peptides were then enriched for using Ubiquilin 1 Tandem UBA 
(TUBE2) beads and quantified by immunoblotting with anti-puromycin antibodies (Fig. 2a).  
 As expected, the addition of 4-NQO increased the amount of puromycylated peptides in 
the ubiquitylated pool regardless of the strain background (Fig. 2b). While shifting wild-type cells 
from the permissive to the restrictive temperature had no observable effect on the accumulation of 
ubiquitylated and puromycylated nascent peptides after 4-NQO treatment, they were dramatically 
increased at the restrictive temperature when ts-cdc48 cells were used (Fig. 2b). This increase was 
also accompanied by an increase in the total levels of ubiquitylated peptides, as expected given the 
general role of Cdc48 in maintaining protein homeostasis(Berner et al., 2018). By contrast, 
deletion of LTN1 from these cells almost completely abolished the effects of 4-NQO on the 
accumulation of ubiquitylated-nascent peptides (Fig. 2b). This effect was not specific to oxidative 
damage, as the addition of MMS produces similar outcomes and leads to accumulation of 
puromycylated-ubiquitinated peptides (Supplementary Fig. 2). Taken together, these observations 
suggest that the addition of either 4-NQO or MMS stalls translation and activates RQC, which 
increases ubiquitylation of nascent peptides by Ltn1 via a route also involving CDC48. 
Alkylating and oxidizing agents lead to protein aggregation 
 Given that our data implicated Ltn1 in clearing incomplete-nascent peptides arising from 
chemically-induced mRNA damage, we speculated that in ltnΔ cells, these peptides misfold and 
aggregate, which in turn would recruit chaperones. To visualize this potential aggregation, we 





Figure 3. The addition of damaging agents leads to the accumulation of Hsp104-mCherry 
foci in the absence of Ltn1 and Hel2.  
a, Representative images of the indicated cells in the absence and presence of MMS. Shown are 
brightfield, mCherry and DAPI signals. Scale bar is 10 m. b, Bar graph showing the 
quantification of cells with >1 focus in the presence of the specified drugs for WT and ltn1 cells. 
c, Similar to b, using WT and hel2 cells. d, Bar graph used to show the consequence of a 
cycloheximide pretreatment on the effect of MMS on foci formation. In all cases, the average foci 




deviation around the mean. For each biological repeat, > 120 cells were counted. Source data are 




and to the Ssa1 and Ssa3 chaperones, which are members of the HSP70 family, to look for 
chaperone-specific foci by fluorescence microscopy of wild-type and ltn1 cells grown under 
normal conditions or in the presence of oxidizing agents, alkylating agents, and translation 
inhibitors. Discernable foci of Ssa1- and Ssa3-mCherry were not observed under all conditions 
tested, suggesting that they do not help yeast cope with chemical-induced RNA damage 
(Supplementary Fig. 3a,b). More specifically, the lack of foci in ltnΔ backgrounds suggested that 
these factors play little to no role during ribosome stalling.  
Conversely, distinct foci decorated with Hsp104-mCherry were seen in more than 10% of 
wild-type cells when treated with the alkylating and oxidizing agents MMS, 4-NQO and MNNG, 
versus only 2% for untreated cells (Fig. 3a,b). Some of these Hsp104-dependent foci were likely 
generated by direct damage to the protein pool by these chemical agents. To resolve this 
possibility, we analyzed ltnΔ cells, which specifically acts on ribosomes to target nascent peptides 
during RQC, to sort out whether these foci arose by stalling-mediated production of incomplete 
peptides. Indeed, loss of Ltn1 increased the number of cells with Hsp104-mCherry foci from ~10% 
to 40-60% in the presence of the damaging agents (Fig. 3b). Hence, the effect of the chemical 
agents on the properties of mRNA was much more pronounced relative to their effect on protein, 
which in turn impacts its translation. In addition to Ltn1, the deletion of Hel2, which acts upstream 
and is required for RQC activation, led to a dramatic increase in the number of cells with Hsp104-
mCherry foci in the presence of damaging agents (Fig. 3c).  
 Consistent with the idea that these aggregates contain nascent peptides evading RQC, 
inclusion of the translation inhibitor cycloheximide prior to MMS treatment caused the loss of 




from ~25% to ~5%, which was close to those measured in the absence of any drugs, suggesting 
that active translation is required for forming Hsp104 foci. Notably, these foci appear distinct from 
P bodies(Swisher and Parker, 2010), as we saw no co-localization of Hsp104-mCherry with the P-
body marker Dcp2-GFP (Supplementary Fig. 3c). Our data suggest that Hsp104 is recruited to 
aggregated nascent peptides generated during damaged-mRNA-induced stalling when RQC is 
overwhelmed or incapable of ubiquitylating them for subsequent proteasome removal.  
Damaging agents trigger ribosomal-protein ubiquitylation 
 As mentioned above, ribosomal protein ubiquitylation by Hel2 is a key signal for mediating 
the downstream events of NGD and RQC during stalling(Ikeuchi et al., 2019a; Juszkiewicz et al., 
2018; Matsuo et al., 2017; Simms et al., 2017). Hel2 recognizes an interface between the small 
subunits of collided ribosomes and adds K63-linked poly-ubiquitin chains to a number of core 
ribosomal subunits, including uS10, uS3, and eS7(Ikeuchi et al., 2019a; Juszkiewicz et al., 2018; 
Matsuo et al., 2017). To address whether damaging agents also induce ribosomal protein 
ubiquitylation, we added MMS, MNNG and 4-NQO to growing yeast cultures and assessed the 
level of protein ubiquitylation in total lysate and in purified ribosomes. Interestingly, while 
alkylating and oxidizing agents only subtly increased the overall level of ubiquitylation, they 
triggered robust ribosomal protein ubiquitylation as measured by immunoblotting with anti-
ubiquitin antibodies (Fig. 4a). By contrast, the addition of the antibiotics cycloheximide and 
hygromycin, which both arrest translation at high concentrations and thus prevent ribosome 
collisions, triggered marginal ribosome ubiquitylation (Fig. 4a). To confirm that the ubiquitylation 
pattern we observe in the presence of 4-NQO reflected ribosomal protein ubiquitylation and not 





Figure 4. Ribosomal proteins are ubiquitinylated by Hel2 in the presence of damaging 
agents.  
a, Western-blot analysis of ubiquitinated proteins in total lysates and ribosome fractions in the 
presence of the indicated compounds. b, Release of nascent peptides by puromycin does not affect 
the ubiquitination pattern of proteins in the ribosome fraction. Right panel is a western analysis of 
the puromycylation reactions under the indicated conditions. Left panel is a western analysis of 
ubiquitination of ribosome-enriched fraction in the presence and absence of puromycin upon the 
addition of 4-NQO. c, Western-bot analysis showing that the ubiquitination of ribosomal proteins 
after MMS addition is completely inhibited when HEL2 is deleted. d, Western-blot analysis used 




eIF4E, and hence initiation, is inactivated. Lines compare WT and cdc33-ts cells in the presence 
of 4-NQO at the restrictive temperature. e, Sucrose-gradient fractionation of lysates obtained from 
endogenous HEL2: 3 ✕ FLAG tag yeast cells in the absence and presence of 4-NQO. The traces 
follow the absorbance at 254 nm, below the traces is the western-blot analysis of the fractions 
using anti-FLAG antibody. f, Heat map showing scaled ubiquitination footprints of ribosome and 
ubiquitin-derived peptides in response to 4-NQO. The samples were digested with trypsin and 
enriched for diGly, prior to tandem MS analysis. Two independent biological replicates are shown 
and the modified lysine residues are indicated to the right of the ribosomal protein name. The 
peptides are organized based on their origin and subsequently ranked by their response to 4-NQO. 
g, Bar graph showing the relative abundance of ubiquitin (eS31) and different ubiquitin chains. h-
k Bar graphs showing the relative abundance of corresponding ribosomal proteins (on the left) and 
diGly modified peptides (on the right) in the absence and presence of 4-NQO (In all cases n=2,  
SD). l-m, Western-blot analysis used to follow the ubiquitination of depicted ribosomal proteins 
in the presence of the indicated compounds. A C-terminal FLAG tag was added to the 
chromosomal copy of ribosomal protein genes. Source data are provided as a Source Data file. 
 
which would release nascent peptides prior to ribosome enrichment. This puromycin pre-treatment 
had no discernable impact on the ubiquitylation of the ribosome-enriched samples (Fig. 4b). 
Therefore, the increased ubiquitylation upon exposure to oxidation and alkylation agents most 
likely reflected direct modification of ribosomal proteins.  
We next sought to confirm that this pattern of ribosome ubiquitylation was distinct from 
those known to arise during oxidation and ER stress by assessing its dependence on E3s associated 
with RQC and nonfunctional ribosomal RNA decay (Fig. 4c, Supplementary Fig. 4a,b). Here, we 
analyzed the level of ribosomal ubiquitylation after treatment with MMS in the presence and 
absence of either Hel2, Mms21, or Rtt101, the latter two of which are known to function during 
non-functional ribosome decay(Fujii et al., 2009; Sakata et al., 2015). A complete loss of ribosomal 
ubiquitylation was only observed in hel2Δ cells (Fig. 4c, Supplementary Fig. 4a,b), supporting the 




Complementing these cells with a plasmid-borne HEL2 restored ubiquitylation to normal levels, 
whereas an empty vector did not (Supplementary Fig. 4c). Using an antibody specific for ubiquitin 
internally linked through K63, we confirmed that the ubiquitin chains bound to ribosomal proteins 
were mostly connected via this lysine (Supplementary Fig. 4c), in agreement with the specificity 
of Hel2 for K63 polyubiquitylation.  
We next showed that ribosomal protein ubiquitylation depends on active translation using 
two different approaches. For the first approach, we exploited an eIF4E temperature sensitive allele 
(cdc33-ts4-2) to suppress translation initiation. Whereas shifting wild-type cells to the restrictive 
temperature had little effect on 4-NQO-induced ribosomal protein ubiquitylation, shifting the 
cdc33-ts4-2 cells to the restrictive temperature greatly reduced this modification (Fig. 4d). For the 
second approach, we used abrupt glucose deprivation to induce ribosome runoff and examined 
how this starvation affected ribosomal protein ubiquitylation. As shown in Supplementary Fig. 4d, 
ribosome runoff prior to 4-NQO addition almost completely inhibited ribosomal proteins 
ubiquitylation, implying that ribosomes must be actively translating for nucleobase-damaging 
agents to trigger their ubiquitylation.  
Hel2 associates with polysomes in the presence of stress 
 To demonstrate that Hel2 is recruited to ribosomes upon the addition of oxidizing and 
alkylating agents, we investigated the association of this E3 with polysomes under different 
conditions. To facilitate detection by immunoblot assays, the endogenous HEL2 gene was tagged 
with a C-terminal FLAG epitope. The samples were crosslinked with formaldehyde to stabilize 
any transient interactions prior to sucrose-gradient fractionation of polysomes. As expected, Hel2-




ribosomes. In the presence of 4-NQO and MMS, Hel2 predominantly associated with the polysome 
fraction (Fig. 4e). Since Hel2 is documented to recognize collided ribosomes, these observations 
suggest that alkylating and oxidizing agents generate ribosome collisions., which together with the 
accumulation of ubiquitylated ribosomal proteins (Fig. 4a, b), implies that alkylating and oxidizing 
agents activate Hel2 through ribosome stalling. 
Characterization of ubiquitin-modified-ribosomal proteins 
To interrogate the dynamics of ribosome ubiquitylation in response to RNA damaging 
agents, we use a quantitative-proteomic approach to measure ubiquitylation that combined 
diglycine (diGly)-modified immuno-affinity enrichment followed by tandem MS to follow site-
specific ubiquitin additions onto individual ribosome proteins(Kim et al., 2011). MS/MS analysis 
of individual peptides from the diGly-peptide-enriched pool revealed that the ubiquitylation status 
of individual proteins within both the large (60S) and small (40S) subunits was altered upon 4-
NQO treatment (Fig. 4f). The majority of proteins displaying increased ubiquitylation in the 
presence of 4-NQO were located on the 40S subunit (Fig. 4f), while the majority of proteins 
displaying a decreased ubiquitylation in the presence of 4-NQO were located on the 60S subunit 
(Fig. 4f) (Supplementary Table 1). 
Given that the nature of the internal linkage used for polyubiquitylation can have a dramatic 
effect on downstream events(Silva and Vogel, 2015), we further characterized by MS/MS the 
dynamics of polyubiquitylation linkages during the 4-NQO treatment. Interestingly, while the total 
amount of ubiquitin bound to purified ribosomes remained unchanged after 4NQO treament, the 
peptide derived from ubiquitins internally linked via K63 increased dramatically (>10 fold) (Fig. 




moderately (1-3 fold) in the presence of the compound (Fig. 4g). Finally, we identified several 
lysine residues on the ribosomal proteins that are highly ubiquitylated as a result of 4-NQO 
treatment. These proteins include: K212 on uS3, K8 on uS10, K83 on eS7B, and K33 on uS5 (Fig. 
4h-k). We further validated the ubiquitination events on uS3, uS10, eS7 and, uS5 by 
immunoblotting (Fig. 4l,m, Supplementary Fig. 4f,g).  
DNA damage does not elicit ribosomal protein-ubiquitination  
To provide further support for our model that MMS, MNNG and 4-NQO activate RQC 
through their modification of RNA and not DNA, we examined the effect of agents that specifically 
target DNA on ribosomal protein ubiquitylation. In particular we tested: cisplatin (an inter-strand 
crosslinker), camptothecin (a topoisomerase I inhibitor), bleomycin (induces DNA-strand breaks), 
mitomycin C (DNA crosslinker), etoposide (a topoisomerase II inhibitor) and hydroxyurea 
(depletes the dNTP pool)(Vesela et al., 2017). As expected, the addition of all of these agents did 
little to increase the ubiquitylation state of ribosomal proteins and uS3. At the same time, they all 
elicited a DNA-damage response to various extents as assessed by phosphorylation of H2AX 
(accumulation of H2AX) (Fig. 5a). This is similar to what has been observed in mammalian cells, 
for which the additions of etoposide, mitomycin C, and cisplatin were not found to impact 
ribosome ubiquitylation(Higgins et al., 2015).  
Interestingly, the only drug that induced appreciable ubiquitylation of ribosomal proteins 
– at least as compared to MMS, MNNG and 4-NQO – was cisplatin, which had been documented 
to crosslink ribosomes(Melnikov et al., 2016), suggesting that it also affects translation and 
activates RQC (Fig. 5a). Indeed, addition of cisplatin at high concentrations was accompanied by 





Figure 5. Agents that strictly compromise the integrity of DNA do not lead to ribosomal-
proteins ubiquitination.  
a, Western-blot analysis of ribosomal-protein ubiquitination and uS3 in the presence of the 
indicated compounds. Phosphorylation of H2AX was used to assess the activation of the DNA-
damage response. b, Western-blot analysis of ribosomal-proteins ubiquitination as a function of 
increasing cisplatin concentrations. c, Western-blot analysis of ribosomal-protein ubiquitination 
and H2AX phosphorylation as a function of time after the addition 4-NQO. Note ribosomal protein 
ubiquitination is observed only after 5 minutes of incubation and saturates at the ten-minute mark. 




data are provided as a Source Data file.concluded that activation of RQC by damaging agents 
results from their impact on RNA properties and not their influence on DNA metabolism.  
 
 To assess the cellular response to the presence of damaging agents through ribosomal 
protein ubiquitylation, we examined these modifications as a function of time upon the addition of 
4-NQO. Interestingly, we detected the accumulation of ubiquitylated ribosomal proteins within 5 
min of treatment with the response saturated by 10-min. In contrast, the accumulation of H2AX 
was not saturated after 45 min of incubation (Fig. 5c). These observations indicate that RNA is 
modified faster than DNA, with subsequent ribosome stalling and activation of RQC occurring 
shortly thereafter.  
Yeast lacking NGD and RQC components are sensitive to damage 
 Thus far, our analyses have focused on the details of RQC activation in response to 
damaging agents through their impact on RNA, but whether the inability to do so diminishes 
cellular fitness remained unclear. To examine whether failure to activate RQC renders cells 
sensitive to oxidizing and alkylating agents, we tested if yeast strains harboring mutations in 
various components of NGD and RQC would recover poorly from oxidation and alkylation stress. 
Briefly, cells were treated with 1 g/mL 4-NQO and 0.1% MMS for 30 min, washed with 
prewarmed fresh medium, and then monitored continuously for growth (Fig. 6a). In the absence 
of any treatment, we observed little to no difference in lag time or growth rate among the strains, 
as assessed by the first derivative of growth curves (Fig. 6b). Upon a 4-NQO challenge, hel2; 
rps3-R116, R117A; dom34; and ski2 strains had significantly increased lag times relative to the 
wild-type cells (Fig. 6b), while the lag time was unchanged in the hsp104 strain (Supplementary 





Figure 6. Mutations in NGD and RQC components render cells sensitive to 4-NQO and MMS 
addition.  
a, Top is a plot of OD600nm over time of the indicated strains after a mock treatment or a 30-minute 
challenge with 4-NQO (1 g/mL) or MMS (0.1 % MMS). Bottom is a plot of the first derivative 
of the data on top to calculate the instantaneous growth rate and the corresponding lag time needed 
to reach the maximum rate. Data was collected in technical duplicates from three biological 
replicates. b, A bar graph showing the determined lag time from a. The mean of three biological 
replicates is plotted and the error bars represent the standard deviation. p-value from two-way 





by its lag time of 7.5 hr relative to 9 hr for wild type, but the additional deletion of HSP104 from 
these cells significantly increased the recovery time (Fig. 6b, Supplementary Fig. 5). These 
observations suggest that in the absence of Ltn1, Hsp104 clears misfolded nascent peptides that 
fail to be ubiquitylated by this E3. Deletion of both factors then renders the cells sensitive to 
nascent peptides that accumulate from stalled translation of damaged mRNA. We note that 
treatment of NGD- and RQC-defective cells with the drugs for 30 min showed no differences in 
cellular death relative to wild-type as assessed by spot assays (Fig. 6c), suggesting that the defects 
we saw in growth rate were indeed caused by increased lag time post treatment. Collectively, our 
data implies that NGD and RQC play an important role in coping with chemical insults that alter 
the chemical properties of RNA. 
One 8-oxoG adduct in the coding sequence destabilizes mRNAs 
Until now, our analysis has focused on the effect of mRNA alkylation and oxidation on the 
activation of NGD and RQC using compounds that target RNA indiscriminately, which likely 
impacts bases throughout the RNA strand, resulting in the formation of a plethora of adducts in 
various locations on the RNA(Simms et al., 2014; Vågbø et al., 2013). As a result, we sought to 
examine how the presence of one disruptive adduct might influence turnover of an mRNA. We 
opted to use HEK293 cells instead of yeast, because that allowed us to use electroporation to 
efficiently deliver in-vitro-generated mRNAs to these cells. Briefly, a short RNA containing an 8-
oxoG was chemically synthesized and ligated to an in-vitro-transcribed mRNA, whose end was 
healed with a hammerhead ribozyme (Fig. 7a,b). The resulting RNA was polyadenylated using 
polyA polymerase and capped with vaccinia capping enzyme in the presence of [-32P]-GTP, 





Figure 7. The presence of one 8-oxoG adduct in the ORF of an mRNA leads to accelerated 
rate of decay in HEK293 cells.  
a, Schematic showing the steps used to make mRNA reporters with 8-oxoG in the ORF. b, 
Ethidium-bromide-stained PAGE gel used to follow the construction of the mRNA showing that 
they migrate as would be predicted based on their size. c, Microscope images of HEK293 cells 
electroporated with capped and uncapped eGFP mRNA used to assess electroporation efficiency. 




measure the decay of the indicated reporters and the control GFP mRNAs post electroporation. 
Reporters were visualized directly by exposing the nylon transfer to a phosphorimager screen. GFP 
and GAPDH were visualized using a radio-labeled DNA probe. At the bottom is the ethidium-
bromide stained agarose gel. The half-lives were determined from duplicates ( SD). 
 
Two constructs were generated with only one difference: one that harbored 8-oxoG in the ORF 
and another that positioned the adduct in the 3’-UTR (Supplementary Table 2). The former was 
expected to be subject to NGD, whereas the latter was not. As a control, we also co-electroporated 
a capped and polyadenylated eGFP mRNA, which allowed us to measure electroporation 
efficiency, found to be >90% (calculated between 92 – 96% across three experiments) (Fig. 7c). 
To confirm that in-vitro-generated mRNAs, like those synthesized in vivo are efficiently 
targeted by mRNA-surveillance pathways, we also engineered a control construct without a 
translation stop codon. This “no-stop” reporter also contained a polyA tail whose translation by 
the ribosome should target the RNA for non-stop decay (NSD). Indeed, when these mRNA 
reporters were electroporated into HEK293 cells, the control mRNA decayed with a half-life of 
~5.3 hr, whereas the non-stop NSD version turned over rapidly with a half-life of <1 hr 
(Supplementary Fig. 6a). Having established that RQC processes appear capable of targeting 
mRNAs synthesized in vitro, we electroporated the 8-oxoG-ORF- or UTR-containing mRNAs into 
HEK293 cells and followed their turn over (Fig. 7d). In agreement with our hypothesis that 
mRNAs containing 8-oxoG in the coding region are subject to NGD, we measured a half-life of 
~2.1 hr for the ORF-modified transcript versus ~4.3 hr for the UTR-modified one (Fig. 7d). 
Similarly, a control-stop mRNA reporter, which replaced the 8-oxoG where the ribosome is 




note that these differences in half-lives are similar to what others have reported for NGD reporters 
with stalling sequences(Doma and Parker, 2006; Saito et al., 2013). Furthermore, the 
undistinguished half-life for the eGFP mRNA of ~3.5 - 4 hr among the experiments confirmed that 
the differences we observe in the half-lives between the two reporters was caused by inherent 
differences between the two mRNAs and no other experimental factors. Taken together, our results 
strongly indicate that translation and hence the ribosome itself plays an important role in governing 





All organisms rely on quality-control mechanisms to deal with defective biological 
molecules. In addition to inherent mistakes that occur during the generation of these molecules, 
chemical agents can alter them following synthesis(Drabløs et al., 2004; Sohal and Weindruch, 
1996). Nucleic acids are especially vulnerable to such insults given the inherent reactivity of the 
oxygen and nitrogen atoms of the nucleobases(Wurtmann and Wolin, 2009). Two classes of 
endogenous and exogenous damaging agents that are particularly deleterious include reactive 
oxygen species (ROS) and alkylating agents(Cadet and Wagner, 2013; Drabløs et al., 2004; Neeley 
and Essigmann, 2006). Endogenous ROS arise as byproducts of mitochondrial respiration and their 
levels are significantly influenced by cellular metabolism(Murphy, 2009). For instance, tissues 
with high-energy demands such as neurons accumulate higher levels of ROS(Itoh et al., 2003; 
Lebon et al., 2002). In addition to endogenous ROS, cells become exposed to exogenous agents 
that can increase ROS levels, include ionizing radiation, ultraviolet light, pollutants, and many 
toxins(Wurtmann and Wolin, 2009). Similarly, alkylating agents appear endogenously, with the 
universal-methylating agent S-adenosyl methionine (SAM) being one of the most 
abundant(Hoffman et al., 1980). SAM reacts with nucleic acids in vitro to form various modified 
bases(Rydberg and Lindahl, 1982). As examples of exogenous alkylating agents, 
chemotherapeutics such as cyclophosphamide, streptozotocin, and temozolomide are known to 
target RNA in addition to DNA(Bellacosa and Moss, 2003). It should come as no surprise then 
that oxidized and alkylated mRNA molecules accumulate in vivo(Nunomura et al., 1999; Shan and 




Given the transient nature of mRNA, it was once assumed that damage is of little 
consequence. However, the discovery that cells evolved multiple pathways to cope with defective 
mRNAs has significantly altered this view(Simms and Zaher, 2016; Wurtmann and Wolin, 2009). 
Furthermore, we have also known for some time that the abundance of oxidized RNA is correlated 
with various neurodegenerative diseases(Nunomura et al., 2007), suggesting that cells have 
evolved pathways to deal with chemically-damaged mRNA. These ideas are bolstered by findings 
that the genomes of almost all organisms and some viruses encode dealkylases involved in RNA 
repair(Jr et al., 2003).  
 First hints about quality-control pathways capable of degrading chemically-damaged 
mRNAs came from studies showing that oxidized mRNAs turn over faster relative to undamaged 
versons(Hofer et al., 2005). The mechanism(s) by which these mRNAs are selectively recognized 
were not immediately obvious(Simms et al., 2014); mainly because the effects of the modified 
bases on mRNA function was unknown. In the past few years, we and a number of other groups 
have begun to dissect the effects of modified bases on protein synthesis using in vitro 
approaches(Hudson and Zaher, 2015; Simms et al., 2014; You et al., 2017). Interestingly, while 
some of the adducts behave as expected based on their structure and the equivalent studies on DNA 
replication (for example, m1A severely inhibits protein synthesis(You et al., 2017)), others have 
revealed unexpected effects on ribosomes. Of particular note is 8-oxoG, which mispairs with A 
during DNA replication by adopting the syn conformation, but on ribosomes severely inhibits 
protein synthesis, presumably because of its failure to adopt the syn conformation in the decoding 
center(Simms et al., 2014). These findings suggested that chemically-damaged mRNA triggers 




mRNAs accumulate in the absence of XRN1 in yeast and associate with polyribosomes(Simms et 
al., 2014). These findings suggest that oxidized mRNAs are subject to NGD, and subsequent 
degradation of the 3’-fragment by Xrn1(Doma and Parker, 2006; Tsuboi et al., 2012). Here, we 
expanded on these observations and provide evidence that other chemically-modified bases 
including m1A, m3C and m1G accumulate in mRNA, when XRN1 is deleted (Fig. 1d). As alluded 
to earlier, all of these adducts are either known or predicted to stall protein synthesis by severely 
disrupting Watson-Crick base pairing . While these findings do not directly demonstrate that 
damaged mRNA is subject to NGD, they are consistent with the notion. 
Typically, studies on damaged RNA have largely relied upon treating cells or bulk RNA 
with chemically modifying agents to assess their effect. To take a more precise look at how 
oxidizing agents impact mRNAs and their translation, we undertook a novel approach, using site-
specifically modified mRNAs to assess whether mammalian cells recognize and remove these 
transcripts from the translating pool. By introducing a single 8oxo-G modification to either the 
ORF or the 3’ UTR, we could measure significant differences in mRNA half-life; the mRNA 
harboring the modification in its ORF was degraded twice as fast as one with the modification in 
its UTR (Fig. 7). This faster degradation implied that cells not only recognize damaged mRNA, 
but exploit the translating ribosome to identify it and target it for breakdown, likely through NGD.  
 To provide further support for our model that NGD and RQC help cells cope with damaged 
mRNAs and the derived defective protein products, we took advantage of chemicals capable of 
modifying nucleic acids. In particular, we used both the alkylating agents MMS and MNNG, and 
the oxidizing agent 4-NQO. Indeed, we showed using LC-MS/MS that the addition of MMS to 




(Fig. 1e), while the addition of 4-NQO led to a dramatic increase in RNAs harboring 8-oxoG (Fig. 
1c). Given the strong increase in these damage marks, we predicted that accumulation of the 
damaged transcripts would induce widespread ribosome stalling. By examining labelled 
ubiquitylated nascent peptides, we provided compelling evidence indicating that alkylative and 
oxidative stress activates RQC. First, the addition of MMS and 4-NQO was accompanied by an 
increase in ubiquitylated puromycylated peptides (Fig. 2b, Supplementary Fig. 2), suggestive of 
an increase in ribosome-associated quality control of nascent peptides. Interestingly, the addition 
of damaging agents had little to no effect on the total levels of ubiquitylated peptides (Fig. 2b), 
suggesting that the drugs do not significantly affect full-length proteins, at least at the drug 
concentrations used. Second, inactivation of Cdc48 via the ts-cdc48 allele induced a dramatic 
increase in ubiquitylated puromycylated peptides (Fig. 2b). Cdc48 functions within the ubiquitin 
system, where it extracts defective proteins from complexes and delivers them to the 
proteasome(Defenouillere et al., 2013). In addition to its involvement in RQC, the CDC48 has 
role(s) in other quality control processes, including ERAD and autophagy(Ju et al., 2009; Neuber 
et al., 2005; Schuberth and Buchberger, 2005; Watts et al., 2004). Notably, our observations that 
Cdc48 inactivation in the presence of MMS, MNNG, or 4-NQO leads to increased levels of 
ubiquitylated peptides that are also puromycylated (Fig. 2b) suggests that the compounds 
appreciably alter mRNA translation. Third, deletion of LTN1, the E3 responsible for ubiquitylating 
nascent peptides during RQC, suppresses the effects of cdc48-ts in the presence of alkylating and 
oxidizing stress and greatly reduced the amount of puromycylated peptides to normal levels (Fig. 




exceptionally susceptible to chemical insults, but also that resulting chemical modifications 
significantly impact its translation.  
While the above observations highlight the potential deleterious effect of chemical 
modification to the function of mRNA, they do not necessarily show that this alteration is 
sufficiently adverse to influence cellular fitness. However, our findings that cells lacking Ltn1 
accumulate protein aggregates in the presence of chemical agents, as visualized through Hsp104-
foci (Fig. 3), shows that mRNA damage could indeed reduce cellular proteostasis. We are not the 
first group to report that Hsp104-containg foci coalesce in the presence of damaging agents(Ford 
et al., 2019; Hanzén et al., 2016; Jacobson et al., 2017), however this accretion was attributed to 
damage to DNA and not to RNA. Furthermore, the relationship between these foci, chemical 
damage, and RQC has not been explored previously. Thus, we identified an unappreciated role for 
Hsp104 in stalling-associated-protein defects as a potential failsafe for RQC. In agreement with 
this model, removal of LTN1 or HSP104 singly did not make yeast sensitive to damaging agents, 
but the combined elimination of both factors rendered the cells sensitive (Supplementary Fig. 5). 
It has been well established that ribosomal ubiquitylation is required for ribosome RQC 
and ribosome rescue as translational stalls in both yeast and mammalian cells(Ikeuchi et al., 2019a; 
Juszkiewicz et al., 2018; Matsuo et al., 2017; Sundaramoorthy et al., 2017). Our observations that 
damaging agents induce ubiquitylation of ribosomes supports our hypothesis that these compounds 
cause translational stresses through stalling (Fig. 3,4). Recent cryoelectron microscopy (cryo-EM) 
studies provided convincing evidence that the two 40S subunits on collided ribosomes form a 
unique interface that discriminates stalled from active ribosomes and provides a potential binding 




is not surprising that 40S subunit ubiquitylation is particularly robust after 4-NQO treatment (Fig. 
4f). Previous proteomics studies identified ubiquitylation events on specific lysine residues within 
stalled yeast ribosomes during RQC induction, including lysines on uS3 (K212), uS10 (K8) and 
eS7A/B(Matsuo et al., 2017; Sugiyama et al., 2019). We hypothesize that damaging agents such 
as 4-NQO cause the ribosome to stall and subsequently elicits a similar ribosome ubiquitylation 
pattern. In agreement, our MS analyses show that all of the lysines that are ubiquitylated upon 
stalling are similarly targeted in the presence of 4-NQO (Fig. 4f). For example, the previously-
identified-stalling target on uS5 (K33) is highly ubiquitylated in the presence of 4-NQO (Fig. 4k, 
Supplementary Fig. 4g). In agreement, uS5 is located on the interface between two collided 40S 
subunits close to uS3 in the entry tunnel, and was identified as a possible regulatory response to 
the accumulation of unfolded proteins in yeast(Higgins et al., 2015). 
While both K48- and K63-linked polyubiquitylation on ribosomes have been reported 
during RQC(Matsuo et al., 2017), Hel2-mediated K63-linked polyubiquitination is required for 
both NGD-induced mRNA degradation, and subunit dissociation and 18S non-functional rRNA 
decay(Ikeuchi et al., 2019a; Sugiyama et al., 2019). The observation that Hel2-dependent-K63-
linked ubiquitylation is highly enriched upon 4-NQO treatment reinforces the critical role of the 
RQC pathway in coping with RNA damage (Fig. 4g). K63-linked polyubiquitin chains play an 
essential role in signal amplification processes for various cellular stress responses, including DNA 
repair and nuclear factor κB (NF-κB) activation (Oh et al., 2018). Its role in signaling has recently 
expanded to translation as it was reported that K63-linked ubiquitylation of ribosomal proteins 
activates multiple downstream quality control pathways, and the modification by Hel2 provides a 




2019b; Matsuo et al., 2017; Sugiyama et al., 2019). Combined with the prevalence of damaging 
adducts in mRNA in the absence of Xrn1 (Fig. 1d), the activation of Hel2-mediated ribosomal 
ubiquitylation might have evolved to resolve the translational stresses induced by mRNA damage.  
Finally, the observation that ribosomal proteins ubiquitylation appears faster than H2A.X 
phosphorylation(Löbrich et al., 2010) offers two notions: 1) RNA damage occurs on a much faster 
time scale relative to DNA damage, 2) stalling of translation appears sooner than changes to DNA 
metabolism (for instance changes to replication). The former implication is reinforced by the 
chemical nature of RNA relative to DNA; RNA, and specifically mRNA, are relatively protein-
free and single-stranded, thus rendering the nitrogen and oxygen atoms of the Watson-Crick face 
of the nucleobase vulnerable to chemical attack(Simms and Zaher, 2016). The latter implication 
suggests a potential avenue for how cells respond to chemical insults; that organisms, in principle, 
utilize ribosome stalling and the associated ribosomal ubiquitylation to mount a protective 






Yeast strains and plasmid constructs 
Yeast strains used in this study are listed in Supplementary Table 3. Unless otherwise 
stated, yeast cells were grown at 30°C in YPD media. Deletion, mutant and chromosomally-tagged 
yeast strains were constructed in the BY4741 background (MATa; his31; leu2 0; met150; 
ura3 0) with PCR-based disruption techniques. Plasmids used are listed in Supplementary Table 
4. Unless otherwise stated, MMS, MNNG, 4-NQO, cycloheximide and hygromycin were added to 
final concentrations of 0.1%, 20 g/mL, 5 g/mL, 100 g/mL and 200 g/mL, respectively. DNA-
damaging agents of cisplatin, camptothecin, bleomycin, mitomycin C, etoposide and hydroxyurea 
were added to final concentrations of 250 g/mL, 30 g/mL, 60 g/mL, 2.6 mM, 1 mg/mL and 
100 mM, respectively. Cells were incubated with drug for 30 minutes, unless stated otherwise. 
Oligonucleotide sequences are listed in Supplementary Table 5. 
Quantification of RNA modifications by LC-MS/MS 
Yeast cells were grown overnight in YPD. The cultures were then diluted to OD 0.05 in 
the same media and grown to OD 0.5-0.8. When indicated, cultures were treated with damaging 
agents for 30 min. RNA was isolated using the hot-phenol extraction method (Simms et al., 2017). 
Two rounds of polydT pulldown were used to enrich mRNAs. Total RNA (1 µg) and Poly(A) 
mRNA (0.1 µg) were digested by nuclease P1 (10 Units) at 50°C for 14-16 hr. Following the 
addition of Tris pH 7.5 to a final concentration of 100 mM to adjust the pH, calf intestinal alkaline 
phosphatase (CIP, NEB) was added (2-2.5 Units) and the reaction was incubated at 37°C for an 




RNA samples were diluted to 30-50 μL and filtered (0.22 μm pore size). 10-15 μL of the sample 
was used for LC-MS/MS. Briefly, nucleosides were separated on a C18 column (Zorbax Eclipse 
Plus C18 column, 2.1 x 50mm, 1.8 Micron) paired with an Agilent 6490 QQQ triple-quadrupole 
LC mass spectrometer using multiple-reaction monitoring in positive-ion mode. The nucleosides 
were quantified using the retention time of the pure standards and the nucleoside to base ion mass 
transitions of 268.1 to 136 (A), 244.1 to 112 (C), 284.2 to 152 (G), 245.1 to 113 (U), 300 to 168.1 
(8-oxoG), 282.2 to 150 (m1A), 298 to 166 (m1G), 258 to 126 (m3C), 282.1 to 150 (m6A), 298 to 
166 (m7G). Standard-calibration curves were generated for each nucleoside by fitting the signal 
intensities against concentrations of pure-nucleoside preparations. The curves were used to 
determine the concentration of the respective nucleoside in the sample. The A, G, and C standards 
were purchased from ACROS ORGANICS; U was purchased from TCI America. m7G, m1G and 
m3C were purchased from Carbosynth, m6G and m6A were purchased from Berry’s Associates, 
and m1A was from Cayman Chemical Company. The unmodified nucleosides were quantified 
using the UV-Vis absorbance data that was recorded by a diode-array detector (DAD). The 
modification level on the nucleosides was calculated as the ratio of modified to unmodified. Data 
were analyzed using Excel (Microsoft) and Prism 7 (Graphpad) software. 
Polysome analysis 
Yeast cells were grown to mid-log phase before cycloheximide (CHX) was added to the 
indicated concentration. The cultures were chilled on ice and centrifuged at 4°C. Cells were then 
resuspended in polysome lysis buffer (20 mM Tris pH 7.5, 140 mM KCl, 5 mM MgCl2, 0.5 mM 
DTT, 0.1% Triton-100, CHX to the indicated concentration, 200 g/mL heparin), washed once 




lysates corresponding to 0.5-1 mg of total RNA were layered over a 10%–50% sucrose gradient 
and centrifuged at 35,000 rpm for 160 min in an SW41Ti (Beckman) swinging bucket rotor. 
Gradients were then fractionated using a Brandel tube-piercing system combined with continuous 
absorbance reading at 254 nm.  
Western-blot analysis 
Cells were grown to mid-log-phase and treated with chemicals. The total lysates were 
harvested with ice cold lysis buffer (150 μl of 1.85 M NaOH, 7.5% beta-mercaptoethanol) and 
55% trichloroacetic acid. Lysates were then pelleted and resuspended in an appropriate volume of 
HU buffer (normalized to the number of cells harvested). HU buffer is composed of 8M urea, 5% 
SDS, 200 mM Tris pH 6.8, 1 mM Ethylenediaminetetraacetic acid (EDTA), bromophenol blue, 
100 mM DTT. Proteins were separated by SDS-PAGE and analyzed by immunoblotting. The 
following antibodies were used: mouse anti-ubiquitin HRP (Santa Cruz, Cat#: sc8017; 1:2,000 v/v 
dilution), mouse anti-FLAG (Sigma; Cat#: F1804; 1:5,000 v/v dilution), mouse anti-puromycin 
(Millipore, Cat#: MABE343; 1:5,000 v/v dilution), rabbit anti-uS4 (Rps9) (Abcam, 
Cat#:ab117861; 1:5,000 v/v dilution), rabbit anti-phospho-Histone H2A.X (Cell Signaling, Cat#: 
ab11174; 1:3,000 v/v dilution), anti-ubiquitin (K48-linked-ubiquitin chains) (Cell Signaling, Cat#: 
4289s; 1:3,000 v/v dilution, linkage-specific k48), anti-ubiquitin (K63-linked-ubiquitin chains) 
(Cell Signaling, Cat#: ab179434; 1:3,000 v/v dilution, linkage-specific k63), and rabbit anti-
eRF1(Eyler et al., 2013) (1:2000 dilution). Secondary antibodies of goat anti mouse IgG (Thermo 
Scientific, Cat#: 31430) and goat anti rabbit IgG (Thermo Scientific, Cat#: 31460) were used at 




To examine the ubiquitination on ribosomes, yeast cells were first harvested and washed 
with ice-cold polysome-wash buffer (20 mM Tris pH 7.5, 140 mM KCl, 5 mM MgCl2, 5 mM 
DTT). Cell pellets were then resuspended in 200-500 µL of polysome-lysis buffer [100 µg/mL 
Heparin, 1 mM Pheylmethylsulfonyl fluoride (PMSF), 20 mM Tris pH 7.5, 140 mM KCl, 5 mM 
MgCl2, 5 mM N-ethylmaleimide (NEM), 5 mM DTT]. Cells were homogenized by FastPrep-24 
(MP Biomedical #116004500) with 200-500 µL of glass beads (Sigma, acid-free, Ø 425-600µm, 
#G8772-500G) at 4ºC. Cells were processed at top speed for 1 min with 1 min resting on ice for 5 
cycles. Cell debris was removed by pelleting at 15,000   g for 10 min at 4°C. Ribosome enriched 
fractions were pelleted over a 0.5 mL sucrose cushion (1.1 M sucrose, 20 mM Tris-HCl pH 7.5, 
500 mM NH4Cl, 0.5 mM EDTA, 10 mM MgCl2, 5 mM NEM, 1 mM PMSF) by centrifugation at 
287,000 g for 2 hr at 4°C in an MLA rotor. Ribosomes were resuspended in 15-30 μl of RNase-
free water. The concentration of ribosomes was measured using absorbance at 260 nm, and an 
appropriate volume of HU buffer was added (normalized to ribosome concentration). 
UBA purification and subsequent analysis of puromycylation 
Overnight cultured cells were inoculated into 50 mL of fresh media to an OD600 nm of 0.05 
and incubated at 30°C. At OD ~0.6, 4-NQO and MMS were added and cells incubated for an 
additional 30 minutes. Cells were harvested by centrifugation and washed 3 times with wash buffer 
(20 mM Tris pH 7.5, 140 mM KCl, 5 mM MgCl2 and 10 mM NEM). Cell pellets were flash frozen 
and stored at -80°C. Frozen cell pellets were resuspended in 200 L of lysis buffer [20 mM Tris 
pH 8.0, 140 mM KCl, 5 mM MgCl2, 200 g/mL heparin, 5 mM NEM, 0.5 mM DTT and protease 
inhibitor complete (ThermoFisher)]. Cells were lysed using glass beads using a FastPrep and the 




was measured at 260 nm to estimate total RNA concentration. A total of 500 g was diluted to 100 
L in lysis buffer, puromycin added to a final concentration of 2 mM and the reaction was 
incubated at 30°C for 1 hr. Following the incubation, a 10-L aliquot was added to 10 L of HU 
buffer for input. The remaining volume was added to 20 L UBA beads (BostonBiochem, #AM-
130), which were prewashed with 20 mM Tris-HCl pH 7.5, 5 mM NEM, 0.1% NP40. The total 
volume was adjusted to 1 mL with the prewash buffer and lysates were incubated with beads for 
1 hour at 4°C. The beads were washed 5  with wash buffer [25 mM Tris, pH 7.5, 150 mM NaCl, 
0.2% NP40] followed by collection over a spin column in wash buffer without detergent. 50 L 
of HU buffer was added, heated briefly before loading on 8 or 10% SDS-PAGE gels. After transfer, 
western-blotting on the input and UBA-bound samples was conducted as described above.  
Fluorescence microscopy 
Yeast cells expressing Hsp104-mCherry or Dcp2-GFP were fixed with 4% 
paraformaldehyde post-treatment for 15 min. Cells were then centrifuged and resuspended in 0.1 
M KPO4 pH 7.5, 1.2 M sorbitol, and sonicated briefly prior to mounting for fluorescence 
microscopy. Samples were imaged on a Nikon Eclipse E600 upright microscope at 60  using 
OpenLab software (Improvision) through a Retiga EX charge-coupled-device (CCD) camera (Q-
Imaging). Image quantification was done using ImageJ software.   
Yeast-sensitivity assay 
Yeast cells in biological triplicates were back-diluted from overnight culture and were 
treated with various damaging agents at mid-log-phase (OD600 of 0.5-0.7) for 30 min(Toussaint 




density of OD 0.8. 5 μL of cell suspensions were added to 195μl of YPD in 96-well non-treated 
polystyrene microplates, in technical repeats. The plates were incubated at 30°C with shaking, and 
cell density was monitored every 10 min over 24-48 hours at 600 nm on a microplate scanning 
spectrophotometer (Biotek PowerWave XS2).  
Peptide preparation for mass spec analysis 
Yeast cell lysis and peptide digestion was performed as follows. Specifically, 3 L of mid-
log cells were treated with various chemicals for 30 min at 30°C. Cells were then pelleted, washed 
and resuspended in 5 mL of lysis buffer [20 mM Tris-HCl pH7.5, 140 mM KCl, 10 mM MgCl2, 
0.5 mM DTT, 5 mM NEM, 1 mM PMSF]. Cells were lysed by FastPrep-24 with glass beads (top 
speed for 1 min with 1 min resting on ice for 5 cycles). Debris was pelleted at 15,000   g for 10 
min at 4°C and the lysates were clarified twice at 30,000  g for 20 min at 4°C. The ribosome 
fraction from the lysate was enriched twice by centrifuging over a sucrose cushion (1.1M sucrose, 
20 mM Tris-HCl pH 7.5, 500 mM NH4Cl, 0.5 mM EDTA, 10 mM MgCl2, 5 mM NEM, 1 mM 
PMSF) at 107,100  g for 16 hr at 4°C in a Ti-45 rotor. The polysome enriched fraction was 
resuspended in 10 mL RNase free water and then incubated with 0.1 M NaOH at 37°C for 30 min. 
Protein concentration was determined by Bradford assay. Proteins were precipitated with 10% 
trichloroacetic acid (TCA) at 4°C for 16 hr. Samples were then centrifuged at 10,000 x g for 15 
min at 4°C. Pellets were washed with cold acetone and then resuspended in 8 M urea, 5 mM NEM, 
1 mM PMSF. The samples were reduced for 1 hour with 1/25 volume of 200 mM DTT in 25 mM 
NH4HCO3. Alkylation was performed by the addition of 200 mM chloroacetamide in 25 mM 




adding the same volume of reducing agent as the chloroacetamide and incubated at RT for 5 min. 
The urea concentration was adjusted to 1M using 25 mM NH4HCO3, pH > 8. Proteins were 
digested first by LysC protease (Wako Chemicals USA, #NC9223464) at a protein ratio of 1:250 
(w/w) for 4 hr at 37°C. Lysate were further digested using Trypsin (Pierce Trypsin Protease 
#90057) at a protein ratio of 1:50 (w/w) at 37°C for 16 hr. The digestion was quenched by adding 
trifluoroacetic acid (TFA) to a final concentration of 1%. The precipitate in the sample was 
removed by centrifuging at 3,000   g for 5 min. The peptides were desalted by Sep-Pak C18 
purification. Pre-enrichment samples were collected at the end of the elution step. Peptides were 
then dried.  
K-ε-GG peptide immunoprecipitation for LC-MS/MS 
K-ε-GG peptide immunoprecipitation was performed using the PTMScan Ubiquitin-
Remnant Motif (K--GG) Kit (#5562, Cell Signaling Technology) as per the standard protocol. 
Following the final elution of the protocol, peptides were cleaned using Millipore Ziptips 
(Millipore Sigma #Z720070), dried and stored at -20°C until LC-MS analysis.   
Tandem mass spectrometry analysis 
The sample was resuspended in 17 µl 5% acetonitrile, 0.1% formic acid. Nano-scale liquid 
chromatography (LC) separation of tryptic peptides was performed on a Dionex Ultimate™ 3000 
Rapid Separation LC system (Thermo Scientific). Of the digests, 4 µl was loaded onto a 20 μl 
nanoViper™ sample loop (Thermo Scientific), and separated on a C18 analytical column 
(Acclaim® PepMap™ RSLC C18 column, 2 μm particle size, 100 Å pore size, 75 µm x 25 cm 




acetonitrile in 0.1% formic acid for the analysis of the ribosome enriched samples and a linear-2-
hour gradient from 4% to 36% acetonitrile for the analysis of subsequent glygly enrichment, with 
a column flow rate set to 250 nL/min.  
Analysis of the eluted tryptic peptides was performed online using a Q Exactive™ Plus 
mass spectrometer (Thermo Scientific) possessing a Nanospray Flex™ Ion source (Thermo 
Scientific) fitted with a stainless steel nano-bore emitter operated in positive electro-spray 
ionisation (ESI) mode at a capillary voltage of 1.9 kV. Settings that differed for detecting glygly 
enriched peptides are shown in brackets. Data-dependent acquisition of full MS scans within a 
mass range of 380-1500 m/z at a resolution of 70,000 was performed, with the automatic gain 
control (AGC) target set to 3  106, and the maximum fill time set to 200 ms. High-energy 
collision-induced dissociation (HCD) fragmentation of the top 15 (8) most intense peaks was 
performed with a normalized collision energy of 28, with an intensity threshold of 4  104 (1.3  
104) counts and an isolation window of 3.0 m/z, excluding precursors that had an unassigned, +1, 
+7 or +8 charge state. MS/MS scans were conducted at a resolution of 17,500, with an AGC target 
of 2  105 and a maximum fill time of 100 ms (300 ms). Dynamic exclusion was performed with 
a repeat count of 2 and an exclusion duration of 30 seconds, while the minimum MS ion count for 
triggering MS/MS was set to 4  103 counts. The resulting MS/MS spectra were analyzed using 
Proteome Discoverer™ software (version 2.0.0.802, Thermo Scientific), which was set up to 
search the S. cerevisiae proteome database, as downloaded from www.uniprot.org/proteomes (ID 
number UP000002311). Peptides were assigned using SEQUEST HT (Eng et al., 1994), with 
search parameters set to assume the digestion enzyme trypsin with a maximum of 2 missed 




tolerances of 0.02 Da. Carbamidomethylation of cysteine was specified as a static modification, 
while glygly on lysine, oxidation of methionine and N-terminal acetylation were specified as 
dynamic modifications. The target false discovery rate (FDR) of 0.01 (strict) was used as 
validation for peptide-spectral matches (PSMs) and peptides. Proteins that contained similar 
peptides and which could not be differentiated based on the MS/MS analysis alone were grouped, 
to satisfy the principles of parsimony. Label-free quantification as previously described (Silva et 
al., 2006) was performed in Proteome Discoverer™ with a minimum Quan value threshold of 
0.0001 using unique peptides, and “3 Top N” peptides used for area calculation. All samples were 
analyzed in triplicate, and the resulting values were averaged. 
Polysomes analysis, hel2 3   FLAG crosslinking to ribosomes 
Yeast cultures were grown to mid-log phase before addition of either cycloheximide (to a 
final concentration of 100 μg/mL, 3 μg /mL, or 0.015 μg /mL), or 0.1% MMS, or 5 μg /mL 4-NQO 
for 30 minutes. Cultures were chilled on ice and formaldehyde added to 1% of the culture volume. 
After 1 hour, these were quenched by addition of 1/10 volume of 2.5 M glycine in 25 mM Tris-
base. Cells were pelleted by centrifugation at 4°C, resuspended in polysome lysis buffer (20 mM 
Tris pH 7.5, 140 mM KCl, 5 mM MgCl2, 0.5 mM DTT, 1% Triton-100, 100 μg/mL cycloheximide, 
200 μg/mL heparin), washed once and lysed with glass beads using a FastPrep (MP Biomedical). 
Supernatant from cleared lysate corresponding to 1 mg of total RNA was layered over a 10-50% 
sucrose gradient and centrifuged at 37,000 rpm for 160 min in an SW41Ti (Beckman) swinging 
bucket rotor. Gradients were fractionated using a Brandel tube-piercing system combined with 
continuous absorbance reading at A254 nm. Protein was extracted by the NaOH/TCA method and 




Reporters for measuring mRNA decay in mammalian-cell culture 
Control mRNAs were prepared using runoff transcription on PCR-amplified DNA 
templates and T7 RNA polymerase (Zaher and Unrau, 2004), followed by PAGE purification. 
8oxo-G-mRNAs were generated by ligating an RNA oligo containing the modified guanosine to a 
similarly in-vitro-transcribed RNA. To eliminate heterogeneity at the ligation site, the 3’ end 
contained a self-cleaving hammerhead ribozyme sequence, which results in a 2’-3’ cyclic 
phosphate after cleavage. The ends were dephosphorylated using T4 polynucleotide kinase (NEB) 
in 100 mM morpholinoethanesulfonate (MOPS)-NaOH [pH 5.5], 10 mM MgCl2, 10 mM β-
mercaptoethanol, 300 mM NaCl (Schurer, 2002) leaving a 3’-OH group; the reaction was 
incubated at 37°C for 5 hours, extracted with phenol/chloroform and ethanol precipitated. 
An RNA oligo with a modified guanosine was purchased from Chemgenes (5’-
GGACUACAAAGAC (8-oxo-rG) ACGACGACAAGUAAUCUCU). The 5’ end of the oligo was 
phosphorylated using T4 PNK (NEB) in the presence of ATP followed by ligation to the 3’ end of 
the mRNA using T4 RNA ligase 2 (NEB) and a DNA splint at a molar ratio of (1:1.5:1.2). The 
RNA and DNA were combined, heated to 80°C, and slowly cooled to room temperature before 
addition of buffer and ligase followed by incubation at 37°C overnight. The ligated products were 
purified on denaturing PAGE, eluted in 300 mM NaCl overnight and ethanol precipitated. 
In order to observe turnover of the mRNA reporters in vivo, both the ligated RNA and 
transcribed RNA controls were capped using the Vaccinia capping system (NEB) in the presence 
of [ -32P]-GTP and SAM. This was followed by addition of a 3’ polyA sequence using E coli 




incubated for 30 min at 37°C, phenol/chloroform extracted, and ethanol precipitated. Prior to 
electroporation, the RNAs were CIP treated (NEB) to remove 5’ phosphates, followed by phenol 
chloroform extraction and ethanol precipitation. 
Measurements of mRNA decay 
TREx HEK cells (ThermoFisher Scientific) were cultured in DMEM (Gibco/life 
technologies) +FBS (Sigma) +Pen/Strep (Gibco/life technologies) using standard protocols. RNA 
was electroporated into cells using a Neon Transfection System (Thermo Fisher Scientific). On 
the day of experiment, cells were washed and resuspended in buffer R at ~1-2x107 cells/mL. 
Approximately 5 g of reporter mRNA and 5 g of GFP mRNA were combined with 100 L of 
cells/buffer for each reaction. After electroporation, cells were immediately added to 1 mL media 
without antibiotics and recovered for 30 min. The cells and media were then divided equally into 
six aliquots and incubated until reaching the indicated timepoints. RNA was isolated using Trizol 
and precipitated in isopropanol before analysis by northern blotting. 
Northern blotting 
1 g of RNA from each timepoint was resolved on 1.5% formaldehyde agarose gel, 
followed by transfer to positively-charged nylon membrane (GE Lifesciences) using a vacuum 
blotter (Biorad). Nucleic acids were UV cross-linked to the membrane and baked at 80°C for 15 
minutes. Membranes were then pre-hybridized in Rapid-Hyb buffer (GE Lifesciences) for 30 
minutes in a hybridization oven. Radiolabeled DNA probe, which was labeled using 
polynucleotide kinase and [ -32P]-ATP, was added to the buffer and incubated overnight. 




followed by three washes in stringent buffer (0.2 × SSC, 0.1% SDS), all at hybridization 
temperature. Membranes were exposed to a phosphorimager screen and analyzed using a Biorad 
personal molecular imager. 
Data was analyzed using Prism (Graphpad) and half-life calculated by fitting the data using 
linear regression to a one phase decay equation. 
Data availability 
 The mass spec data, including the .msf and .xml files for the proteomics data, are available 
in the ProteomeXchange database under accession number PXD013834 within the PRIDE 
repository (http://www.ebi.ac.uk/pride/archive/projects/PXD013834 ). The source data used to 
generate plots in Figs. 1a-e, 2b-d, 3g-k and 6a; and Supplementary Figs. 1b-d, 1g-j and 5 are 
provided as a Source Data file. Uncropped and unprocessed immunoblot scans for Fig. 4i-m and 
5 are also provided as a Source Data File. All other data are available from the corresponding 
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CHAPTER 5: Ribosome-quality control 
antagonizes the activation of the integrated-
stress response on colliding ribosomes 
 





Stalling during translation triggers ribosome quality control (RQC) to maintain 
proteostasis. Recently, stalling has also been linked to the activation of integrated-stress response 
(ISR) by Gcn2. How the two processes are coordinated is unclear. Here we show that activation 
of RQC by Hel2 suppresses that of Gcn2. We further show that Hel2 and Gcn2 are activated by a 
similar set of agents that cause ribosome stalling, with maximal activation of Hel2 observed at a 
lower frequency of stalling. Interestingly, inactivation of one pathway was found to result in the 
overactivation of the other, suggesting that both are activated by the same signal of ribosome 
collisions. Notably, the processes do not appear to be in direct competition with each other; ISR 
prefers a vacant A site, whereas RQC displays no preference. Collectively, our findings provide 
important details about how multiple pathways that recognize stalled ribosomes coordinate to 





A defining feature of all organisms is their ability to sense and respond to a constantly changing 
environment. For instance, they excel at recognizing fluctuations in nutrient availability and 
respond by reprogramming gene expression to meet metabolic needs (Hinnebusch, 2005; Pakos‐
Zebrucka et al., 2016). They are also able to react to endogenous and exogenous stresses. Among 
the different cellular responses, the Integrated Stress Response (ISR), by which eukaryotic cells 
alter their translational and transcriptional output in response to a number of homeostatic 
imbalances and disease conditions, is perhaps one of the most important adaptive pathways (Hetz 
et al., 2013; Kroemer et al., 2010; Masson, 2019). To this end, dysregulation of ISR signaling has 
been linked to various pathological disorders that include diabetes, cancer and neurodegeneration 
(Augusto et al., 2019; Bi et al., 2005; Delépine et al., 2000; Eyries et al., 2014; Lin et al., 2013; 
Ma et al., 2013; Mouton-Liger et al., 2012; Ye et al., 2010).  
Unique to ISR is its activation in response to diverse stress conditions (Pakos‐Zebrucka et al., 
2016). These stimuli all lead to the phosphorylation of eukaryotic initiation factor 2 (eIF2). 
Mammals have four distinct eIF2 kinases: GCN2, PERK, PKR and HRI; which are activated in 
response to amino-acid deprivation, ER stress, double-stranded RNA (typically associated with 
viral infections) and heme availability, respectively. Phosphorylation of eIF2 by these kinases 
shifts the factor from a substrate to a competitive inhibitor for the guanine exchange factor eIF2B, 
inhibiting recycling of the GDP-bound eIF2 to a GTP-bound one (Gomez et al., 2002; 
Krishnamoorthy et al., 2001; Sudhakar et al., 2000). This results in depletion of initiator-
tRNA•eIF2•GTP ternary complex and leads to a global reduction of protein synthesis, but allows 




including ATF4 in mammals and Gcn4 in yeast. Both undergo an atypical-initiation mechanism 
(Dever et al., 1992; Harding et al., 2000; Hinnebusch, 1993, 2005; Vattem and Wek, 2004), and 
are the main effectors of ISR as they upregulate biosynthetic pathways as well as autophagy 
(B’Chir et al., 2013; Hinnebusch, 2005; Kroemer et al., 2010; Natarajan et al., 2001; Valasek et 
al., 2002). 
Saccharomyces cerevisiae has only one eIF2 kinase, Gcn2, and the organism has proven to 
be an invaluable model for studying ISR (Masson, 2019), especially in response to amino-acid 
starvation (Sonenberg and Hinnebusch, 2009). Initial studies focused on clues afforded by its 
domain architecture and possible analogies to the stringent response in bacteria, which is activated 
by Rel-A mediated recognition of deacylated tRNAs bound to the ribosome (Atkinson et al., 2011). 
In addition to its kinase domain, Gcn2 harbors ribosome- and tRNA-binding domains (Ramirez et 
al., 1991; Wek et al., 1995; Zhu and Wek, 1998; Zhu et al., 1996). The latter is homologous to 
His-tRNA synthetase (HisRS-like), and allows the factor to preferentially bind deacylated tRNA 
over aminoacylated ones (Dong et al., 2000; Lageix et al., 2015). These observations led to the 
hypothesis that Gcn2 is activated in response to the accumulation of deacylated tRNA. Several 
biochemical and genetics studies supported this model; for instance mutations that abrogate 
binding to the ribosome or deacylated tRNAs inhibit activation of ISR (Dong et al., 2000; Lageix 
et al., 2015; Qiu et al., 2001, 2002; Ramirez et al., 1992). Furthermore in yeast, for full activation 
of ISR in response to amino-acid depletion, Gcn2 requires two additional factors: Gcn1 and Gcn20 
(Garcia-Barrio, 2000; Marton et al., 1997; Sattlegger and Hinnebusch, 2005). Each of these factors 
possesses a domain similar to elongation factor eEF3 (Marton et al., 1997; Visweswaraiah et al., 




Gcn2 activation is appealing, several new studies have called it into question and suggested a more 
ribosome-centric mode of activation. For example, in mice lacking a tRNA isoacceptor and a 
ribosome recycling factor, which leads to ribosome stalling, eIF2 is phosphorylated in a GCN2-
dependent manner without accumulation of uncharged tRNAs (Han et al., 2018; Ishimura et al., 
2016). In agreement with this model, two recent studies have shown the factor to be robustly 
activated by the P stalk of the ribosome relative to deacylated tRNAs (Harding et al., 2019; Inglis 
et al., 2019). These observations suggest a direct role for ribosome slowing or stalling in activating 
Gcn2.  
 In eukaryotes, ribosome stalling also activates the mRNA-surveillance pathway of no-go 
decay (NGD) and the associated ribosome-quality-control pathway (RQC). Briefly, upon stalling 
on defective mRNA, the trailing ribosomes collide into the stalled ribosome (Yan and Zaher, 
2019). The E3 ligase Hel2 (Znf598 in mammals) recognizes collided ribosomes and adds ubiquitin 
to a number of ribosomal proteins (Ikeuchi et al., 2019; Juszkiewicz et al., 2018; Simms et al., 
2017). The ubiquitination appears to play an important role in recruiting downstream factors 
involved in ribosome rescue, mRNA degradation and nascent-peptide ubiquitination (Garzia et al., 
2017; Juszkiewicz and Hegde, 2017; Matsuo et al., 2017; Sundaramoorthy et al., 2017). How ISR 
activation is coordinated with that of RQC during stalling is unknown. 
 Here we show that, in yeast, Gcn2 is activated under conditions that promote ribosome 
stalling, including alkylation and oxidation stresses known to modify mRNAs and activate RQC. 
We further show that activation of RQC, through Hel2-mediated ubiquitination of ribosomal 
proteins, antagonizes activation of ISR, and vice versa. Notably, Hel2 was found to suppress the 




suggests that, similar to RQC, Gcn2 is activated by ribosome collisions, but prefers the A site of 
the stalling ribosome to be empty. Altogether, our findings suggest that cells carefully monitor 





Hel2 antagonizes the activation of Gcn2 
 We recently showed that alkylation and oxidation stresses modify mRNAs and trigger 
ribosome stalling (Yan et al., 2019). The resulting ribosome collisions were in turn found to 
activate K63-linked ubiquitination of ribosomal proteins by the E3 ligase Hel2. Interestingly, our 
group and others have identified several conserved targets for Hel2 on colliding ribosomes 
(Matsuo et al., 2017; Yan et al., 2019), suggesting that ribosome collisions are likely to serve 
important roles for multiple signals. As a result, we were motivated to investigate whether 
ribosomal-protein ubiquitination is utilized by organisms to alter gene expression in response to 
stress. We carried out RNA-sequencing analysis of wild-type and hel2 yeast cells in the absence 
and presence of MMS (Figure 1, Supplementary Figure 1 and Supplementary Table 1). We note 
that deletion of HEL2 completely inhibits MMS-mediated ribosomal-protein ubiquitination (Yan 
et al., 2019) and hence any changes to RNA-expression levels in this strain is likely to be the result 
of the absence of ribosome modification.  
We initially focused on differences between wild-type cells and those lacking HEL2 under 
normal conditions. Our analysis showed the deletion of HEL2 to result in modest changes to 
mRNA levels. A closer examination of the data, however, revealed that these cells display a 
signature typically observed in response to environmental and physiological stresses. In particular, 
we observed an overexpression of genes associated with DNA-damage response as well as heat-
shock ones (Supplementary Figure 1, Supplementary Table 1). We further noted an upregulation 
of genes typically associated with amino-acid deprivation conditions, including those involved in 




reports showing that deletion of HEL2 leads to the activation of ISR (Meydan and Guydosh, 2020). 
It, thus, seems that the absence of Hel2 triggers an unwarranted stress response and that ribosome-
protein ubiquitination could suppress its activation. 
We were next interested in exploring how this signature is altered in response to alkylation 
stress. As expected (Jelinsky and Samson, 1999), the addition of MMS was found to have profound 
effects on gene expression. We observed induction of genes involved in multiple processes; 
including those involved in DNA-damage, heat-shock and integrated-stress responses (Figure 1B). 
In the DNA-damage and heat shock responses, DDR2, HSP12 and RNR3 were induced by almost 
a hundredfold. In the integrated-stress response, genes in the arginine-biosynthetic pathway 
(ARG1, ARG4 and ARG7) stood out and were induced by more than tenfold. Consistent with 
MMS-induced activation of ISR, expression of ribosomal-protein genes was significantly reduced. 
Collectively, our analysis of MMS-stressed cells revealed that multiple stress responses are 
robustly activated in response to alkylation stress, consistent with earlier observations in budding 






Figure 1. Transcriptional profiling of wild-type and hel2 cells in the absence and presence of 
MMS.  
A) Volcano plots of -log10p values against log2 relative-fold-changes in the RNA levels of all genes 
in the hel2 strain to the wild-type one. Genes that are significantly upregulated are shown in red 
and those that are significantly downregulated are shown in blue. B) Similar to A, but for the 
relative change between wild-type cells treated with MMS and mock-treated ones. C) Volcano 
plot used to follow the relative change in mRNA levels for hel2 cells in the presence of MMS 
versus wild-type cells in the presence of MMS, but only for genes that were upregulated in the 
presence of MMS in the wild-type cells, i.e. genes shown in red in B. D) Similar to C, but for genes 
that were downregulated in the presence of MMS in the wild-type cells, i.e. those shown in blue 
dots in B. E) Bar graphs of -log10p values of the gene-ontology (GO) analysis conducted on the 
100 most upregulated genes in the hel2 cells relative to the wild-type ones in the presence of 




mock-treated ones for each biological replicate. The genes are hierarchically organized based on 




Since Hel2 appears to suppress the activation of a stress response in the absence of any 
stressors, we wondered if the factor could also play a role in altering the response under alkylation 
stress. RNA-sequencing analysis of genes induced in response to MMS revealed that most of these 
genes are further induced, by as much as 30-fold, in the absence of Hel2 (Figure 1C). In contrast, 
most of the genes that were repressed in the presence of MMS were further repressed in the absence 
of the factor (Figure 1D). These observations suggest that Hel2 antagonizes the pathways that are 
activated in response to alkylation stress. To gain an unbiased insight into the identity of these 
pathways, we performed a gene-ontology (GO) analysis of the top 100 genes that were further 
induced in Hel2 cells relative to the wild-type ones. As expected, GO analysis identified amino-
acid synthetic pathways as the top ten processes that are modulated by Hel2 (Figure 1E). Since 
many of the genes involved in these processes are targets of Gcn4 (the main ISR effector), this 
suggests that Hel2 suppresses its activation. Indeed, analysis of the expression levels of the Gcn4 
regulon (Rawal et al., 2018) showed that deletion of HEL2 results in significant over-induction of 
these targets (Figure 1F). Collectively, our RNA-sequencing analysis suggests that Hel2 
suppresses the premature activation of Gcn2 and attenuates it under alkylation stress. 
Deletion of Hel2 increases eIF2a phosphorylation by Gcn2 
 During ISR, yeast eIF2 is phosphorylated by Gcn2, which suppresses global translation 
initiation while simultaneously promoting the translation of Gcn4 (Hinnebusch, 2005), which our 
RNA-sequencing analysis suggested to be induced. To add further support for these observations, 
we investigated the phosphorylation status of eIF2 in response to MMS addition and 





Figure 2. Ribosome stalling activates eIF2 phosphorylation in a process that is antagonized 
by Hel2.  
A) Western-blot analysis of total proteins isolated from wild-type and hel2 cells treated with 
0.1% MMS for the indicated times. B) Bar graph of western-blot analysis used to follow phospho-
eIF2 a levels in WT and hel2D cells upon MMS treatment for the indicated times. The signal for 
phospho-eIF2a was normalized to that of PGK1. p-value for time point 0 is 0.0018 as determined 
by a multiple-t test in GraphPad Prism. C) Bar graph of qPCR analysis used to measure the relative 
levels of the ARG1 transcript in the indicated cells with no treatment. D) Similar to C, but for cells 
treated with MMS for the depicted times. E) Western-blot analysis of proteins isolated from the 
indicated cells that were grown in the absence of presence of 0.1% MMS for 30 minutes. In all 
cases, plotted is the mean values determined from at least three biological repeats with the error 





accumulation of phospho-eIF2 in a time-dependent manner (Figure 2A, 2B), and in agreement 
with our model, deletion of HEL2 accelerated its accumulation (Figure 2A, 2B). Notably, in the 
absence of Hel2, the levels of phospho-eIF2 increased by more than fivefold in the absence of 
MMS (Figure 2B). These observations were confirmed by directly immunoblotting for Gcn4, 
which showed the transcription factor to accumulate to much higher levels in the absence of HEL2 
(Figure 2A). qPCR analysis of the ARG1 transcript, a Gcn4 target, confirmed that ISR is 
prematurely activated in the absence of Hel2. More specifically, we observe an almost twofold 
increase in ARG1 transcript levels in the hel2 cells relative to wild-type ones (Figure 2C), 
corroborating our RNA-sequencing data (Figure 1A). Additionally, while the addition of MMS 
was found to increase the levels of ARG1 transcript by as much as 25-fold, deletion of HEL2 
increased its levels more rapidly and almost to a hundredfold after only 15 minutes of incubation 
with the drug (Figure 2D). To confirm that the increased phosphorylation of eIF2a observed in the 
absence of Hel2 is mediated by Gcn2, we deleted the kinase from wild-type and hel2D cells. As 
expected, and since Gcn2 is the only known kinase of eIF2a in yeast, we could not detect any 
phospho-eIF2 in hel2D; gcn2D in the absence or presence of MMS (Figure 2E). Altogether, our 
western-blot and qPCR analyses confirmed our transcriptomic analysis that Hel2 suppresses the 
activation of ISR.  
Gcn2 and its coactivators suppress RQC activation 
 Our analysis so far focused on the suppressive effect of Hel2 on Gcn2 activation and our 
findings suggest that two pathways may compete with each other. Consistent with this proposal, 
we document overactivation of Gcn2 in the absence of Hel2 (Figures 1 and 2). Logically, this 




As expected, in the absence of Gcn1 and Gcn2 we observe no accumulation of phospho-eIF2 
upon addition of MMS. In the absence of Gcn20, phosphorylation of eIF2 was reduced but not 
completely inhibited (Figure 3A). This is in agreement with previous reports showing Gcn1 and 
Gcn2 are essential for eIF2 phosphorylation, but Gcn20 is not (Hinnebusch, 2005). More 
relevant, however and corroborating our prediction, was the observation that MMS-induced 
ubiquitination was increased in the absence of Gcn1 and Gcn2, suggesting that the factors compete 
with Hel2 for collided ribosomes (Figures 3A and 3B). 
An inability to phosphorylate eIF2 results in increased Hel2-mediated 
ubiquitination 
 The finding that deletion of Gcn1 and Gcn2 was accompanied by increased ribosomal-
protein ubiquitination (Figure 2B) can be rationalized by at least two non-mutually exclusive 
models. In the first one, Gcn1 and/or Gcn2 compete with Hel2 for the same interface on the 
collided ribosomes. In the second model, deletion of GCN1 or GCN2 suppresses the effect of 
MMS on translation initiation- allowing loading of ribosomes even when many of the mRNAs 
are damaged- and hence increases the occurrence of collisions. In this latter model, bypassing the 
requirement of Gcn1/Gcn2 deletion to inhibit MMS-induced eIF2 phosphorylation would result 
in increased Hel2-mediated ubiquitination. To accomplish this, we generated SUI2- (the gene 
encoding eIF2) mutant strains where serine 52 was altered to alanine in wild-type and hel2 
backgrounds. As expected, addition of MMS to sui2-S52A cells resulted in no phosphorylation of 
eIF2, irrespective of the background (Figure 3C). Most important, however, was the 




almost threefold relative to SUI2 cells (Figure 3D). This increase in ubiquitination is Hel2 
mediated, as no MMS-induced ubiquitination was observed in hel2 strains (Figure 3C).  
 
Figure 3. RQC and ISR do not appear to directly compete with each other.  
A) Western-blot analysis used to follow eIF2 phosphorylation and ubiquitination as a function 
of MMS in wild-type, gcn1, gcn2 and gcn20 cells. B) Bar-graph analysis of three independent 
immuno blots similar to the one shown in (A), used to follow the relative levels of indicated 
ubiquitin bands in the denoted samples. C) Western-blot analysis of total protein isolated from 
wild-type, sui2-S52A (eIF2 cannot be phosphorylated), hel2 and sui2-S52A;hel2 cells that 
had been grown in the absence or presence of 0.1% MMS for 30 minutes. D) Relative levels of 
ubiquitin bands and phospho-eIF2a in the indicated cells, respectively. Analysis was carried out 




the mean values determined from three biological repeats with the error bars representing the 





Since Gcn1 and Gcn2 are present in sui2 cells, the increase in ubiquitination from MMS addition 
is likely to be the result of increased initiation on damaged mRNA rather than direct competition 
between Gcn1/Gcn2 with Hel2. 
Ribosome collisions activate Gcn2 
MMS is an alkylating agent known to modify nucleic acids, including RNA (Lawley, 
1974). Consequently, this leads to ribosome stalling and eventual collisions, which we previously 
showed to activate Hel2 (Yan et al., 2019). Ribosome stalling has been recently found to be 
important for activating GCN2 in mammals (Ishimura et al., 2016). If the observed MMS-induced 
activation of Gcn2 is the result of ribosome stalling, one would predict that addition of compounds 
that promote readthrough to suppress the accumulation of P-eIF2. The aminoglycoside 
paromomycin is such a compound and has been documented to lead to readthrough of rare codons 
by allowing for the misincorporation of near-cognate aa-tRNAs (Kramer et al., 2010). Addition of 
the drug to yeast cells on its own resulted in no observable change to the phosphorylation status of 
eIF2. However, its addition to cells in the presence of MMS slightly delayed the accumulation 
of P-eIF2 (Supplementary Figure 2). We note that this slight effect of paromomycin is expected, 
given that the drug cannot suppress the impact of many of the MMS-induced modified nucleotides 
on tRNA selection.   
Although our data so far suggest that MMS activates Gcn2 through stalling, whether this 
activation is mediated by collisions is currently unknown. To address this, we titrated MMS from 
low to very-high concentrations (0-3%) and assessed P-eIF2 accumulation, reasoning that at high 
concentrations mRNAs are damaged at multiple positions. As this would stall multiple ribosomes 




Strikingly, we observe maximal phosphorylation of eIF2a to occur at intermediate concentration 
of 0.33%-1% (Figures 4B and 4C), suggesting that Gcn2 is activated in response to ribosome 
collision. As expected, and since Hel2 is known to be activated in response to ribosome collisions, 
ubiquitination of uS3 (as assessed by immunoblotting for FLAG-tagged uS3) was also found to 
saturate at intermediate concentrations of MMS (0.12%) (Figures 4B and 4C). Similarly, using an 
anti-ubiquitin antibody we observe accumulation of smaller ubiquitinated-protein products at these 
intermediate concentrations of MMS (Figure 4B). No ubiquitination of these proteins was 
observed in hel2 cells (Figure 4D), suggesting that anti-ubiquitin blots can be used to follow Hel2 
activity circumventing the need to tag individual ribosomal proteins in all of our cells. 
Interestingly, for eIF2 phosphorylation, the levels of phospho-eIF2 saturate at higher 
concentrations of MMS compared to that of Hel2-mediated ubiquitination; 0.3% and 0.04%, 
respectively (Figures 4B, C, D and E), suggesting that higher frequency of ribosome collisions are 
needed to activate Gcn2. In agreement with this idea, in hel2 cells, for which collided ribosomes 
cannot be rescued through RQC, the levels of phosphorylated factor saturate at half the 
concentration of MMS (0.12%) (Figure 4E). As a result, it is highly likely that Gcn2 is activated 
by collided ribosomes and that under low frequency of collisions Hel2 resolves these ribosomes 
before they can initiate ISR. 
Drugs that stall translation but stabilize A-site tRNA binding do not activate 
Gcn2 
 We previously showed that induction of ribosome collisions through the addition of 
cycloheximide at an intermediate concentration, around its Kd for the ribosome, results in Hel2-




addition of emetine at intermediate concentrations activates ZNF598-mediated ubiquitination 
(Juszkiewicz et al., 2018). As a result, we hypothesized that if collisions are also responsible for 
Gcn2 activation that cycloheximide addition to intermediate concentrations should result in the 
accumulation of phospho-eIF2. We were, therefore, surprised to observe no significant 
phosphorylation of eIF2 at any concentrations tested (0.015-100 mg/mL) independent of the 
presence of Hel2 (Supplementary Figure 3A). Notably, we observed robust Hel2-dependent 
ribosome ubiquitination at intermediate concentrations of the inhibitor (Supplementary Figure 
3B). This was in disagreement with our model and suggested that activation of Gcn2 by stalled 
ribosomes is distinct from that of Hel2. In support of these ideas, we observe a similar pattern in 
the presence of the unrelated translation inhibitor anisomycin. The drug has no observable effect 
antibiotics inhibits binding of the A-site tRNA (Brodersen et al., 2000), but most of these do not 
work in eukaryotes. Recently, tigecycline has been used effectively in lysates to carry out profiling 
of ribosomes with an empty A site (Wu et al., 2019). The compound, however, does not work 
efficiently in live yeast cells, presumably due to its permeability. Nevertheless, we can show that 
addition of the compound to very high concentrations (2 mg/mL) inhibits cellular growth, 
suggesting that we can overcome some of the permeability issues (Supplementary figure 3D). This 
in turn allowed us to address whether the compound can activate Gcn2 at intermediate 
concentrations. Addition of tigecycline was found to robustly activate phosphorylation of eIF2 





Figure 4. Intermediate concentrations of MMS and tigecycline are required for maximal 




A) Schematic showing how intermediate, but not high, concentrations of inhibitors lead to 
ribosome collision. B) Western-blot analysis used to follow phosphorylation of eIF2 and uS3 
ubiquitination as a function of MMS concentration. In all cases cells were treated with the indicated 
concentration of MMS for 30 minutes. C) Relative levels of phospho-eIF2a, Ub-uS3 and indicated 
Ubiquitin bands in (B) collected from cells treated with the depicted concentration of MMS for 30 
minutes. Quantification was conducted by densitometry analysis of at least three independent 
immuno-blots similar to the ones shown in (B); band intensities were normalized to Pgk1 signal. 
D) Western-blot analysis of total proteins isolated from wild-type and hel2 cells treated with the 
indicated MMS concentration for 30 minutes. E) Bar graph showing the relative levels of phospho-
eIF2a and Ubiquitin bands in WT and hel2D cells treated with the indicated concentration of MMS 
for 30 minutes. Analysis was conducted as per (C). F) and G), similar to D) and E), respectively, 
but for cells treated with tigecycline for 30 minutes. H) Western-blot analysis of total proteins 
isolated from wild-type and hel2 cells treated with the indicated compounds for the indicated 
amount of time. I) Bar graph analysis of three biological repeats of the immuno-blots shown in 
(H) used to assess the relative levels of phospo-eIF2a and Ubiquitin bands. J) Fluorescence image 
of an ethidium-bromide-stained acid-PAGE gel used to resolve tRNAs isolated from wild-type 
and hel2 cells treated with the indicated compounds for 30 minutes. Note a sample, which was 
isolated from wild-type cells in the absence of any compounds, was deacylated with mild-base 
treatment and resolved on the left most lane. In all cases, plotted is the mean values determined 
from at least three biological repeats with the error bars representing the standard deviation around 
it.  
 
HEL2 was found to decrease the concentration of drug required for robust activation of Gcn2 
(Figure 4F). In particular, we measured a maximal increase of ~sevenfold for Phospho-eIF2a levels 
at tigecycline concentration of 5 mg/mL for wild-type cells compared to that of ~tenfold at 
tigecycline concentration of 2.5 mg/mL for hel2D ones (Figure 4G). The observation that 
tigecycline and MMS robustly induce both RQC and ISR activation, but cycloheximide and 
anisomycin only activate RQC, suggests that ISR activation by Gcn2 prefers the stalled ribosomes 
to have an empty A site. In agreement with this model, addition of 4-NQO, which oxidizes RNA 
and inhibits tRNA selection (Simms et al., 2014; Thomas et al., 2019) activates both processes. 




resulting in depletion of His-tRNAHis- also activates both processes. We note that the addition of 
hydroxyurea (HU), which has been shown to activate ISR through an unknown mechanism 
(Hughes et al., 2000), activates Hel2-mediated ubiquitination (Figures 4H and 4I). Collectively, 
these observations suggest that activation of ISR and RQC converges on collided ribosomes; with 
ISR being sensitive to the status of the A site, whereas RQC is not. 
 In addition to ribosome-mediated activation of Gcn2, the factor is activated in response to 
accumulation of deacylated tRNAs. As a result, it is likely that many of the conditions used in our 
previous experiments can result in tRNA deacylation; although, apart from 3-AT, it is unclear how 
they would mediate the deacylation process. Regardless, we isolated total RNA from wild-type 
and hel2 cells in the absence of any compound and in the presence of MMS, 4-NQO and HU, 
and resolved the tRNAs on acid-PAGE gels (Varshney et al., 1991). We deacylated tRNAs through 
mild-base treatment to serve as a control. As predicted, none of the conditions resulted in general 
changes to the global levels of deacylated tRNAs as assessed by their mobility-shift relative to the 
deacylated control (Figure 4J). In contrast, nitrogen starvation, which activated ISR 
(Supplementary Figure 3E) resulted in a slight increase of deacylated-tRNA levels (Supplementary 
3F). While our data are consistent with a model whereby alkylation and oxidation stresses activate 
Gcn2 through ribosome stalling, given that the concentration of total tRNAs is estimated to be > 
1000 fold in excess of that of Gcn2, we cannot rule out a role for tRNA deacylation in the process.  
Stalling by a catalytically inactive release factor activates RQC but not ISR 
 Our analysis with translation inhibitors, and alkylation and oxidation agents suggests that 
Gcn2 activation is sensitive to the status of the A site of the ribosome. To add further support for 




strategy that does not rely on addition of compounds. More specifically, we took advantage of a 
dominant-negative variant of release factor eRF1, for which the universal GGQ motif in the active 
site that is required to engage the peptidyl-transferase center of the ribosome (Brown et al., 2015; 
Frolova et al., 1999) is mutated to GAQ. We and others have shown that this mutation has no effect 
on binding, but almost completely inhibits peptide release (Petropoulos et al., 2014; Shaw and 
Green, 2007). As a result, expression of this mutant factor will cause ribosome stalling and 
collisions at stop codons with the lead ribosome having its A site occupied with the release factor 
(Figure 5A). The wild-type eRF1 and GAQ mutant were introduced on a plasmid into wild-type 
cells under galactose induction. As expected, only the GAQ mutant promoted ubiquitination 
(Figure 5B), in agreement with the idea that it induces ribosome collisions. We note that, 
ubiquitination was observed in the absence of galactose most likely due to leaky induction as these 
cells were cultured in Raffinose (absence of glucose). Indeed, even in the absence of galactose, the 
growth rate of these cells was slower than that of ones transformed with wild-type eRF1. 
Furthermore, induction of the GAQ variant was much less than that of the GGQ wild-type factor 
(Figure 5B) due to its toxic effect. More important than its effect on ubiquitination was the 
observation that induction of the GAQ mutant resulted in little to no change in the levels of 
phsopho-eIF2 (Figure 5B), especially when compared to that observed in the presence of MMS 
(Supplementary Figure 4). These observations suggest that ribosome collisions induced by an 
eRF1-bound-lead ribosome do not trigger ISR. To directly confirm that expression of GAQ leads 
to ribosome collisions, we conducted sucrose-gradient fractionation of polysomes isolated from 
cells expressing eRF1GGQ and eRF1GAQ. Polysome profiles of the GAQ cells indicated that they 




structures were found to be resistant to RNase I treatment (Figure 5C, bottom). Under normal 
conditions, during which ribosomes are sparsely distributed across mRNAs, addition of RNase I 
collapses polysomes into monosomes. Under conditions where ribosomes collide, RNase I is 
incapable of accessing mRNA between them and polysomes collapse to higher order structures 
such as disomes instead (Guydosh and Green, 2014). These observations suggest that eRF1GAQ 








Figure 5. Collided ribosomes with an eRF1-bound-lead ribosome do not activate ISR but 
activate RQC.  
A) Schematic showing how a catalytically dead mutant (GAQ) of eRF1 can be used to cause 
ribosome collisions at stop codons with the factor bound to the A site of the lead ribosome. B) 
Western-blot analysis of total proteins isolated from cells expressing wild type or catalytically 
dead mutant of eRF1 in the absence and presence of induction by galactose. C) Polysome profiles 
of lysates isolated from cells expressing the indicated-release-factor variants. Top shows profiles 
of untreated lysates; bottom shows those of RNase I-treated lysates. 
 
Inhibition of collided-ribosomes clearance activates Gcn2 and ribosomal-
protein ubiquitination 
 During RQC, following Hel2-mediated ubiquitination of ribosomal proteins, stalled 
ribosomes are rescued through the action of Slh1 (Ikeuchi et al., 2019). Hence, in the absence of 
this factor, collided ribosomes are likely to linger a while longer. Consequently, in our model of 
ribosome collisions being responsible for Gcn2 activation, one would predict that deletion of 
SLH1 would result in greater phosphorylation of eIF2. Furthermore, one should also observe 
greater MMS-induced ubiquitination. In complete agreement with this prediction, in the absence 
of Slh1, we observe significant accumulation of phospho-eIF2 in the absence of any stressors 
(Figure 6A). More specifically, we measured a ~fourfold increase in the levels of P-eIF2 
phospho-eIF2 levels in slh1 cells relative to wild-type ones (Figure 6B). In agreement with 
these observations, qPCR analysis revealed that MMS induction of the Gcn4 target ARG1 is 
twofold higher in the slh1 strain relative to the wild-type one; upon the addition of MMS, 
ARG1 expression is increased by less than tenfold in the wild-type strain, whereas in slh1 its 





Figure 6. Ribosome collisions activate Gcn2.  
A) Western-blot analysis of total proteins isolated from the depicted cells treated with 0.1% MMS 
for the indicated times (oe indicates overexpression). B) Bar-graph analysis of three independent 
immuno blots similar to the one shown in (A), used to follow the relative levels of phospho-eIF2a 
and ubiquitin bands in the indicated samples. C) qPCR analysis of the AGR1 transcript in wild-
type and slh1 cells after a 10-minute incubation period with 0.1% MMS. D) Ribosome profiles 
of lysates isolated from the indicated strains that were incubated in the absence or presence of 
0.1% MMS for 30 minutes. The lysates were either mock treated or RNase I treated, as shown, 
before resolving them over a 10-50% sucrose gradient. The disome peak that appears to be resistant 
to RNase I is labeled as such. For all bar graphs, plotted is the mean values determined from three 





deletion of SLH1, resulted in a significant increase in MMS-induced protein ubiquitination 
(Figures 6A and B). These findings greatly suggest that in the absence of Slh1, collided ribosomes 
are not cleared efficiently and as a result activate both Gcn2 and Hel2. 
Alkylation stress causes ribosome collisions.  
The observation that MMS and 4-NQO activate RQC, suggests that these compounds lead 
to ribosome collisions, but we could not demonstrate that this actually occurs in vivo (Yan et al., 
2019). Our observation that these compounds also induce ISR (Figure 4) gave us a rationale as to 
why collisions were not detected under these conditions. In particular, since these compounds 
cause eIF2 phosphorylation, their addition also results in global inhibition of translation and, as 
a result, loading and eventual collision of ribosomes on mRNAs is severely limited. These ideas 
were confirmed by utilizing a GCN2-deletion strain. We used an RNase-protection assay of 
mRNAs in polysomes and in complete agreement with our model, upon addition of MMS, only in 
the gcn2 strain were we able to observe significant accumulation of disomes (Figure 6D). These 
findings suggest that indeed alkylation stress results in ribosome collisions. 
Gcn1 associates with collided ribosomes 
 Previous studies have shown that Gcn1, Gcn2 and Gcn20 co-sediment with polysomes 
during sucrose-gradient fractionation (Marton et al., 1997; Sattlegger, 2000; Sattlegger and 
Hinnebusch, 2005). This together with the observation that Gcn1 and Gcn20 have a domain 
homologous to elongation factor 3 (Visweswaraiah et al., 2012), suggest that the factors directly 
bind to ribosomes. But whether the factors recognize specific conformations of the ribosomes that 
accumulate under stress is currently unknown. The observation that conditions that increase levels 




ribosomes. To test this prediction, we set out to conduct sucrose-gradient fractionation of RNAse 
I-treated lysates and investigate the association of Gcn1 with different ribosome fractions as 
function of MMS addition. We note that addition of cycloheximide, which is used routinely during 
profiling, results in significant levels of collided ribosomes even in the absence of any stressors 
(Supplementary Figure 5). As a result, we opted not to use any antibiotics in our profiling analysis. 
The absence of inhibitor explains why we observe significantly lower levels of polysomes due to 
increased ribosome runoff during our lysate preparation. This, however, should not affect our 
analysis of stalled ribosomes especially in the absence of Hel2, during which collided ribosomes 
cannot be rapidly resolved. 
 As expected, the addition of MMS to wild-type cells resulted in an almost complete loss 
of polysomes resulting from phospho-eIF2-induced inhibition of translation (Supplementary 
Figure 6). In contrast, the profile of the sui2-mutant cells exhibited polysomes in the presence of 
MMS (Supplementary Figure 6), due to the inability of these cells to inhibit initiation in the 
presence of alkylation stress. Interestingly, further deletion of HEL2 from these cells resulted in 
increased levels of polysomes in the presence of MMS; this is in agreement with the fact that these 
cells are incapable of resolving collided ribosomes. As a result, we used these cells to assess the 
association between Gcn1 and ribosomes (Figure 7A). Similar to what others have reported 
(Marton et al., 1997; Sattlegger, 2000; Sattlegger and Hinnebusch, 2005), Gcn1 was observed to 
only marginally associate with polysomes. Remarkably, in the presence of MMS, Gcn1 was found 





Figure 7. Gcn1 associates with collided ribosomes.  
A) Ribosome profiles of lysates isolated from sui2-S52A;hel2 cells incubated in the absence and 
presence of 0.1% MMS for 30 minutes. Shown is the absorbance at 254 nm of lysates fractionated 
over a 10-35% sucrose gradient. Below the profiles is western-blot analysis of fractions collected 
from sucrose-gradient fractions for the indicated proteins. B) Similar to A), but lysates were treated 
with RNase I prior to fractionation over a 10-35% sucrose gradient. C) and D) Densitometry 
analysis of immuno blots similar to the ones shown in (A) and (B), respectively, which was used 
to analyze the relative distribution of the indicated proteins across sucrose gradients. Analysis was 
conducted on three biological repeats, with the mean values plotted and the error bars representing 





stalled ribosomes (Figure 7A). We then conducted polysome profiling on RNase I-treated lysates, 
which collapsed most of the polysomes into a monosome. Even under these conditions, Gcn1 was 
observed to remain associated with the heavy fractions, suggesting that factor associates with 
collided ribosomes (Figure 7B). Quantification of the signal corresponding to Gcn1 to assess its 
distribution across the sucrose gradient confirmed that the protein indeed migrates with the heavy 
polysome fractions (Figure 7C). This is in contrast to proteins that are known not to stably associate 
with ribosomes such as PGK1 and eRF1 (Figure 7C and Supplementary Figure 7). Notably, similar 
analysis of RNaseI-treated lysates revealed that in the presence of MMS, the factor remains 
associated with the resulting collided ribosomes (Figure 7D). In particular, in the absence of MMS, 
~7% of the protein was found to remain associated with the collided ribosomes (fractions 5-7) 
relative to 20% that was observed to associate with polysomes when lysates were not treated with 
RNase I (Figures 7C and 7D). In contrast, for MMS-treated cells the relative association of the 
factor with polysomes only slightly decreased from 30% to 27% as a result of RNase I treatment. 
The observation that under conditions that activate Gcn2, more of its coactivator associates with 





During protein synthesis, the ribosome receives multiple cues to ensure that the correct 
protein is made at the right place, right time and at the right concentration. These cues are the result 
of signals triggered by varying cellular needs and environmental conditions such as proliferation 
and stress. The integrated-stress response (ISR), which responds to stresses through the activation 
of initiation factor eIF2 kinases, is one such important pathway in eukaryotes. Phosphorylation 
of eIF2 represses global translation, but also derepresses translation of key pro-survival mRNAs. 
In yeast, ISR is activated by the eIF2 kinase Gcn2 in response to amino-acid deprivation. The 
most widely accepted model evokes an active role for deacylated tRNA in the process (Dong et 
al., 2000). In this model, under amino-acid-deprivation conditions, deacylated tRNAs accumulate 
and are recognized by Gcn2 and its coactivators Gcn1 and Gcn20. Interestingly, Gcn1 and Gcn20 
have been shown to bind the ribosome, and they are thought to deliver the deacylated tRNA from 
the A site of the ribosome to Gcn2, activating its kinase activity (Sattlegger, 2000). In addition to 
amino-acid deprivation, recent data has shown Gcn2 to respond to other stressors that do not 
change the levels of deacylated tRNAs, suggesting an alternative mechanism for its activation 
(Harding et al., 2019; Inglis et al., 2019; Ishimura et al., 2016). In this alternative model, the 
ribosome itself, and in particular ribosome stalling, plays a more critical role in activating Gcn2. 
In agreement with this model, here we showed that alkylation and oxidation agents that modify 
mRNAs and stall the ribosome robustly activate Gcn2 as assessed by accumulation of phospho-
eIF2 (Figures 1, 2, 3 and 4). Interestingly, ribosome stalling also activates the mRNA-
surveillance pathway of no-go decay (NGD) and ribosome-quality control (RQC) of nascent 




alkylating and oxidizing agents that activate Gcn2 also activate Hel2 (Yan et al., 2019), suggesting 
that ISR and RQC must be coordinated somehow. Indeed, here we provide compelling evidence 
that suggests that the two processes antagonize each other (Figures 1, 2, 3, 4 and 6).  
In addition to this apparent competition between the two processes, ISR and RQC appear 
to be exquisitely sensitive to the concentration of stressor. Optimum activation was observed to 
take place at intermediate concentrations of damaging agents (Figure 4B), with RQC activation 
occurring at lower concentrations. It thus appears that Hel2 is more sensitive to changes to the 
translation apparatus and responds faster than Gcn2. The sensitivity of Hel2 to the concentration 
of translation inhibitors has been noted by several groups (Ikeuchi et al., 2019; Juszkiewicz et al., 
2018; Simms et al., 2017), and has been used to formulate a model for its activation through 
ribosome collisions (Simms et al., 2017). Structural studies provided a molecular rational for this 
activation, for which collided ribosomes form an interface that can be recognized by the ligase 
(Ikeuchi et al., 2019; Juszkiewicz et al., 2018). Interestingly, however, promoting ribosome 
collisions through the addition of translation inhibitors at intermediate concentrations, known to 
activate RQC, was found not to activate ISR (Supplementary Figure 3A-C). A simple model that 
could explain these observations is that Gcn2 is not activated by ribosome collisions, and instead 
the factor responds to ribosome stalling through a different mechanism, although this model cannot 
explain why stalling by translation inhibitors is incapable of triggering ISR. In an alternative 
model, Gcn2 is sensitive to the status of the stalled ribosome during collisions. Given that chemical 
agents and translation inhibitors stall the ribosome through different mechanisms, this model could 
explain the observed disparities between the effect of the two classes of molecules on ISR 




ribosome empty; whereas inhibitors such as cycloheximide and anisomycin keep the A site 
occupied by a tRNA, albeit in different conformations (Wu et al., 2019). As a result, we 
hypothesized that Gcn2 prefers the A site to be empty for its activation. To test this hypothesis, we 
looked for inhibitors that prevent aminoacyl-tRNA from binding the A site. For instance, the 
tetracycline class of antibiotics is known to accomplish this in bacteria (Brodersen et al., 2000), 
but most have no effect on translation in eukaryotes. Fortuitously, the antibiotic tigecycline was 
recently shown to be effective in preventing A-site occupancy in yeast lysate (Wu et al., 2019), 
suggesting that the drug could be used to inhibit aa-tRNA from binding the A site in vivo. Indeed, 
the addition of drugs to very high concentrations (> 2 mg/mL) was found to inhibit yeast growth 
(Supplementary Figure 3D). Most important and in contrast to cycloheximide and anisomycin, 
tigecycline was found to activate Gcn2 (Figure 4F). Furthermore, robust activation was observed 
at intermediate concentrations of drug, around those that inhibit growth modestly. Therefore, 
similar to Hel2, Gcn2 appears to be activated by ribosome collisions, but its activation is sensitive 
to the status of the A site of the ribosome. In agreement with this model, overexpression of a 
catalytically dead mutant of eRF1, which causes ribosome collisions on stop codon with the A site 
of the lead ribosomes occupied by the factor, does not trigger ISR (Figure 5). 
To add further support for this model of collision-mediated activation of Gcn2, we sought 
to confirm that stressors that activate the factor also lead to the formation of collided ribosomes. 
To this end, we used an RNase I-protection assay, for which collided ribosomes are not accessible 
to the enzyme and remain intact in their higher-order form. As expected, addition of MMS to yeast 
cells that cannot phosphorylate eIF2 (gcn2 and sui2-S52A) results in the formation of stable 




yeast lysate (Figures 6 and 7, and Supplementary Figure 6). More notable was the observation that 
Gcn1 (a Gcn2 coactivator and is required for ISR) remains associated with the polysomes even 
after the RNase I treatment (Figure 7). Moreover, addition of MMS was observed to result in 
further association between the factor and polysomes, suggesting that Gcn1 is likely to prefer 
collided ribosomes over spread-out polysomes.  
Our data suggest that both Hel2 and Gcn2 are activated by the very same signal of ribosome 
collisions. We find that inhibition of RQC, through deletion of HEL2, results in the overactivation 
of ISR, and vice versa (Figures 1, 2, 3 and 6). There are at least three models that can explain this 
connection between the two processes. In the first one, Gcn2 coactivators compete with Hel2 for 
the same interface on the ribosome. In the second one, ubiquitination of ribosomal proteins by 
Hel2 inhibits the activation of Gcn2. In the third and simplest model, inhibition of ISR or RQC 
pathways results in increased ribosome collisions, through de-repression of translation initiation 
or inhibition of collided-ribosome clearance, respectively. This increased frequency of collision 
would then lead to over-activation of whichever of the two pathways that remains intact. We favor 
this last model, since inhibition of eIF2 phosphorylation by using the S52A mutant of the factor 
was found to result in a significant increase in Hel2-mediated ubiquitination in the presence of 
MMS (Figure 3). The observation that Gcn2 prefers a different conformation of collided ribosomes 
is in agreement with this model. Nevertheless, we cannot rule out that multiple models may 
contribute to this apparent competition between the two pathways. 
During revision of this study, Wu et al. (Wu et al., 2020) reported that collided ribosomes 
activate the stress-activated protein kinase (SAPK) pathway through the MAPKKK ZAKa in 




ribosomes and that this association was responsible for its activation of the SAPK (p38/JNK) and 
GCN2, but whether the factor displays a preference of the status of the A site of the stalled 
ribosome was not immediately clear. Notably, Wu and colleagues used the translation inhibitors 
anisomycin and emetine at intermediate concentrations to promote ribosome collisions and showed 
that both of these inhibitors activate Gcn2. As emetine is known not to be able to inhibit protein 
synthesis in yeast, at least in vivo (Battaner and Vazquez, 1971), we could only test anisomycin. 
Interestingly and in contrast to what was observed in mammalian cells, we could not detect 
significant accumulation of phospho-eIF2a in the presence of anisomycin (Supplementary Figure 
3). This distinction between mammals and yeast might be explained by differences in the mode of 
Gcn2 activation. For instance, it is unclear whether yeast has a ZAK homologue that acts upstream 
of Gcn1, Gcn2 and Gcn20 during ISR activation. Alternatively, and given how conserved ISR 
activation is, it is likely that this observed difference is the result of disparate mode of interactions 
between the drug and the ribosome. Anisomycin inhibits peptidyl-transfer, and as a result the A-
site tRNA adopts a so-called A/T state (Valle et al., 2002). This tRNA has been shown to be 
unstable in this state and readily dissociates from the ribosome (Dorner et al., 2006), which may 
give ZAKa or GCN1 enough time to bind collided ribosomes.  
The model of ribosome-collision-mediated ISR activation is appealing because it easily 
rationalizes how Gcn2 and its coactivators (Gcn1 and Gcn20) are activated by ribosomes only 
under stress. Under normal conditions, ribosome collisions occur infrequently as a result of 
aberrant mRNAs, and it makes sense that Hel2 is activated to trigger NGD and RQC. Under stress 
conditions, ribosome collisions occur frequently, Hel2 is likely to get overwhelmed and Gcn2 gets 




consistent with these ideas (Figure 2). Multiple factors could contribute to the ability of Hel2 to 
recognize collided ribosomes and activate RQC before the activation of Gcn2. For instance, the 
factor’s relatively higher affinity, concentration or faster kinetics to those of Gcn2 and its 
coactivators could ensure RQC is activated prior to ISR activation. Future experiments aimed at 
dissecting the thermodynamic and kinetics contributions for both processes are likely to shed 







Yeast strains used in this study are listed below. Yeast cells were grown at 30°C in YPD 
media. Deletion, mutant and chromosomally tagged yeast strains were constructed in the BY4741 
background (MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0) using common PCR-knockout 
techniques. Oligonucleotide sequences are listed in Supplementary Table 2.  
Media Preparation 
All solid and liquid media have been prepared according to standard lab protocols. Unless 
otherwise stated, MMS, 4-NQO, cycloheximide, HU and 3-AT were added to final concentrations 
of 0.1%, 5 μg/mL, 100 μg/mL, 100 mM and 100 mM respectively. Cells were incubated with drugs 
for 30 min, unless stated otherwise.  
RNA seq 
The RNA-seq data sets were prepared from total RNA isolated using the hot-phenol 
extraction method (Simms et al., 2017) from mid-log phase yeast cells in the absence and presence 
of 0.1% MMS incubated for 90-min at 30°C. For each condition, 30 g of total RNA from three 
biological replicates were processed and mRNA libraries were generated and processed by the 
Genome Technology Access Center in the Department of Genetics at Washington University 
School of Medicine. Briefly, polyA enriched libraries were prepared from total RNA using Oligo-
dT beads. Samples were prepared according to library kit manufacturer’s protocol, indexed, 




with Illumina’s RTA version 1.9 and bcl2fastq2 software with a maximum of one mismatch in the 
indexing read. It was then sequenced with 2 X 150-bp paired-end reads. RNA-seq reads were then 
aligned to the Ensembl release 76 (GCA_000146045.2) primary assembly with STAR version 
2.5.1a (Dobin et al., 2013). Gene counts were derived from the number of uniquely aligned 
unambiguous reads by Subread:featureCount version 1.4.6-p5 (Liao et al., 2014). Isoform 
expression of known Ensembl transcripts were estimated with Salmon version 0.8.23. Sequencing 
performance was assessed for the total number of aligned reads, total number of uniquely aligned 
reads, and features detected. The ribosomal fraction, known junction saturation, and read 
distribution over known gene models were quantified with RSeQC version 2.6.2 (Wang et al., 
2012). Genes with more than 20 reads were normalized over all read counts across all samples. 
Differentially expressed genes were identified by Perseus 1.6.12 (Tyanova et al., 2016) using 
pairwise comparisons between genotypes/conditions. Significant changes in transcript abundance 
were calculated by ANOVA contrasts (p ≤ 0.05), excluding transcripts with an FDR > 0.05 to 
account for multiple comparisons. 
Polysome profiling with RNase I 
Yeast cultures from mid-log phase yeast cells were harvested by centrifuging at room 
temperature. Cells were then resuspended in polysome-lysis buffer (20 mM Tris pH 7.5, 140 mM 
KCl, 1.5 mM MgCl2, 0.5 mM DTT, 200 μg/mL heparin, 1% Triton), washed once and lysed with 
glass beads using a FastPrep-24 (MP Biomedical). Supernatants from cleared lysates 
corresponding to 500 ug of total RNA were treated with 100 U of RNase I (Thermo Fisher, 




sucrose gradient and centrifuged at 35,000 rpm for 160 min in an SW41Ti (Beckman) swinging-
bucket rotor. Gradients were then fractionated using a Brandel tube-piercing system combined 
with continuous absorbance reading at 254 nm. Proteins were isolated through a TCA precipitation 
method and resuspended in HU buffer (8 M Urea, 5% SDS, 200 mM Tris pH 6.8, 100 mM DTT, 
1 mM ethylenediaminetetraacetic acid (EDTA), bromophenol blue).  
Overexpression of eRF1 and its GAQ mutant 
 Sequences encoding wild-type and GAQ eRF1 were PCR amplified and cloned into pYES2 
plasmid (ThermoFisher) by Gibson assembly (NEB). Plasmids were transformed into yeast using 
the lithium acetate method (Gietz and Woods, 2002). Individual colonies were inoculated into -
Ura complete synthetic media with raffinose as the sole carbon source. Overnight cultures were 
diluted to an Abs600nm of 0.05 and grown to an Abs of 0.4 before cells were divided into two 
cultures and galactose was added to a final concentration of 2% to only one of the cultures. Cells 
were grown for an additional 3 hours before collecting them for western-blot and ribosome-profile 
analyses.  
Quantitative RT-PCR  
Total RNA from yeast cells was isolated following the hot phenol method (Köhrer and 
Domdey, 1991) . cDNA was generated with M-MuLV reverse transcriptase (NEB, cat#M0253L) 
from 1-10 μg of total RNA that was treated with DNase I (Thermo Scientific, cat# EN0601) using 
a random hexamer (Thermo Scientific, cat# SO142) for priming. Quantitative RT-PCR was 




of cDNA. The relative fold change was obtained by following the Ct method. The relative 
transcript abundance for each gene from three biological repeats was determined by normalizing 
to the expression level of the TAF10 gene.  
Western blotting 
Total lysates from mid-log-phase cells were harvested and lysed in 1 mL of ice-cold lysis 
buffer (300 mM NaOH, 1% -mercaptoethanol). Proteins were precipitated through the addition 
of TCA to 7.5% and resuspended in HU buffer (8 M Urea, 5% SDS, 200 mM Tris pH 6.8, 100 
mM DTT, 1 mM ethylenediaminetetraacetic acid (EDTA), bromophenol blue) using a volume that 
was normalized to the amount of cells harvested. Proteins were separated by SDS–PAGE and 
analyzed by immunoblotting. The following antibodies were used: rabbit anti phospho- eIF2 
(Ser51) (Cell Signaling Technology, cat# 9721S), rabbit anti-Gcn4 (from Thomas Dever lab, 
1:2000 v/v dilution), rabbit anti Gcn1 (from Alan Hinnebusch lab, 1:2000 v/v dilution), mouse 
anti-ubiquitin HRP (Santa Cruz, Cat#: sc8017; 1:2,000 v/v dilution), mouse anti-FLAG (Sigma; 
Cat#: F1804; 1:5,000 v/v dilution), rabbit anti-uS4 (Rps9) (Abcam, Cat#:ab117861; 1:5,000 v/v 
dilution), and rabbit anti-eRF1(Eyler et al., 2013) (1:2000 dilution). Secondary antibodies of goat 
anti mouse IgG HRP (Thermo Scientific, Cat#: 31430) and goat anti rabbit IgG HRP (Thermo 
Scientific, Cat#: 31460) were used at (1:10,000 v/v dilution). Densitometry analysis was conducted 
using Image Lab (Bio-Rad Laboratories). Unless otherwise stated, relative signal of the protein of 
interest was obtained by normalizing to that of PGK1. 




Statistical and graphs analysis for RT-PCR (from 3 biological repeats) and western blot 
(from 3 biological repeats) results were processed by GraphPad Prism 8.4.3 (Graphpad Software, 
La Jolla, CA). For RNA seq analysis, differentially expressed genes from 3 biological repeats were 
identified by Perseus 1.6.12 (Tyanova et al., 2016) using pairwise comparisons between 
genotypes/conditions. Significant changes in transcript abundance were calculated by ANOVA 
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The overarching goal of my thesis research was to understand how elongating ribosomes 
signal to and impact conserved stress-related pathways in eukaryotes. Through several in vitro 
studies, we first identified a molecular rationale for how quality-control factors can identify stalled 
ribosomes while demonstrating that ribosome collisions are required to trigger NGD and RQC. 
Using genetic and biochemical methods, we revealed that ribosome collision is the signaling 
platform for both ISR and ribosome-quality control (RQC), a pathway that mitigates translational 
stresses caused by ribosome stalling. Interestingly, inactivation of one pathway was found to result 
in the over-activation of the other, with RQC activation occurring at a lower frequency of 
collisions. In contrast, the activation of ISR required a high frequency of collisions and was 
sensitive to the status of the A site of the ribosome. As our work has shown, ribosome collisions 
caused by chemically damaged mRNA occur frequently; pathways such as ISR, which are also 
activated by ribosome collisions but drastically alter cellular function, need to be managed with 
additional controls. Hence, this ability to adjust cellular response based on the severity of the stress 
is crucial for the survival of the cell. Altogether, my research has revealed an additional layer of 





SUMMARY: Chemical damages to mRNA trigger ribosome-based quality 
control in the cell.  
 
Ribosomes often face defective adducts that disrupt their movement along the mRNA 
template (Brandman and Hegde, 2016)(Simms et al., 2017). These adducts are primarily caused 
by chemical damage to mRNA and are highly detrimental to the decoding process on the ribosome. 
Hence, unless dealt with, chemical damage to RNA has been hypothesized to lead to the production 
of toxic protein products. In the effort to establish the impact of RQC in eliminating damaged 
mRNA molecules, we investigated the abundance of harmful modifications caused by endogenous 
cellular processes. To achieve this, we conducted quantitative analysis of ribonucleoside 
modifications in both total RNA as well as mRNA by liquid chromatography-mass spectrometry 
(LC-MS) on wildtype (WT) and Xrn1 deletion mutant. Our data show that in mRNA, the ratio of 
8-oxoG to G increased by more than twofold in the absence of XRN1, one of the core component 
of NGD (Simms et al., 2017). Moreover, deletion of XRN1 was found to result in the significant 
increase of alkylative adducts, known to disrupt Watson-Crick base pairing, within mRNA, and to 
result in a more modest increase of ones that do not modify Watson-Crick base pairing. We then 
utilized damaging agents such as 4-Nitroquinoline 1-oxide (4-NQO) and methyl methanesulfonate 
(MMS) that were known to be able to modify nucleic acids (Simms and Zaher, 2016) to determine 
the effect of these damaging agents on RNA molecules in vivo through LC-MS. Our findings 
suggest that the addition of 4-NQQ and MMS leads to widespread accumulation of damaged 
nucleotides in the mRNA, which in turn should lead to pervasive stalling of ribosomes. To 
understand the impact of nucleic-acid-damaging agents on translation in vivo, we evaluated the 




addition of both alkylative and oxidative damaging agents results in significantly more protein 
aggregates (foci) in the absence of a functional RQC pathway (ltn1) and further support our 
hypothesis and show that both alkylative and oxidative damaging agents induced translational 
stresses that require RQC pathway to resolve them. Finally, To interrogate the dynamics of protein 
ubiquitination on the ribosome in response to the presence of a damaging agent, we utilized a 
quantitative proteomic approach coupled with diglycine (diGly)-modified peptides immuno-
affinity enrichment to identify site-specific alterations to ubiquitin-modified peptides on purified 
ribosomes (Kim et al., 2011). Mass spec (MS) analysis revealed that the abundance of diGly-
modified peptides from ribosomal proteins on both large (60s) and small (40s) subunits were 
altered upon 4-NQO treatment. The data also indicates that the K63 ubiquitin on ribosomal 
proteins increased strongly (>10 fold) to 4-NQO treatment, whereas K48 ubiquitin had a moderate 
increase (1-3 fold) to the treatment. We further comforted that the ubiquitination events that 
occurre on ribosomal proteins during stalling are all induced upon 4NQO treatment. Altogether, 
our data demonstrate the detrimental effect of chemically damaged mRNA on cellular homeostasis 




SUMMARY: Ribosome quality control antagonizes the activation of the 
integrated stress response on colliding ribosomes.  
 
Cells evolved multiple cellular pathways to regulate translation in response to fluctuations 
in nutrient availability, endogenous and exogenous stresses (Pakos‐Zebrucka et al., 2016). At the 
global level, pathways such as the integrated Stress Response (ISR) provide eukaryotic cells the 
capacity to adjust translation and transcriptional output and maintain homeostasis in changing 
environments (Hinnebusch, 2005; Pakos‐Zebrucka et al., 2016). Historically, it has been proposed 
that GCN2 is activated in response to the accumulation of deacylated tRNA (Dong et al., 2000; 
Lageix et al., 2015; Qiu, 2002; Qiu et al., 2001; Ramirez et al., 1992). Yet, recent studies on ISR 
suggested an alternative model for activation that points to ribosome stalling, and the P stalk of 
the ribosome instead of deacylated tRNAs as the signal that activates Gcn2 (Harding et al., 2019; 
Inglis et al., 2019; Ishimura et al., 2016). Here we carried out RNA-sequencing analysis of wild-
type and hel2 yeast cells in the absence and presence of MMS. Our analysis showed the deletion 
of HEL2 to result in significant over-induction of Gcn4 targets, which suggests that Hel2 is used 
to suppress premature activation of Gcn2 in the absence of stress conditions. To add further support 
for our RNA-sequencing analysis, we investigated the phosphorylation status of eIF2a in response 
to MMS addition and presence/absence of Hel2. In agreement with our model, deletion of HEL2 
accelerated the accumulation of phospho-eIF2. We then titrated MMS from low and very-high 
concentrations and assessed P-eIF2 accumulation, reasoning that at high concentrations mRNAs 
are damaged at multiple positions. The data demonstrates that the activation of both Hel2 and Gcn2 
is initiated by agents that cause ribosome stalling, while the maximal activation of Hel2 was 




have been documented to induce collision, our data indicate that the processes do not appear to be 
in direct competition with each other. Specifically, our data suggest that activation of ISR and 
RQC converges on collided ribosomes; with ISR being sensitive to the status of the A site, whereas 
RQC is not. To further understand the relationship between ISR and RQC, we generated phosphor-
dead mutation of SUI2 (gene encoding eIF2) where serine 52 was altered to alanine. Significant 
increase in Hel2-mediated ubiquitination in the presence of MMS was observed in the S52A 
mutant while its eIF2 phosphorylation was found to be abolished. Since Gcn1 and Gcn2 are 
present in sui2 cells, the increase in ubiquitination from MMS addition is likely to be the result of 
increased initiation on damaged mRNA rather than direct competition between Gcn1/Gcn2 with 
Hel2. Collectively, our findings provide important details about how multiple pathways that 





FUTURE DIRECTION: Ribosome collision as a platform for coordinating 
stress responses 
One interesting observation made during my thesis work is that ribosomal protein 
ubiquitylation appears faster than H2A.X phosphorylation, a DNA damage response hallmark 
(Löbrich et al., 2010). This data suggests the possibility that RNA damage occurs on a much faster 
time scale than DNA damage. This difference might be due to the fact that the chemical structure 
of RNA, and specifically mRNA, is relatively protein-free and single-stranded, thus exposing the 
nitrogen and oxygen atoms of the Watson-Crick face of the nucleobase to potential chemical attack 
(Simms and Zaher, 2016). It is also likely that stalling of translation appears sooner than changes 
to DNA metabolism, such as changes to replication, which suggests a potential avenue for how 
cells respond to chemical insults.  
This hypothesis is reinforced by the observation that Hel2-dependent-K63-linked 
ubiquitylation is highly enriched upon DNA damage agent treatment (Yan et al., 2019). 
Furthermore, recent publications report that Hel2-mediated k63-linked polyubiquitination on 
ribosomal proteins is required for multiple pathways that utilize ribosomes as a signaling platform, 
including NGD and 18S non-functional rRNA decay (Matsuo et al., 2017b),(Ikeuchi et al., 2019a; 
Sugiyama et al., 2019a). More importantly, K63-linked polyubiquitin chains play an essential role 
in signal amplification processes for various cellular stress responses, including DNA repair and 
nuclear factor κB (NF-κB) activation (Oh et al., 2018). Their role in signaling has recently 
expanded to translation, as it was reported that K63-linked ubiquitylation of ribosomal proteins 
activates multiple downstream quality control pathways, and the modification by Hel2 provides a 
platform for the interaction of ribosomes with other E3s or regulatory components (Ikeuchi et al., 




Finally, we recently reported that RQC and ISR are activated by similar signals and 
antagonize each other’s activity (Yan and Zaher, 2021). Indeed, many of the stressors that activate 
ISR also modify nucleic acids and often disrupt their functional properties. These changes to the 
chemical structure of the nucleobase can alter the metabolic processes while compromising 
replication, transcription and translation (Yan and Zaher, 2019a). To address this challenge, 
multiple signaling processes that include DNA damage response (DDR) and ribosome-quality 
control (RQC)(Yan and Zaher, 2019b) have evolved to maintain genome integrity and cellular 
proteostasis, respectively. How these activities of ISR, DDR and RQC are coordinated under stress 
conditions is currently unclear. Altogether, we hypothesize that ribosome ubiquitination, resulting 
from damaged mRNAs, could be read for downstream expression of stress genes.  
To address this hypothesis, and as a proof of concept, I first analyzed the RNAseq data 
generated from WT and Hel2 deletion mutants that are treated with MMS. Our preliminary data 
show that the expression level of DDR gene (RNR3) increases 100 fold in the presence of MMS, 
which is validated by qRT-PCR analysis (Figure 1). To further reinforce our hypothesis that the 
DDR response is directly dependent on translation, we pretreated cells with cycloheximide. 
Inhibiting transition before the addition of a DNA damaging agent almost completely inhibited the 
induction of DDR gene (RNR3). Similar suppression of RNR genes after MMS treatment was 







Figure 1. RNR3 activation in response to alkylation is reduced in the absence of Hel2 and 
Not4.  
A,B) Bar graph showing the relative transcript levels of RNR3 as assessed by qRT-PCR. Means 
and SD of three biological repeats are plotted. 
 
This is interesting because genes encoding the ribonucleotide reductase complex, responsible for 
generating dNTPs, are an integral part of this pathway, as many DNA-repair pathways are 
replication-based and require dNTPs (Chabes et al., 2003). For instance, a DNA damaging agent 
such as MMS strongly induces the transcription of RNR3 (Zhou and Elledge, 1992), and as such 
the abundance of RNR3 has served as an important diagnostic in dissecting how DDR is activated. 
More importantly, there is a potential overlap between RQC and DDR, since a high-throughput 



























































































al., 2013), while the induction of the RNR genes also requires the presence of Not4, an E3 ligase 
that has roles in RQC, transcription, mRNA decay (Mulder et al., 2005). All these observations 
point to a role for Hel2 in DDR, but whether its relationship with the ribosome is related to DDR 
is unknown.  
In the effort to explore the mechanism by which Hel2 is contributing to DDR activation 
and RQC activation, studies such as epistatic analysis that explore how deletion of HEL2 affects 
RNR3 induction in the presence of DDR-signaling mutants would provide clues as to whether Hel2 
contributes to DDR. We can use the alpha factor of yeast in combination with MMS to uncover 1) 
whether the connection between Hel2 and DDR is cell cycle related, and 2) the specific DDR 
pathway that is activated by Hel2. The result would be further validated by evaluating the 
accumulation of phosphorylated factors, such as Rad53, using western blotting in the presence and 
absence of Hel2. Furthermore, the phosphorylation status of Hel2 can be quantified by using 
western blotting technique such as Phos-tag acrylamide (Fujifilm) in the presence and absence of 
DDR kinases such as Rad53 and Dun1. Finally, the phosphorylation sites of Hel2 can be mapped 
by LC-MS/MS, and phospho-dead mutations of Hel2 will be studied for their function in DDR 
and RQC signaling. Together, these experiments will provide information on whether Hel2 is an 
integral part of DDR signaling or serves as an alternative signaling pathway.  
We should next assess the localization of Hel2 during stress response. Hel2 is known to 
recognize and ubiquitinate collided ribosomes in the cytosol,(Ikeuchi et al., 2019a; Juszkiewicz et 
al., 2018) yet if Hel2 is a substrate of Rad53 during stress response, and since the Rad53 is a known 
nuclear protein (Smolka et al., 2006), then the localization of Hel2 upon the addition of MMS 




To achieve this goal, we will monitor the dynamic of the localization of Hel2 through 1) 
immunoblotting with subcellular fractionation (Oh et al., 2020) of a strain of Hel2 tagged with 
Flag epitope tag; 2) with fluorescence microscopy with GFP-tagged Hel2 in the presence or 
absence of stressors such as MMS. If Hel2 localizes to nucleus upon stress, we will assess whether 
this nuclear localization is important for its function in DDR and/or RQC. The result will be further 
validated by tagging the endogenous HEL2 gene with a nuclear-export signal (NES) from protein 
kinase A inhibitor (PKI) (Fornerod et al., 1997). We should evaluate the impact of localization of 
Hel2 on both RNR3 induction and ubiquitination of ribosomal proteins upon the addition of MMS. 
The results of these experiments will provide clues as to whether the nuclear localization of Hel2 
contributes to its function in DDR and RQC.  
If nuclear localization of Hel2 is important, we should determine how it might be regulating 
the recruitment of RNA polymerase II (pol II) to DDR gene loci such as RNRs. Since Hel2 was 
initially identified as a histone E3 ligase that removes excessive histone during stress condition 
(Singh et al., 2012), it is possible that Hel2 is recruited to the promoter regions of DDR genes upon 
stress and making the DNA accessible for transcription machinery. Interestingly, by reanalyzing 
previously published immunoprecipitation mass spectrometry data of Hel2 without any treatment 
(Sitron et al., 2017), I identified that all core components of polymerase-associated factor 1 (Paf1) 
complex (Paf1C) potentially interact with Hel2, with Ctr9 being the one with the highest hits. It 
has been suggested that Paf1C plays a vital role in transcriptional elongation and chromatin 
modifications (Jaehning, 2010; Tomson and Arndt, 2013; Xie et al., 2018). In summary, PAF1C 
is recruited to pol II through CTR9 (Kim et al., 2010). Aside from its interactions with the 




procession (Kim et al., 2010; Krogan et al., 2002; Squazzo et al., 2002; Xie et al., 2018). As a 
result, the interaction between Hel2 and Paf1C might be one of the mechanisms through which 
Hel2 is recruited to the promoter regions of DDR genes. To test this hypothesis, we should first 
validate the interaction between Hel2 and Ctr9 through immunoblotting. We should then perform 
chromatin immunoprecipitation analysis using a tagged Hel2 (C-terminal). After validating the 
function of the tagged Hel2 for RQC activation and MMS-induced RNR3 induction, we will 
examine the recruitment of Hel2 to the RNR loci upon the MMS treatment with or without Ctr9 
using a ChIP-grade myc antibody. ChIP analysis on RNAP II will be conducted to monitor its 
recruitment to the same loci in the presence and absence of Hel2 and/or Ctr9. The role of Paf1C in 
regulating the function of Hel2 will be further investigated by monitoring 1) the localization of 
Hel2 in the absence and presence of Ctr9, 2) the amount of excessive H3 in the presence and 
absence of Ctr9 and/or Hel2, and 3) the MMS-induced expression of RNR3 in the presence and 
absence of Ctr9 and/or Hel2. Since phosphorylation status regulates protein interactions, it would 
be informative to investigate the interaction between Ctr9 and phosphor-dead mutant of Hel2 
through immunoblotting. And finally, in the effort to map the interactome of Hel2 and its partners 
during DNA damage response, we should preform immunoprecipitation mass spectrometry of 
tagged Hel2 (flag) with or without NES in the presence or absence of MMS. These results would 
provide evidence to support the function of Hel2 in facilitating Pol II and the transcription 
machinery during stress condition.   
The next question to address is which domains of Hel2 are important for its role in DDR 





Figure 2. RNR3 activation in response to alkylation in K to R mutation in eS7, uS3 and 
uS10.  
RNR3 is significantly reduced in ubiquitin K to R mutation in eS7 (A) but not in uS3 and uS10 
ubiquitin K to R mutation (B,C). Bar graph showing the relative transcript levels of RNR3 as 
assessed by qRT-PCR. Means and SD of three biological repeats are plotted. 
 
type zinc-finger domains and a proline-rich domain at its C-terminus (Winz et al., 2019). In terms  
of the function of domains related to ribosome quality control, deletion of the RING domain or 
mutations of conserved cysteines in its ZnF completely abrogates NGD and RQC, whereas a 
protein lacking the C-terminal domain only fails to activate RQC, and instead activates a different 
branch of NGD (Ikeuchi et al., 2019c). The function of the domains can be investigated by 
complementing the deletion strain with truncation/single-point mutants of the protein. Moreover, 
studying the impact of these mutations on 1) the localization of Hel2, 2) the interaction with Paf1C 
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components, and 3) the autophosphorylation with Rad53 will give us important clues about how 
signaling to DDR might be propagated from a stalled ribosome. 
Having characterized the involvement of Hel2 during DDR, we should investigate the role 
of ribosomal-protein ubiquitination in activating the factor responsible for relaying signals to the 
nucleus. Since Hel2 modifies many ribosomal proteins upon stalling, instead of mutating Hel2, we 
should focus on identifying the ribosomal protein/s responsible for initiating the signal. Moreover, 
many Hel2 targets appear to serve independent roles in downstream signaling pathways. For 
instance, uS10 ubiquitination is required for RQC (Ikeuchi et al., 2019c), whereas that of uS3 is 
important for nonfunctional ribosome decay (NRD) (Sugiyama et al., 2019b). Hence, the 
regulation of DDR might be achieved through the ubiquitination of one of the ribosomal proteins. 
What makes this appealing is the fact that many of the agents that cause DNA damage also modify 
RNA and lead to ribosome stalling. As a result, it makes sense for crosstalk to occur between the 
two processes.  
Based on our previous work using mass-spec analysis that identified lysine residues on 
ribosomal proteins that are targeted by Hel2 (Yan et al., 2019), we generated lysine to arginine 
mutations that compromise the major ubiquitination events involving ribosomal proteins such as 
eS7, uS3 and uS10. We then measured their effect on MMS activation of RNR3. Our preliminary 
data shows that the mutations on eS7 reduces the induction of RNR3 significantly upon MMS 
treatment (Figure 2). This result indicates that the ubiquitination events on different ribosomal 
proteins upon ribosome stalling impact DDR differently. Since eS7 is first modified by another E3 
ligase (Not4) before Hel2 adds K63-linked chains, it is possible that Not4 also plays a role in 




by the observation that NOT4 deletion reduces MMS induced RNR3 expression to about 10 times 
lower than that of HEL2 mutants. The role of Not4 in connecting RQC to DDR remains unclear, 
but genetic and biochemistry data indicates that its role extends from RQC to mRNA decay and 




CONCLUSIONS OF THE THESIS  
 The overarching goal of my thesis research was to understand how elongating ribosomes 
signal to and impact conserved stress-related pathways in eukaryotes. For my research, we first 
identified a molecular rationale for how quality-control factors can identify stalled ribosomes 
while demonstrating that ribosome collisions are required to trigger NGD and RQC. To investigate 
the role of the ribosome as a platform for downstream signaling events, we revealed that both ISR 
and ribosome-quality control (RQC) mitigate translational stresses caused by ribosome stalling. 
Moreover, we provided evidence that the inactivation of one pathway was found to result in the 
over-activation of the other, with RQC activation occurring at a lower frequency of collisions. In 
contrast, the activation of ISR required a high frequency of collisions and was sensitive to the 
status of the A site of the ribosome.  
As our work has shown that ribosome collisions caused by chemically damaged mRNA 
occur frequently, it is possible that pathways such as ISR, which are also activated by ribosome 
collisions but drastically alter cellular function, need to be managed with additional controls. As 
the field progresses, this data will be integral to our understanding of how cells adjust cellular 
response based on the severity of the stress for survival. This data also revealed an additional layer 
of regulation during the coordination of multiple signaling events that likely extends to other 
biological systems. 
 One exciting discovery during my thesis work is that modifications on the ribosome as a 
result of stresses such as the addition of damaging agents happens much faster than DNA damage 
responses. Our preliminary data indicates that there is likely to be cross-talk between RQC and 




might have a role in removing histone for transcription machinery to access DDR genes. Future 
discoveries are needed to fully appreciate and understand the complexity and beauty of 
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